{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os \n",
    "import spacy\n",
    "import re\n",
    "import pandas as pd\n",
    "\n",
    "nlp = spacy.load('en_core_web_sm')\n",
    "\n",
    "files = [f for f in os.listdir(\"data/\") if f.endswith('txt')]\n",
    "def readFiles(filename='5369.txt', dirname='data/'):\n",
    "    return open(dirname+filename).read().replace('\\n', ' ')\n",
    "def stitch_words(text):\n",
    "    return re.sub(r'- ',r'', text)\n",
    "def getNC(doc):\n",
    "    return [[chunk.text, chunk.root.text, chunk.root.dep_,\n",
    "              chunk.root.head.text] for chunk in doc.noun_chunks]\n",
    "def getNER(doc):\n",
    "    return [[ents.text, ents.label_, ents.start, ents.end] for ents in doc.ents]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>filename</th>\n",
       "      <th>rawContent</th>\n",
       "      <th>doc</th>\n",
       "      <th>NC</th>\n",
       "      <th>NER</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1003.txt</td>\n",
       "      <td>ORIGINAL ARTICLE The Epidemiology of Panic Att...</td>\n",
       "      <td>(ORIGINAL, ARTICLE, The, Epidemiology, of, Pan...</td>\n",
       "      <td>[[ORIGINAL ARTICLE, ARTICLE, ROOT, ARTICLE], [...</td>\n",
       "      <td>[[Panic Disorder, ORG, 8, 10], [Agoraphobia, G...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1007.txt</td>\n",
       "      <td>ORIGINAL ARTICLE Lifetime Prevalence and Age-o...</td>\n",
       "      <td>(ORIGINAL, ARTICLE, Lifetime, Prevalence, and,...</td>\n",
       "      <td>[[ORIGINAL ARTICLE Lifetime Prevalence, Preval...</td>\n",
       "      <td>[[the National Comorbidity Survey Replication ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>1005.txt</td>\n",
       "      <td>MarketWatch Medicaid Cost Containment And Acce...</td>\n",
       "      <td>(MarketWatch, Medicaid, Cost, Containment, And...</td>\n",
       "      <td>[[MarketWatch Medicaid Cost Containment, Conta...</td>\n",
       "      <td>[[MarketWatch Medicaid Cost Containment And Ac...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>1006.txt</td>\n",
       "      <td>Unmet Need for Personal Assistance Services: E...</td>\n",
       "      <td>(Unmet, Need, for, Personal, Assistance, Servi...</td>\n",
       "      <td>[[Unmet, Unmet, nsubj, Need], [Personal Assist...</td>\n",
       "      <td>[[Hours, TIME, 11, 12], [Mitchell P. LaPlante,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>1001.txt</td>\n",
       "      <td>ANNALS OF FAMILY MEDICINE  WWW.ANNFAMMED.ORG  ...</td>\n",
       "      <td>(ANNALS, OF, FAMILY, MEDICINE,  , WWW.ANNFAMME...</td>\n",
       "      <td>[[FAMILY MEDICINE, MEDICINE, pobj, OF], [AUGUS...</td>\n",
       "      <td>[[FAMILY MEDICINE, ORG, 2, 4], [1, CARDINAL, 9...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   filename                                         rawContent  \\\n",
       "0  1003.txt  ORIGINAL ARTICLE The Epidemiology of Panic Att...   \n",
       "1  1007.txt  ORIGINAL ARTICLE Lifetime Prevalence and Age-o...   \n",
       "2  1005.txt  MarketWatch Medicaid Cost Containment And Acce...   \n",
       "3  1006.txt  Unmet Need for Personal Assistance Services: E...   \n",
       "4  1001.txt  ANNALS OF FAMILY MEDICINE  WWW.ANNFAMMED.ORG  ...   \n",
       "\n",
       "                                                 doc  \\\n",
       "0  (ORIGINAL, ARTICLE, The, Epidemiology, of, Pan...   \n",
       "1  (ORIGINAL, ARTICLE, Lifetime, Prevalence, and,...   \n",
       "2  (MarketWatch, Medicaid, Cost, Containment, And...   \n",
       "3  (Unmet, Need, for, Personal, Assistance, Servi...   \n",
       "4  (ANNALS, OF, FAMILY, MEDICINE,  , WWW.ANNFAMME...   \n",
       "\n",
       "                                                  NC  \\\n",
       "0  [[ORIGINAL ARTICLE, ARTICLE, ROOT, ARTICLE], [...   \n",
       "1  [[ORIGINAL ARTICLE Lifetime Prevalence, Preval...   \n",
       "2  [[MarketWatch Medicaid Cost Containment, Conta...   \n",
       "3  [[Unmet, Unmet, nsubj, Need], [Personal Assist...   \n",
       "4  [[FAMILY MEDICINE, MEDICINE, pobj, OF], [AUGUS...   \n",
       "\n",
       "                                                 NER  \n",
       "0  [[Panic Disorder, ORG, 8, 10], [Agoraphobia, G...  \n",
       "1  [[the National Comorbidity Survey Replication ...  \n",
       "2  [[MarketWatch Medicaid Cost Containment And Ac...  \n",
       "3  [[Hours, TIME, 11, 12], [Mitchell P. LaPlante,...  \n",
       "4  [[FAMILY MEDICINE, ORG, 2, 4], [1, CARDINAL, 9...  "
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.DataFrame(files, columns=['filename'])\n",
    "df['rawContent'] = [stitch_words(readFiles(i)) for i in df.filename]\n",
    "df['doc'] = [nlp(i) for i in df.rawContent]\n",
    "df['NC'] = [getNC(i) for i in df.doc]\n",
    "df['NER'] = [getNER(i) for i in df.doc]\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "df['NERF'] = [[e for e in i if e[1]=='ORG'] for i in df.NER]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>filename</th>\n",
       "      <th>rawContent</th>\n",
       "      <th>doc</th>\n",
       "      <th>NC</th>\n",
       "      <th>NER</th>\n",
       "      <th>NERF</th>\n",
       "      <th>sents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1003.txt</td>\n",
       "      <td>ORIGINAL ARTICLE The Epidemiology of Panic Att...</td>\n",
       "      <td>(ORIGINAL, ARTICLE, The, Epidemiology, of, Pan...</td>\n",
       "      <td>[[ORIGINAL ARTICLE, ARTICLE, ROOT, ARTICLE], [...</td>\n",
       "      <td>[[Panic Disorder, ORG, 8, 10], [Agoraphobia, G...</td>\n",
       "      <td>[[Panic Disorder, ORG, 8, 10], [the National C...</td>\n",
       "      <td>[(ORIGINAL, ARTICLE, The, Epidemiology, of, Pa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1007.txt</td>\n",
       "      <td>ORIGINAL ARTICLE Lifetime Prevalence and Age-o...</td>\n",
       "      <td>(ORIGINAL, ARTICLE, Lifetime, Prevalence, and,...</td>\n",
       "      <td>[[ORIGINAL ARTICLE Lifetime Prevalence, Preval...</td>\n",
       "      <td>[[the National Comorbidity Survey Replication ...</td>\n",
       "      <td>[[the National Comorbidity Survey Replication ...</td>\n",
       "      <td>[(ORIGINAL, ARTICLE, Lifetime, Prevalence, and...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>1005.txt</td>\n",
       "      <td>MarketWatch Medicaid Cost Containment And Acce...</td>\n",
       "      <td>(MarketWatch, Medicaid, Cost, Containment, And...</td>\n",
       "      <td>[[MarketWatch Medicaid Cost Containment, Conta...</td>\n",
       "      <td>[[MarketWatch Medicaid Cost Containment And Ac...</td>\n",
       "      <td>[[MarketWatch Medicaid Cost Containment And Ac...</td>\n",
       "      <td>[(MarketWatch, Medicaid, Cost, Containment, An...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>1006.txt</td>\n",
       "      <td>Unmet Need for Personal Assistance Services: E...</td>\n",
       "      <td>(Unmet, Need, for, Personal, Assistance, Servi...</td>\n",
       "      <td>[[Unmet, Unmet, nsubj, Need], [Personal Assist...</td>\n",
       "      <td>[[Hours, TIME, 11, 12], [Mitchell P. LaPlante,...</td>\n",
       "      <td>[[Charlene Harrington Disability Statistics Ce...</td>\n",
       "      <td>[(Unmet, Need, for, Personal, Assistance, Serv...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>1001.txt</td>\n",
       "      <td>ANNALS OF FAMILY MEDICINE  WWW.ANNFAMMED.ORG  ...</td>\n",
       "      <td>(ANNALS, OF, FAMILY, MEDICINE,  , WWW.ANNFAMME...</td>\n",
       "      <td>[[FAMILY MEDICINE, MEDICINE, pobj, OF], [AUGUS...</td>\n",
       "      <td>[[FAMILY MEDICINE, ORG, 2, 4], [1, CARDINAL, 9...</td>\n",
       "      <td>[[FAMILY MEDICINE, ORG, 2, 4], [HMO, ORG, 43, ...</td>\n",
       "      <td>[(ANNALS, OF, FAMILY, MEDICINE,  , WWW.ANNFAMM...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   filename                                         rawContent  \\\n",
       "0  1003.txt  ORIGINAL ARTICLE The Epidemiology of Panic Att...   \n",
       "1  1007.txt  ORIGINAL ARTICLE Lifetime Prevalence and Age-o...   \n",
       "2  1005.txt  MarketWatch Medicaid Cost Containment And Acce...   \n",
       "3  1006.txt  Unmet Need for Personal Assistance Services: E...   \n",
       "4  1001.txt  ANNALS OF FAMILY MEDICINE  WWW.ANNFAMMED.ORG  ...   \n",
       "\n",
       "                                                 doc  \\\n",
       "0  (ORIGINAL, ARTICLE, The, Epidemiology, of, Pan...   \n",
       "1  (ORIGINAL, ARTICLE, Lifetime, Prevalence, and,...   \n",
       "2  (MarketWatch, Medicaid, Cost, Containment, And...   \n",
       "3  (Unmet, Need, for, Personal, Assistance, Servi...   \n",
       "4  (ANNALS, OF, FAMILY, MEDICINE,  , WWW.ANNFAMME...   \n",
       "\n",
       "                                                  NC  \\\n",
       "0  [[ORIGINAL ARTICLE, ARTICLE, ROOT, ARTICLE], [...   \n",
       "1  [[ORIGINAL ARTICLE Lifetime Prevalence, Preval...   \n",
       "2  [[MarketWatch Medicaid Cost Containment, Conta...   \n",
       "3  [[Unmet, Unmet, nsubj, Need], [Personal Assist...   \n",
       "4  [[FAMILY MEDICINE, MEDICINE, pobj, OF], [AUGUS...   \n",
       "\n",
       "                                                 NER  \\\n",
       "0  [[Panic Disorder, ORG, 8, 10], [Agoraphobia, G...   \n",
       "1  [[the National Comorbidity Survey Replication ...   \n",
       "2  [[MarketWatch Medicaid Cost Containment And Ac...   \n",
       "3  [[Hours, TIME, 11, 12], [Mitchell P. LaPlante,...   \n",
       "4  [[FAMILY MEDICINE, ORG, 2, 4], [1, CARDINAL, 9...   \n",
       "\n",
       "                                                NERF  \\\n",
       "0  [[Panic Disorder, ORG, 8, 10], [the National C...   \n",
       "1  [[the National Comorbidity Survey Replication ...   \n",
       "2  [[MarketWatch Medicaid Cost Containment And Ac...   \n",
       "3  [[Charlene Harrington Disability Statistics Ce...   \n",
       "4  [[FAMILY MEDICINE, ORG, 2, 4], [HMO, ORG, 43, ...   \n",
       "\n",
       "                                               sents  \n",
       "0  [(ORIGINAL, ARTICLE, The, Epidemiology, of, Pa...  \n",
       "1  [(ORIGINAL, ARTICLE, Lifetime, Prevalence, and...  \n",
       "2  [(MarketWatch, Medicaid, Cost, Containment, An...  \n",
       "3  [(Unmet, Need, for, Personal, Assistance, Serv...  \n",
       "4  [(ANNALS, OF, FAMILY, MEDICINE,  , WWW.ANNFAMM...  "
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from nltk.tokenize import sent_tokenize, word_tokenize\n",
    "\n",
    "df['sents'] = [[nlp(j) for j in sent_tokenize(i)] for i in df.rawContent]\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 118,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>filename</th>\n",
       "      <th>rawContent</th>\n",
       "      <th>doc</th>\n",
       "      <th>NC</th>\n",
       "      <th>NER</th>\n",
       "      <th>NERF</th>\n",
       "      <th>docF</th>\n",
       "      <th>sents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1003.txt</td>\n",
       "      <td>ORIGINAL ARTICLE The Epidemiology of Panic Att...</td>\n",
       "      <td>(ORIGINAL, ARTICLE, The, Epidemiology, of, Pan...</td>\n",
       "      <td>[[ORIGINAL ARTICLE, ARTICLE, ROOT, ARTICLE], [...</td>\n",
       "      <td>[[Panic Disorder, ORG, 8, 10], [Agoraphobia, G...</td>\n",
       "      <td>[[Panic Disorder, ORG, 8, 10], [the National C...</td>\n",
       "      <td>ORIGINAL ARTICLE The Epidemiology of Panic Att...</td>\n",
       "      <td>[(ORIGINAL, ARTICLE, The, Epidemiology, of, Pa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1007.txt</td>\n",
       "      <td>ORIGINAL ARTICLE Lifetime Prevalence and Age-o...</td>\n",
       "      <td>(ORIGINAL, ARTICLE, Lifetime, Prevalence, and,...</td>\n",
       "      <td>[[ORIGINAL ARTICLE Lifetime Prevalence, Preval...</td>\n",
       "      <td>[[the National Comorbidity Survey Replication ...</td>\n",
       "      <td>[[the National Comorbidity Survey Replication ...</td>\n",
       "      <td>ORIGINAL ARTICLE The Epidemiology of Panic Att...</td>\n",
       "      <td>[(ORIGINAL, ARTICLE, Lifetime, Prevalence, and...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>1005.txt</td>\n",
       "      <td>MarketWatch Medicaid Cost Containment And Acce...</td>\n",
       "      <td>(MarketWatch, Medicaid, Cost, Containment, And...</td>\n",
       "      <td>[[MarketWatch Medicaid Cost Containment, Conta...</td>\n",
       "      <td>[[MarketWatch Medicaid Cost Containment And Ac...</td>\n",
       "      <td>[[MarketWatch Medicaid Cost Containment And Ac...</td>\n",
       "      <td>ORIGINAL ARTICLE The Epidemiology of Panic Att...</td>\n",
       "      <td>[(MarketWatch, Medicaid, Cost, Containment, An...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>1006.txt</td>\n",
       "      <td>Unmet Need for Personal Assistance Services: E...</td>\n",
       "      <td>(Unmet, Need, for, Personal, Assistance, Servi...</td>\n",
       "      <td>[[Unmet, Unmet, nsubj, Need], [Personal Assist...</td>\n",
       "      <td>[[Hours, TIME, 11, 12], [Mitchell P. LaPlante,...</td>\n",
       "      <td>[[Charlene Harrington Disability Statistics Ce...</td>\n",
       "      <td>ORIGINAL ARTICLE The Epidemiology of Panic Att...</td>\n",
       "      <td>[(Unmet, Need, for, Personal, Assistance, Serv...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>1001.txt</td>\n",
       "      <td>ANNALS OF FAMILY MEDICINE  WWW.ANNFAMMED.ORG  ...</td>\n",
       "      <td>(ANNALS, OF, FAMILY, MEDICINE,  , WWW.ANNFAMME...</td>\n",
       "      <td>[[FAMILY MEDICINE, MEDICINE, pobj, OF], [AUGUS...</td>\n",
       "      <td>[[FAMILY MEDICINE, ORG, 2, 4], [1, CARDINAL, 9...</td>\n",
       "      <td>[[FAMILY MEDICINE, ORG, 2, 4], [HMO, ORG, 43, ...</td>\n",
       "      <td>ORIGINAL ARTICLE The Epidemiology of Panic Att...</td>\n",
       "      <td>[(ANNALS, OF, FAMILY, MEDICINE,  , WWW.ANNFAMM...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   filename                                         rawContent  \\\n",
       "0  1003.txt  ORIGINAL ARTICLE The Epidemiology of Panic Att...   \n",
       "1  1007.txt  ORIGINAL ARTICLE Lifetime Prevalence and Age-o...   \n",
       "2  1005.txt  MarketWatch Medicaid Cost Containment And Acce...   \n",
       "3  1006.txt  Unmet Need for Personal Assistance Services: E...   \n",
       "4  1001.txt  ANNALS OF FAMILY MEDICINE  WWW.ANNFAMMED.ORG  ...   \n",
       "\n",
       "                                                 doc  \\\n",
       "0  (ORIGINAL, ARTICLE, The, Epidemiology, of, Pan...   \n",
       "1  (ORIGINAL, ARTICLE, Lifetime, Prevalence, and,...   \n",
       "2  (MarketWatch, Medicaid, Cost, Containment, And...   \n",
       "3  (Unmet, Need, for, Personal, Assistance, Servi...   \n",
       "4  (ANNALS, OF, FAMILY, MEDICINE,  , WWW.ANNFAMME...   \n",
       "\n",
       "                                                  NC  \\\n",
       "0  [[ORIGINAL ARTICLE, ARTICLE, ROOT, ARTICLE], [...   \n",
       "1  [[ORIGINAL ARTICLE Lifetime Prevalence, Preval...   \n",
       "2  [[MarketWatch Medicaid Cost Containment, Conta...   \n",
       "3  [[Unmet, Unmet, nsubj, Need], [Personal Assist...   \n",
       "4  [[FAMILY MEDICINE, MEDICINE, pobj, OF], [AUGUS...   \n",
       "\n",
       "                                                 NER  \\\n",
       "0  [[Panic Disorder, ORG, 8, 10], [Agoraphobia, G...   \n",
       "1  [[the National Comorbidity Survey Replication ...   \n",
       "2  [[MarketWatch Medicaid Cost Containment And Ac...   \n",
       "3  [[Hours, TIME, 11, 12], [Mitchell P. LaPlante,...   \n",
       "4  [[FAMILY MEDICINE, ORG, 2, 4], [1, CARDINAL, 9...   \n",
       "\n",
       "                                                NERF  \\\n",
       "0  [[Panic Disorder, ORG, 8, 10], [the National C...   \n",
       "1  [[the National Comorbidity Survey Replication ...   \n",
       "2  [[MarketWatch Medicaid Cost Containment And Ac...   \n",
       "3  [[Charlene Harrington Disability Statistics Ce...   \n",
       "4  [[FAMILY MEDICINE, ORG, 2, 4], [HMO, ORG, 43, ...   \n",
       "\n",
       "                                                docF  \\\n",
       "0  ORIGINAL ARTICLE The Epidemiology of Panic Att...   \n",
       "1  ORIGINAL ARTICLE The Epidemiology of Panic Att...   \n",
       "2  ORIGINAL ARTICLE The Epidemiology of Panic Att...   \n",
       "3  ORIGINAL ARTICLE The Epidemiology of Panic Att...   \n",
       "4  ORIGINAL ARTICLE The Epidemiology of Panic Att...   \n",
       "\n",
       "                                               sents  \n",
       "0  [(ORIGINAL, ARTICLE, The, Epidemiology, of, Pa...  \n",
       "1  [(ORIGINAL, ARTICLE, Lifetime, Prevalence, and...  \n",
       "2  [(MarketWatch, Medicaid, Cost, Containment, An...  \n",
       "3  [(Unmet, Need, for, Personal, Assistance, Serv...  \n",
       "4  [(ANNALS, OF, FAMILY, MEDICINE,  , WWW.ANNFAMM...  "
      ]
     },
     "execution_count": 118,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 119,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'ORIGINAL ARTICLE The Epidemiology of Panic Attacks , <NER> , and <NER> in <NER> , <NER> ; <NER> , AM ; <NER> , <NER> ; <NER> , <NER> ; <NER> , <NER> ; <NER> , <NER> : Only limited information exists about the epidemiology of <NER> panic attacks ( PAs ) and panic disorder ( <NER> ) . Objective : To present nationally representative data about the epidemiology of PAs and <NER> with or without agoraphobia ( <NER> ) on the basis of <NER> findings . Design and Setting : Nationally representative faceto - face household survey conducted using the fully structured <NER> . Participants : <NER> - speaking respondents ( N=9282 ) <NER> . Main Outcome Measures : RespondentswhometDSMIV lifetime criteria for PAs and <NER> with and without <NER> . Results : <NER> prevalence estimates are <NER> for isolated panic without <NER> only ) , <NER> for <NER> with <NER> without <NER> ) , <NER> for <NER> without <NER> ( <NER> only ) , and <NER> for <NER> ) . <NER> , lifetime number of attacks , and number of <NER> with attacks increase monotonically across these <NER> subgroups . All <NER> subgroups are significantly comorbid with other lifetime <NER> disorders , with the highest odds for <NER> and the lowest for <NER> only . Scores on <NER> are also highest for <NER> ( <NER> moderate or severe ) and lowest for <NER> only ( <NER> moderate or severe ) . <NER> is associated with substantial severity , impairment , and comorbidity . <NER> treatment is high ( from <NER> for <NER> to <NER> for <NER> only ) , but <NER> treatment meeting published treatment guidelines is low ( from <NER> for <NER> to <NER> for <NER> only ) . Conclusion : Although the major societal burden of panic is caused by <NER> and <NER> , isolated PAs also have high prevalence and meaningful role impairment . <NER> . <NER> - 424 EPIDEMIOLOGICAL SURVEY INvestigators have helped advance understanding of panic by studying the prevalence and distribution,1 - <NER> onset and course,4 associations with comorbid <NER> and societal costs.8,9 Despite these advances , important questions remain unanswered about the epidemiology of panic,10 among the most important of them regarding the finding that many people have isolated panic attacks ( PAs ) that do not meet criteria for panic disorder ( <NER> ) . These people have elevated prevalence of other mental disorders.6,11 They report greater impairment , use of psychotropic medication , and psychiatric help - seeking than people with many <NER> I disorders.8 Such findings have led to the view that PAs are fairly nonspecific risk markers for psychopathology.12 Some people with isolated PAs meet criteria for agoraphobia ( AG).13 It is not known , though , whether the persistent course and poor outcome associated with <NER> among people with PD14 also apply to PAs with <NER> . As a result , the boundary between <NER> and <NER> and the relative role of <NER> within each are not well understood . Investigation and comparison of these symptom presentations in community samplesmighthelpclarifytheseissues . The current report presents initial data of this sort from the recently completed <NER> ( <NER> ) . METHODS SAMPLE The <NER> is a nationally representative survey of <NER> <NER> - speaking household residents18yearsorolderinthecoterminousUnited States . Face - to - face interviews were performed <NER> and <NER> . The response rate was <NER> . <NER> was oral rather Author Affiliations : <NER> , <NER> , <NER> , <NER> ( <NER> and <NER> , <NER> and <NER> , and <NER> ) ; and <NER> and Clinic , <NER> , Pa ( Dr Shear ) . ( <NER> , <NER> 2006 WWW.ARCHGENPSYCHIATRY.COM <NER> © <NER> <NER> . All rights reserved . Downloaded From : http://archpsyc.jamanetwork.com/ on 04/10/2014 \\x0c than written to parallel the baseline <NER> procedures . The human subjects committees of <NER> , <NER> ) and <NER> ( <NER> ) approved the <NER> recruitment and consent procedures . Respondents were interviewed in <NER> parts . The part <NER> interview , administered to all respondents , included the core diagnostic assessment . The part <NER> interview , administered to all part <NER> respondents who met criteria for any lifetime core disorder plus a probability subsample of others ( for a total of <NER> part <NER> respondents ) , was used to assess correlates and disorders of secondary interest . The part <NER> sample is used here to examine prevalence and course , clinical severity and role impairment , and most aspects of comorbidity . The part <NER> sample is used to examine comorbidity with disorders of <NER> interest to the survey , sociodemographic correlates , and treatment . The part <NER> sample was weighted to adjust for differential probability of selection and discrepancies between the sample and the <NER> population concerning census sociodemographic and geographic variables . The part <NER> sample was weighted additionally to adjust for differential probability of selection from the part <NER> sample . More details on <NER> sampling and weights are reported elsewhere.15 PANIC AND <NER> and <NER> were assessed using <NER> version of <NER> ( CIDI),16 a fully structured lay - administered diagnostic interview ( available at www.hcp.med.harvard.edu/wmhcidi ) . The assessment of panic was comparable to that in previous versions of the <NER> , except that a distinction was made between uncued PAs ( described as occurring \" out of the blue \" with no triggering event ) and cued PAs . A series of parallel questions was asked about each of these 2 types of attacks . Panic disorder was defined as the occurrence of <NER> or more uncued PAs not caused by substance use or a general medical condition accompanied by <NER> or more of persistent concern about recurrence , worry about the implications of the attacks , or significant change in behavior because of the attacks . <NER> was defined as anxiety about <NER> or more situations that had to include being in crowds , going to public places , traveling by yourself , or traveling away from home associated with a fear of having a <NER> and fear that it might be difficult or embarrassing to escape . This fear had to result in avoidance of the feared situations , distress when exposed to these situations , or the necessity of a companion during these situations . We used these classifications to define <NER> subgroups for comparative analysis : <NER> without <NER> or <NER> only ) , <NER> with <NER> ) , <NER> without <NER> ( <NER> only ) , and <NER> with <NER> ( <NER> ) . The <NER> - only category is not a codable <NER> - IV12 disorder ; <NER> is a subset of <NER> category <NER> without a history of <NER> , excluding respondents with <NER> who never had a <NER> . This latter subgroup is not considered in this report because we focus exclusively on people with a history of panic . As detailed elsewhere,17,18 blinded clinical reappraisal interviews using the lifetime nonpatient version of <NER> ( <NER> were administered to a probability subsample of <NER> <NER> - R respondents to assess concordance with CIDI diagnoses . The CIDI - SCID concordance for <NER> diagnosis had an area under the receiver operating characteristic curve of <NER> , a moderate   value ( standard error ) of <NER> ( <NER> ) , and a high odds ratio ( OR ) of <NER> ( <NER> confidence interval , <NER> - 204.6 ) . No bias was found in the <NER> prevalence estimate compared with that in the SCID by using a <NER> test ( <NER> = <NER> , P=.82 ) . The CIDI - SCID concordance was not assessed for <NER> because <NER> was not evaluated separately in the SCID ; concordance also was not assessed for <NER> because <NER> occurred too infrequently in the clinical reappraisal study for reliable analysis of concordance . <NER> requires recurrent uncued PAs , which could be interpreted as <NER> or more , for a <NER> diagnosis . However , <NER> respondents who reported <NER> lifetime uncued PAs generally were found in the SCID to have had <NER> full <NER> with additional limited - symptom attacks . Validity of the <NER> in relation to the SCID consequently was improved when we required <NER> lifetime uncued attacks in the <NER> . The <NER> test result documents that the <NER> PD prevalence estimate does not differ significantly from the <NER> estimate despite the SCID requiring <NER> attacks . <NER> , SEVERITY , AND <NER> who met <NER> lifetime criteria for <NER> were asked to estimate the age of onset ( <NER> ) of their <NER> attack and <NER> of having <NER> uncued attacks with <NER> of persistent worry . They also were asked to estimate their age at the most recent attack , lifetime number of uncued and cued attacks , and number of <NER> with <NER> attack . Clinical severity was assessed only for 12-month cases by using a fully structured version of the <NER> Panic Disorder Severity Scale ( PDSS ) that was developed specifically for <NER> wording is posted at www.hcp.med.harvard.edu/ncs . ) The clinicianadministered version of the <NER> yields a reliable and valid assessment of overall <NER> clinical severity.20 A separate fully structured version of the <NER> , developed independently of the <NER> - R version but with similar wording , has excellent concordance with the clinician - administered version.21 Published PDSS cut points ( none , mild , moderate , or severe ) were used to define severity . Although <NER> of the <NER> PDSS questions assess role impairment , a more generic measure of role impairment , the Sheehan Disability Scale ( SDS),22 also was included in each section of the <NER> . The <NER> asked respondents with <NER> panic to focus on <NER> in <NER> when their panic , their worry about having another <NER> , or their restriction of activity because of this worry interfered most with their life and activities and to rate this interference on a <NER> to <NER> visual analog scale with response options of none ( 0 ) , mild ( <NER> - 3 ) , moderate ( <NER> ) , severe ( <NER> ) , or very severe ( <NER> ) . <NER> ratings were obtained for <NER> role domains : home management , work , social life , and personal relationships . Responses were combined by taking the highest score across the <NER> ratings and collapsing the severe and very severe response categories . <NER> The <NER> was used to assess a number of other <NER> disorders : other anxiety disorders ( generalized anxiety disorder , specific phobia , social phobia , posttraumatic stress disorder , obsessive - compulsive disorder , and adult manifestations of separation anxiety disorder ) , mood disorders ( major depressive disorder , dysthymic disorder , and bipolar disorder I or II ) , substance use disorders ( alcohol and illicit drug abuse and dependence , in which abuse and dependence on specific illicit drugs were combined with polysubstance abuse and dependence ) , and impulse - control disorders ( intermittent explosive disorder and adult manifestations of <NER> child - adolescent impulsecontrol disorders : attention - deficit / hyperactivity disorder , oppositional - defiant disorder , and conduct disorder ) . <NER> exclusion rules and diagnostic hierarchy rules were used in making all diagnoses . As reported in more detail elsewhere,18 blinded clinical reappraisal interviews using the nonpatient version of the SCID19 showed generally good concordance between <NER> and SCID diagnoses of anxiety , mood , and substance use <NER> ) ARCH GEN PSYCHIATRY / VOL 63 , <NER> 2006 WWW.ARCHGENPSYCHIATRY.COM <NER> © <NER> <NER> . All rights reserved . Downloaded From : http://archpsyc.jamanetwork.com/ on 04/10/2014 \\x0c orders , withareaunderthereceiveroperatingcharacteristiccurve in the range of <NER> to <NER> , <NER> in the range of <NER> to <NER> , and ORs in the range of <NER> to <NER> . Diagnoses of impulse - control disorders were not validated because the SCID does not assess these disorders . TREATMENT <NER> questions about lifetime and <NER> treatment of panic were asked at the end of the panic section . Part <NER> respondents additionally were asked more general questions about whether they ever received treatment for any problems with your emotions or nerves or your use of alcohol or drugs and , if so , about types of professionals <NER> was distinguished in <NER> sectors : psychiatry , nonpsychiatry mental health specialty , general medical , human services , and complementaryalternative . Questions about treatment in <NER> before interview asked about number and duration of visits ; number and duration of psychotherapy sessions ; and name , dose , and duration of each medication used . No information was obtained about the content of psychotherapy . A rough measure of <NER> guideline - concordant treatment of panic was developed using these reports on the basis of available evidencebased <NER> - concordant treatment was defined as receiving either pharmacotherapy ( <NER> of an appropriate medication , defined as antidepressants or anxiolytics,25 plus <NER> visits to any type of medical physician ) or psychotherapy ( <NER> visits with any health care or human services professional lasting an average of <NER> ) . The decision to require <NER> physician visits for pharmacotherapy was based on the recommendation of <NER> visits for medication evaluation , initiation , and monitoring during the early and continuation phases of <NER> medication treatment.24 The decision to require <NER> psychotherapy sessions was based on the fact that clinical trials demonstrating effectiveness generally have included <NER> psychotherapy <NER> Because respondents who began a course of treatment only shortly before the interview could not fulfill the requirements , we counted respondents with <NER> visits to an appropriate treatment sector if they were in treatment at the time of interview . ANALYSIS <NER> - tabulations were used to estimate prevalence and patterns of treatment . The actuarial <NER> was used to estimate <NER> distributions . Mean comparisons were used to examine illness course and severity or impairment . Logistic regression <NER> was used to estimate associations with sociodemographic variables and comorbid <NER> disorders . Because the <NER> - R sample design featured weighting and clustering , all analyses used the <NER> series design - based method,28 implemented in the <NER> software <NER> tests of sets of coefficients in the logistic regression equations were made using <NER> tests based on design - corrected coefficient variance - covariance matrices . Statistical significance was evaluated using <NER> , design - based P.05-level tests . RESULTS PREVALENCE <NER> ( standard error ) ( <NER> [ <NER> ] ) of respondents met criteria for lifetime <NER> and <NER> ( <NER> ) for 12-month <NER> , whereas <NER> ( <NER> ) of respondents ( <NER> of those with lifetime <NER> ) met criteria for lifetime <NER> and <NER> ( 0.2 ) for <NER> . <NER> <NER> of <NER> of all respondents ( <NER> of those with a lifetime <NER> ) met criteria for lifetime <NER> and <NER> ( <NER> ) for <NER> , whereas <NER> ( <NER> ) of respondents ( <NER> of those with lifetime <NER> and <NER> of those with lifetime <NER> ) met criteria for lifetime <NER> and <NER> ( <NER> ) for <NER> . <NER> As described , respondents with lifetime panic were placed into <NER> mutually exclusive subgroups ( Figure <NER> ) : PA only , <NER> of the sample ; <NER> , <NER> ; <NER> only , <NER> ; and <NER> , <NER> . A small proportion of respondents without <NER> ( <NER> with <NER> only and <NER> with <NER> ) reported a sufficient number of uncued attacks to qualify for <NER> ( with means of <NER> and <NER> lifetime uncued attacks , respectively ) but failed to meet other requirements for a <NER> diagnosis ( Table <NER> ) . Most respondents in <NER> of the <NER> subgroups , the exception being <NER> only , reported <NER> cued <NER> attack ( from <NER> in <NER> to <NER> in <NER> ) . A significantly lower <NER> of <NER> - only cases reported any cued <NER> attack . Mean number of cued attacks among those with any varies significantly across subgroups ( F3,1568 = <NER> , <NER> ) . Panic disorder is associated with a significantly higher mean number of cued attacks than <NER> among those without ( <NER> vs <NER> , <NER> , <NER> ) and those with ( <NER> vs <NER> , z=2.1 , <NER> . <NER> is associated with a significantly higher mean number of cued attacks among those with <NER> ( <NER> <NER> , z=2.4 , <NER> ) but not among those with <NER> ( <NER> vs <NER> , <NER> , <NER> ) . In the subsample of respondents who reported ever <NER> Only ( <NER> ) Any PAs ( <NER> ) <NER> Only ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) Figure <NER> . <NER> prevalence estimates of <NER> panic attacks ( PAs ) and panic disorder ( <NER> ) with and without agoraphobia ( <NER> ) . PA only indicates lifetime history of <NER> but not <NER> ; <NER> , lifetime history of <NER> with <NER> but not <NER> ; <NER> only , lifetime history of <NER> without <NER> ; <NER> , lifetime history of <NER> with <NER> . The prevalence estimates of <NER> only ( <NER> ) and <NER> ( <NER> ) sum to more than the observed <NER> prevalence of all <NER> because of rounding . ( REPRINTED ) ARCH GEN PSYCHIATRY / VOL 63 , <NER> 2006 WWW.ARCHGENPSYCHIATRY.COM <NER> <NER> <NER> . All rights reserved . Downloaded From : http://archpsyc.jamanetwork.com/ on 04/10/2014 <NER> having a cued attack , the mean number of such attacks substantially exceeds the mean number of uncued attacks in the <NER> - only subgroup ( <NER> vs <NER> , z=7.4 , <NER> ) and in <NER> subgroup ( <NER> vs 46.0 , z=4.0 , <NER> ) . No meaningful difference exists in mean <NER> among the <NER> subgroups ( <NER> ; F3,2188 = <NER> , <NER> ) ; the entire <NER> distribution is similar across these subgroups ( Figure <NER> ) . Mean AOO of <NER> is <NER> than mean <NER> and does not differ significantly between the <NER> - only and <NER> subgroups ( <NER> vs <NER> , F3,1568 = <NER> , P=.62 ) . Persistence ( <NER> prevalence of <NER> among lifetime cases ) , however , varies substantially , from <NER> in <NER> only to <NER> in <NER> ( <NER> <NER> = <NER> , <NER> ) . Persistence is significantly higher in the <NER> than PA subgroups in the absence of <NER> ( <NER> vs <NER> , z=5.4 , <NER> ) and the presence of <NER> ( <NER> vs <NER> , <NER> , P=.002 ) but does not vary as a function of <NER> either in the <NER> PA subgroups ( <NER> vs <NER> , z=0.9 , P=.34 ) or in the <NER> PD subgroups ( <NER> vs <NER> , z=0.9 , P=.36 ) . Mean number of <NER> with attacks also varies significantly across the subgroups ( F3,2188 = <NER> , <NER> ) with the same rank ordering as persistence . SOCIODEMOGRAPHIC CORRELATES We failed to find consistent variation in magnitude of significant sociodemographic correlates of lifetime prevalence across the <NER> subgroups , although the ORs associated with being female are noticeably higher for the <NER> than the <NER> subgroups , whereas the ORs associated with other employment status are noticeably higher for the <NER> than non - AG subgroups ( Table 2 ) . <NER> ( vs younger ages ) and non - <NER> blacks ( vs nonHispanic whites ) have reduced odds of panic in all <NER> subgroups , although not all are significant . Women and previously married people have consistently elevated odds of panic in all <NER> subgroups . <NER> classified as having other employment status , made up largely of the unemployed and disabled , have elevated odds of all outcomes other than <NER> only , whereas retired people have elevated odds of <NER> but not the other <NER> outcomes . None of these associations is strong in substantive terms , though , as indicated by the <NER> contingency coefficients for the set of sociodemographic predictors all being quite small ( in the range of <NER> ) . COMORBIDITY Respondents in all <NER> panic subgroups have significantly increased odds of virtually all other lifetime <NER> disorders assessed in the survey ( Table <NER> ) . <NER> or more comorbid conditions are found in <NER> of the <NER> - only <NER> . Prevalence , <NER> , and <NER> Among Respondents in 4 Mutually Exclusive Lifetime Panic Subgroups Parameter PA Only ( n = <NER> ) <NER> ( n = <NER> ) PD Only ( n = <NER> ) <NER> ( n = <NER> ) <NER> <NER> prevalence and persistence * Prevalence <NER> ( <NER> ) <NER> ( <NER> ) 3.7 ( <NER> ) <NER> ( <NER> ) <NER> Lifetime cued attacks <NER> ( <NER> ) <NER> ( <NER> ) 46.8 ( <NER> ) <NER> ( <NER> ) <NER> <NER> uncued attacks <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> F3,9278 Age of onset of <NER> <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> <NER> onset <NER> ( <NER> ) <NER> ( <NER> ) <NER> <NER> onset <NER> 19.3 ( <NER> ) <NER> ( <NER> ) 0.9 Course of illness * <NER> <NER> <NER> persistence * <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) 48.7 F3,9278 <NER> with attacks <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> <NER> <NER> cued attacks <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> <NER> uncued attacks <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> Median <NER> lifetime cued attacks <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> Median <NER> <NER> uncued attacks <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) 16.6 ( <NER> ) <NER> : <NER> , agoraphobia ; <NER> , not applicable ; <NER> , panic attack ; <NER> , panic disorder ; <NER> only , lifetime history of <NER> but not of <NER> ; <NER> , lifetime history of <NER> with <NER> but not of <NER> ; <NER> only , lifetime history of <NER> without <NER> ; <NER> , lifetime history of <NER> with <NER> . * Data are given as percentage ( standard error ) . Data are given as mean ( standard error ) unless otherwise indicated .   Significant at P=.05 , <NER> test . <NER> 80 70 60 <NER> <NER> <NER> 90 <NER> 0 0 20 10 30 50 70 90 40 <NER> PA Only <NER> PD Only <NER> 80 <NER> <NER> , y <NER> of Lifetime Prevalence Figure <NER> . Age of onset of <NER> lifetime panic attack in <NER> mutually exclusive <NER> panic subgroups ( <NER> = <NER> , <NER> ) . See legend to Figure <NER> for an explanation of abbreviations . ( REPRINTED ) ARCH GEN PSYCHIATRY / VOL <NER> , <NER> 2006 WWW.ARCHGENPSYCHIATRY.COM <NER> © <NER> <NER> . All rights reserved . Downloaded From : http://archpsyc.jamanetwork.com/ on 04/10/2014 <NER> subgroup , <NER> of the <NER> - only subgroup , and <NER> of the other <NER> subgroups . The ORs for particular comorbid conditions differ significantly across the <NER> subgroups , with the lowest ORs consistently in the <NER> - only subgroup . In the case of comorbidity with other anxiety disorders and major depression , <NER> is more important than <NER> , as shown by the <NER> ORs ( <NER> ) consistently being higher than the <NER> - only ORs ( <NER> ) and often as high as the <NER> ORs ( <NER> ) . In the case of the other mood disorders and alcohol use disorders , the <NER> ORs ( <NER> ) are comparable to the <NER> - only ORs ( <NER> ) , whereas the <NER> ORs ( <NER> - 13.6 ) are considerably larger . A distinct pattern for drug use disorders for the ORs is associated with all <NER> <NER> or <NER> subgroups to be comparable in magnitude ( <NER> ) . <NER> <NER> SEVERITY AND ROLE <NER> PDSS ratings of clinical severity vary significantly across the <NER> <NER> panic subgroups ( <NER> = <NER> , <NER> ) , with the highest ratings in the <NER> subgroup ( <NER> with moderate or severe rating , and <NER> with severe rating ) and the lowest in the <NER> - only subgroup ( <NER> with moderate or severe rating , and <NER> with severe rating ) ( Table <NER> ) . ReTable <NER> . Sociodemographic Correlates of <NER> Mutually Exclusive Lifetime Panic Subgroups * <NER> ( <NER> Confidence Interval ) PA Only ( n = <NER> ) <NER> ( n = <NER> ) PD Only ( n = <NER> ) <NER> ( n = <NER> ) Age , y <NER> <NER> <NER> 30 - 44 1.0 ( <NER> ) <NER> <NER> ( <NER> ) <NER> ( <NER> ) <NER> - 59 0.9 ( <NER> ) <NER> ( <NER> ) 1.3 ( <NER> ) <NER> <NER> ) <NER> ( <NER> ( <NER> - 3.7 ) 0.4 ( <NER> ) <NER> ( 0 - 0.2 ) <NER> <NER> <NER> <NER> <NER> <NER> <NER> <NER> ( <NER> ) 1.3 ( <NER> <NER> ( <NER> ) <NER> ( <NER> ) <NER> <NER> <NER> <NER> <NER> <NER> 0.6 ( <NER> - 0.8 ) <NER> ( <NER> - 3.2 ) <NER> <NER> - 1.3 ) 0.8 ( <NER> ) Black 0.7 ( <NER> <NER> ( <NER> ) 0.4 ( <NER> <NER> ( <NER> ) Other <NER> ( <NER> ) 2.1 ( <NER> ) <NER> ( <NER> ) 0.6 ( <NER> 1.9 ) <NER> <NER> <NER> 1.0 <NER> <NER> 5.1 <NER> , y <NER> 1.0 1.0 <NER> 1.0 <NER> ( <NER> ) 0.7 ( <NER> 0.9 ( <NER> ) <NER> ( <NER> ) <NER> 0.9 ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> 1.9 ) 0.8 ( <NER> 1.9 ) 16 0.9 ( <NER> ) <NER> ( <NER> ) <NER> <NER> - 1.2 ) <NER> ( <NER> ) <NER> 0.7 <NER> <NER> <NER> status <NER> <NER> / widowed / divorced <NER> ( <NER> ) <NER> ( <NER> ) 1.6 ( <NER> ) <NER> ( <NER> ) Never married <NER> ( <NER> ) <NER> ( <NER> - 3.2 ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> 0.5 <NER> <NER> 1.2 Employment status <NER> 0.8 ( <NER> ) <NER> <NER> ) <NER> ( 0.1 - 1.4 ) <NER> ( <NER> - 4.9 ) <NER> 0.8 ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> <NER> - 3.7 ) <NER> ( <NER> ) 1.2 ( <NER> ) <NER> ( <NER> - 1.9 ) <NER> ( <NER> ) Other <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> - 2.2 ) <NER> ( <NER> ) <NER> 1.7 <NER> 15.1 <NER> <NER> family income Low 1.2 ( <NER> - 1.6 ) 1.0 ( <NER> ) <NER> ( <NER> - 2.0 ) <NER> ( <NER> ) Low - average <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> <NER> ) High - average <NER> ( <NER> ) <NER> ( <NER> - 1.7 ) 1.3 ( <NER> ) <NER> ( <NER> ) High <NER> 1.0 <NER> <NER> 8.4 <NER> <NER> <NER> , agoraphobia ; <NER> , panic attack ; <NER> , panic disorder ; <NER> only , lifetime history of <NER> but not <NER> ; <NER> , lifetime history of <NER> with <NER> but not <NER> ; <NER> only , lifetime history of <NER> without <NER> ; <NER> , lifetime history of <NER> with <NER> . * Based on multivariate logistic regression analyses that separately compare respondents in each of the <NER> panic subgroups with respondents who have no lifetime history of panic ; the sample sizes differ because respondents in each of the <NER> mutually exclusive panic subgroups ( <NER> <NER> only , <NER> <NER> , <NER> <NER> only , and <NER> ) are compared separately with the <NER> respondents who have no history of panic . Significant at the <NER> level , <NER> test . ( <NER> , <NER> 2006 WWW.ARCHGENPSYCHIATRY.COM <NER> <NER> <NER> <NER> . All rights reserved . Downloaded From : http://archpsyc.jamanetwork.com/ on 04/10/2014 <NER> spondents in the <NER> subgroup have higher PDSS ratings ( <NER> with moderate or severe rating , and <NER> with severe rating ) than those in the <NER> - only subgroup ( <NER> with moderate or severe rating , and <NER> with severe rating ) . <NER> ratings of role impairment are similar to PDSS ratings in being highest in <NER> subgroup ( <NER> with moderate or severe rating , and <NER> with severe rating ) and lowest in the <NER> - only subgroup ( <NER> with moderate or severe rating , and <NER> with severe rating ) . Unlike PDSS ratings , however , the <NER> subgroup has lower <NER> ratings ( <NER> with moderate or severe rating , and <NER> with severe rating ) than the PDonly subgroup ( <NER> with moderate or severe rating , and <NER> with severe rating ) , although the modal rating is severe in all <NER> subgroups other than in the <NER> - only subgroup . In the latter , the modal rating is no disability ( <NER> ) . TREATMENT Most patients with <NER> obtained lifetime treatment for psychiatric problems , although somewhat more so among those with <NER> ( <NER> ) than without ( <NER> ) ( Table <NER> ) . <NER> treatment proportions are lower in <NER> ( <NER> ) and <NER> - only ( <NER> ) subgroups . The proportions that obtained panic - specific treatment are only slightly lower than overall treatment in the <NER> - only ( <NER> vs <NER> ) and <NER> ( <NER> vs <NER> ) subgroups , but substantially lower in the <NER> - only ( <NER> vs <NER> ) and <NER> ( <NER> vs <NER> ) subgroups . The most common site of treatment was the general medical sector in <NER> of the <NER> subgroups ( <NER> ) . The exception is <NER> , in which nonmedical mental health treatment ( <NER> ) is slightly more common than general medical treatment ( <NER> ) . As with lifetime treatment , the proportion of <NER> cases that received treatment in <NER> before interview is highest in the <NER> subgroup ( <NER> ) , lowest in the <NER> - only subgroup ( <NER> ) , and intermediate in <NER> ( <NER> ) and <NER> - only ( <NER> ) subgroups . Also similar to the lifetime treatment data , <NER> panic - specific treatment made up a higher proportion of all treatment in the <NER> - only ( <NER> ) and <NER> ( <NER> vs <NER> ) subgroups than in the <NER> - only ( <NER> vs <NER> ) and <NER> ( <NER> vs <NER> ) subgroups . <NER> treatment was obtained in the general medical sector more often than in any other sector in each Table <NER> . Comorbidities of <NER> Mutually Exclusive Lifetime Panic Subgroups With Other DSM - IV Disorders * Disorder PA Only <NER> Only <NER> <NER> <NER> Percentage OR ( <NER> <NER> ) Percentage OR ( <NER> <NER> ) Percentage OR ( <NER> <NER> ) Percentage OR ( <NER> <NER> ) Other anxiety disorders <NER> anxiety disorder <NER> <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> Specific phobia <NER> <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> 25.8 ( <NER> ) <NER> Social phobia <NER> <NER> ( <NER> ) <NER> 16.6 ( <NER> ) <NER> 3.1 ( <NER> ) 66.5 <NER> ( <NER> - 25.8 ) <NER> Posttraumatic stress disorder <NER> ( <NER> ) 24.2 5.8 ( <NER> - 14.6 ) <NER> <NER> ) <NER> 11.6 ( <NER> ) <NER> Obsessive - compulsive disorder <NER> ( <NER> ) <NER> NA <NER> ( <NER> ) <NER> ( <NER> - 73.9 ) <NER> anxiety disorder <NER> <NER> ( <NER> ) 13.8 <NER> ( 2.7 - 14.5 ) <NER> ( 2.6 - 7.5 ) <NER> 11.6 ( <NER> - 19.0 ) <NER> Any other anxiety disorder <NER> 3.2 ( <NER> - 3.8 ) <NER> ( <NER> ) <NER> 7.2 ( <NER> - 9.3 ) <NER> ( <NER> ) <NER> <NER> disorders Major depressive disorder <NER> ( <NER> ) 48.7 <NER> ( <NER> ) <NER> ( <NER> ) <NER> 2.5 ( <NER> ) <NER> <NER> 3.2 ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> Bipolar disorder I or II 7.1 <NER> ( <NER> ) 15.5 5.1 ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> Any mood disorder <NER> ( <NER> ) 64.2 <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> Impulse - control disorders <NER> deficit / hyperactivity disorder <NER> ( <NER> ) <NER> <NER> <NER> ( <NER> ) <NER> <NER> 20.0 Oppositional defiant disorder <NER> ( <NER> ) <NER> <NER> <NER> ( <NER> ) <NER> <NER> disorder <NER> ( <NER> ) <NER> <NER> 21.7 <NER> ( <NER> - 6.4 ) <NER> <NER> <NER> Intermittent explosive disorder <NER> 1.7 ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( 0.8 - 3.6 ) <NER> Any impulse - control disorder <NER> ( <NER> ) <NER> <NER> <NER> ( <NER> ) <NER> <NER> <NER> Substance use disorders Alcohol abuse or dependence <NER> ( <NER> ) <NER> 3.2 ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> <NER> dependence <NER> ( <NER> ) <NER> 4.0 ( <NER> ) <NER> ( <NER> ) 23.4 <NER> ( <NER> ) <NER> Illicit drug abuse or dependence <NER> ( <NER> ) <NER> ( <NER> ) <NER> <NER> ( <NER> ) <NER> ( <NER> ) <NER> <NER> drug dependence <NER> ( <NER> ) 10.6 <NER> ( <NER> ) <NER> ( <NER> ) 9.3 4.6 ( <NER> ) <NER> Any substance use disorder <NER> <NER> ( <NER> ) 31.4 <NER> ( <NER> ) <NER> ( 2.4 - 4.5 ) <NER> ( <NER> ) <NER> Any disorder <NER> ( <NER> ) <NER> <NER> ( <NER> ) <NER> <NER> , agoraphobia ; <NER> , confidence interval ; <NER> , not applicable ; <NER> , odds ratio ; <NER> , panic attack ; <NER> , panic disorder ; <NER> only , lifetime history of <NER> but not <NER> ; <NER> , lifetime history of <NER> with <NER> but not <NER> ; <NER> only , lifetime history of <NER> without <NER> ; <NER> , lifetime history of <NER> with <NER> . * Based on a separate multivariate logistic regression equation for each row of the table in which dummy variables defining the <NER> panic subgroups are used to predict lifetime occurrence of the comorbid disorder controlling for age at interview ( in <NER> intervals ) , sex , and race - ethnicity . The ORs compare respondents in each of the <NER> panic subgroups with respondents who have no lifetime history of panic . Significant at the <NER> level , <NER> test . Insufficient precision for estimation because of the low prevalence of <NER> and <NER> . ( <NER> ) ARCH GEN <NER> , <NER> WWW.ARCHGENPSYCHIATRY.COM <NER> © <NER> <NER> . All rights reserved . Downloaded From : http://archpsyc.jamanetwork.com/ on 04/10/2014 \\x0c of the <NER> subgroups ( <NER> ) . The proportions that obtained treatment consistent with basic treatment guidelines did not differ markedly across the <NER> subgroups with <NER> ( <NER> ) . Although treatment meeting basic guidelines was received by a substantially lower proportion of patients in the <NER> - only subgroup ( <NER> ) , published treatment guidelines apply to <NER> , not to isolated PAs . <NER> These results should be interpreted in light of several limitations . <NER> , the response rate was <NER> . As described in more detail elsewhere,15 we assessed this problem in a nonrespondent survey in which a subsample of initial nonrespondents was offered a large financial incentive ( $ <NER> ) to complete a short ( 15-minute ) telephone interview that included CIDI diagnostic stem questions . No significant difference was found in panic stem question endorsement compared with responses in the main survey sample , indirectly arguing against large nonresponse bias on the basis of panic . <NER> , although good concordance with <NER> diagnoses was found , no validity data were obtained for <NER> . <NER> , possibly biased information about <NER> , persistence , and other important course and treatment variables were obtained retrospectively . As described in more detail elsewhere,16 a number of strategies were used in the <NER> to reduce recall bias . Evidence exists that these strategies improved the accuracy of retrospective <NER> reports,30 but we have no data about effects on other aspects of recall . With these limitations as a backdrop , the <NER> - R lifetime prevalence estimates of <NER> and <NER> ( <NER> and <NER> , respectively ) are similar to the DSM - III - R1 estimates in the baseline <NER> ( <NER> and <NER> , respectively ) . The <NER> - R estimate of <NER> - only prevalence ( <NER> ) is substantially higher than in the <NER> ( <NER> Although higher than in earlier epidemiological <NER> the concordance of the <NER> prevalence estimate with an independent SCID estimate argues against upward bias . In the case of <NER> , the concern is more with downward than upward bias because the <NER> requirement of anxiety about multiple situations is stricter than <NER> requirement . Estimates of persistence , sociodemographic correlates , and psychiatric comorbidity are broadly consistent with the baseline <NER> and other previous epidemiological surveys,14,31,33 - 35 although direct comparison is not possible because previous surveys did not disaggregate panic into the <NER> subgroups considered here . High prevalence among women , low prevalence among the elderly , and strong comorbidity with other anxiety and mood disorders are all noteworthy consistencies with previous survey findings . <NER> notable difference is a much higher estimated lifetime prevalence of PAs in <NER> ( <NER> ) than in the <NER> ( <NER> ) , a discrepancy presumably caused by the more detailed stem questions in <NER> version of the <NER> than in the DSM - III - R version that suggests PAs were underestimated in the baseline <NER> . We are aware of no previous general population research in which investigators compared the prevalence and correlates of isolated PAs vs <NER> with and without <NER> . The most striking results of this comparison are that isolated PAs are common and significantly comorbid with other <NER> disorders . These results are consistent with results from clinical studies.36,37 Most people with isolated PAs fail to meet <NER> criteria because they never had recurrent uncued attacks , although they typically had numerous cued attacks . Another notable subgroup result is that cued attacks are more common than uncued attacks even among people with <NER> . This finding is especially striking given that probing often uncovers initially unrecognized panic <NER> which means that the <NER> - R probably leads to underestimating the proportion of attacks that are cued . We also found that persistence and lifetime number of attacks are more strongly related to <NER> than to <NER> ; that comorbidity , especially with other anxiety disorders , is more strongly related to <NER> than to <NER> ; and that isolated PAs are associated with substantial role impairment when they occur in conjunction with <NER> . The subgroup results suggest that <NER> and <NER> are to some extent distinct , <NER> of all respondents with <NER> never met criteria for <NER> . This finding is consistent with family aggregation studies , which show that <NER> . Clinical Severity and Role Impairment Among Respondents in <NER> Mutually Exclusive 12-Month Panic Subgroups Parameter Percentage ( Standard Error ) 2 3 PA Only ( n = <NER> ) * <NER> ( n = <NER> ) * PD Only ( n = <NER> ) * <NER> ( n = <NER> ) * Clinical severity Severe <NER> ( <NER> ) <NER> ( <NER> ) 6.0 ( <NER> ) <NER> ( <NER> ) <NER> Moderate <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> Mild <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> None 78.4 ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) 0 NA Impairment§ Severe 11.1 ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> Moderate <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) 10.3 ( <NER> ) <NER> Mild <NER> ( <NER> ) <NER> ( <NER> ) 13.8 ( <NER> ) <NER> ( <NER> ) <NER> None 70.6 ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) 0 62.9 Abbreviations : <NER> , agoraphobia ; <NER> , not applicable ; <NER> , panic attack ; <NER> , panic disorder ; <NER> only , lifetime history of <NER> but not <NER> ; <NER> , lifetime history of <NER> with <NER> but not <NER> ; <NER> only , lifetime history of <NER> without <NER> ; <NER> , lifetime history of <NER> with <NER> . * The number of respondents in each subgroup who reported <NER> prevalence does not equal the sample size in <NER> multiplied by the estimate of <NER> persistence in that table because persistence is estimated on weighted data and the sample sizes report the actual numbers of ( unweighted ) cases . The original <NER> categories of severe and very severe were collapsed to define the severe category reported here . Significant at the <NER> level , <NER> test . § Responses to the <NER> Sheehan Disability Scale questions ( impairments in work , home , social , and personal relationship functioning ) were combined by assigning respondents their most severe score across the <NER> . The original <NER> Scale categories of severe and very severe were collapsed to define the severe category reported here . Because the number of respondents with at least mild impairment is the additive inverse of the number with no impairment , the <NER> value in this row is identical to the value in <NER> . ( REPRINTED ) ARCH GEN <NER> , <NER> <NER> <NER> © <NER> <NER> . All rights reserved . Downloaded From : http://archpsyc.jamanetwork.com/ on 04/10/2014 <NER> risk of <NER> is significantly elevated among relatives of people with <NER> and relatives of people with <NER> compared with those with <NER> only.39,41 Family genetic studies also suggest that <NER> and <NER> may have at least some distinct pathogenic mechanisms.42,43 At the same time , our finding of higher conditional prevalence of <NER> among people with <NER> than <NER> is consistent with the strong association between <NER> and <NER> long observed in clinical settings . The subgroup results document monotonic increases from <NER> only to <NER> in number of attacks , comorbidity , clinical severity , role impairment , and treatment seeking , with intermediate values for <NER> and <NER> only . Together with the finding that a high proportion of <NER> is associated with <NER> , these results could be interpreted as suggesting that panic exists along a continuum in which <NER> and <NER> differ in degree rather than in kind . This interpretation is consistent with prior findings that infrequent , spontaneous PAs are common in the general population,41,42 that these attacks typically include fewer and less severe symptoms than those in patients with PD,43 and that infrequent <NER> aggregates with <NER> in families.40,44 The distinction between cued and uncued attacks might be called into question as part of this same line of thinking based on the view that most PAs are to some extent cued.37,45,46 It would be premature to conclude from these results that the boundary between <NER> and <NER> is arbitrary . Nevertheless , given the high prevalence of <NER> only and the negative outcomes associated with <NER> only , future <NER> whether diagnostic criteria or symptom thresholds for <NER> should be modified to improve differentiation between pathological and normal panic experiences . An innovation of the <NER> was the use of a fully structured version of the <NER> to assess clinical severity . Although lower than in clinical samples , <NER> of respondents with <NER> and <NER> to <NER> of those with <NER> and <NER> only were in the clinically important range on the <NER> . A related finding is that clinical severity assessed in the <NER> and role impairment assessed in the <NER> appear to be influenced nearly as much by <NER> vs PA only ) as by <NER> ( <NER> only vs <NER> only ) . This finding is consistent with prior findings that <NER> is associated with panic severity , anticipatory anxiety , and cognitive correlates of <NER> and our finding that <NER> is more common among people with <NER> than <NER> . Also consistent with this pattern is the higher average lifetime number of PAs among respondents with vs those without <NER> in both the <NER> and <NER> samples . <NER> possible interpretation of this pattern is that <NER> is a severity marker of panic , although this is at least superficially inconsistent with the notion in previous paragraphs that <NER> is distinct from <NER> disorder . Another possibility is that <NER> has a direct effect on impairment . The treatment results are consistent with previous <NER> reports that most people with <NER> eventually obtain treatment,23 that most active cases receive treatment in a given year,50 and that most current treatment ( <NER> across the <NER> <NER> subgroups ) fails to meet basic treatment <NER> The latter result is all the more striking in that our definition of treatment quality is liberal . For example , no distinction was made among psychotherapies despite much more evidence for the effectiveness of some types of psychotherapy than others in treating panic,51 - <NER> nor was a distinction made among antidepressants or anxiolytics despite much more evidence for the effectiveness of some than others.54,55 In interpreting the finding that many patients fail to receive guideline - concordant treatment , some patients were so classified because they dropped Table <NER> . <NER> and <NER> of Respondents in <NER> Mutually Exclusive Panic Subgroups Treatment Percentage ( Standard Error ) <NER> * PA Only <NER> PD Only <NER> <NER> treatment ( n = <NER> ) ( n = <NER> ) ( n = <NER> ) ( n = <NER> ) <NER> <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> Other mental health <NER> ( <NER> ) <NER> ( <NER> ) 38.0 ( <NER> ) <NER> ( <NER> ) <NER> General medical <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> Human services <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> Complementary - alternative <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> Panic - specific treatment <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> Any treatment <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> 12-mo treatment ( n = <NER> ) ( n = <NER> ) ( n = <NER> ) ( n = <NER> ) <NER> 12.1 ( 1.8 ) 21.6 ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> Other mental health <NER> ( <NER> ) <NER> ( <NER> ) 28.7 ( <NER> ) <NER> ( <NER> ) <NER> General medical <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> <NER> services <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> <NER> alternative <NER> ( <NER> ) 11.7 ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> Panic - specific treatment <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> Any treatment <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> <NER> - concordant treatment <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) <NER> ( <NER> ) 54.5 Abbreviations : <NER> , agoraphobia ; <NER> , panic attack ; <NER> , panic disorder ; <NER> only , lifetime history of <NER> but not <NER> ; <NER> , lifetime history of <NER> with <NER> but not <NER> ; <NER> only , lifetime history of <NER> without <NER> ; <NER> , lifetime history of <NER> with <NER> . * This set of statistics tests the significance of the differences among the <NER> percentages in each row . Significant at the <NER> level , <NER> test . ( <NER> , <NER> 2006 WWW.ARCHGENPSYCHIATRY.COM <NER> © <NER> <NER> . All rights reserved . Downloaded From : http://archpsyc.jamanetwork.com/ on 04/10/2014 \\x0c out of treatment prematurely rather than because treatment providers delivered inappropriate care . Both problems need to be addressed in future practice - oriented research . <NER> : <NER> ; final revision received <NER> ; accepted <NER> . Correspondence : <NER> , <NER> , <NER> , <NER> , <NER> <NER> , <NER> , <NER> ( kessler@hcp.med.harvard .edu ) . Funding / Support : <NER> ( <NER> ) is supported by grant U01MH60220 from <NER> ( NIMH ) , with supplemental support from <NER> ( NIDA ) , the <NER> and <NER> , grant <NER> from <NER> , and <NER> . <NER> : The views and opinions expressed in this report are those of the authors and should not be construed to represent the views of any of the sponsoring organizations , agencies , or <NER> government . Additional Information : Collaborating investigators include <NER> ( principal investigator , <NER> ) , <NER> ( coprincipal investigator , <NER> ) , <NER> ( <NER> , <NER> ) , <NER> ( <NER> , <NER> , <NER> ) , <NER> ( NIDA ) , <NER> ( <NER> , <NER> , <NER> ) , <NER> ( <NER> , <NER> ) , <NER> ( <NER> , <NER> , <NER> ) , <NER> ( <NER> , <NER> , Pa ) , <NER> ( <NER> , <NER> , <NER> ) , <NER> ( <NER> ) , <NER> ( <NER> ) , <NER> ( <NER> , <NER> ) , <NER> ( <NER> , <NER> , <NER> ) , and <NER> ( <NER> , <NER> , <NER> , and <NER> , <NER> , <NER> ) . A complete list of <NER> publications and the full text of all <NER> instruments is available at http://www.hcp.med.harvard .edu / ncs . Send correspondence to <NER> .edu . The <NER> is performed in conjunction with <NER> . These activities were supported by grant <NER> <NER> from <NER> ; the <NER> and <NER> ; <NER> ; grants <NER> , <NER> , and <NER> from <NER> ; grant FIRCA R01TW006481 from <NER> ; <NER> ; <NER> ; <NER> ; <NER> ; and <NER> . A complete list of <NER> publications is available at http://www .hcp.med.harvard.edu / wmh/. <NER> : We thank the staff of <NER> and <NER> for assistance with instrumentation , fieldwork , and consultation on data analysis . <NER> . <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> . <NER> and <NER> prevalence of <NER> - R psychiatric disorders in <NER> : results from <NER> . <NER> . <NER> . <NER> . <NER> , <NER> , <NER> , <NER> . Panic and panic disorder in <NER> . Am J Psychiatry . <NER> . <NER> . <NER> , <NER> , <NER> . Gender differences in panic disorder : findings from <NER> . Am <NER> . <NER> . <NER> . <NER> , Burke JD Jr , <NER> , <NER> . Age of onset of selected mental disorders in <NER> community populations . <NER> . <NER> . <NER> . <NER> . The prevalence of psychiatric comorbidity . In : <NER> , <NER> , eds . <NER> . <NER> , <NER> : <NER> ; <NER> . <NER> . <NER> , <NER> , <NER> <NER> , <NER> - <NER> , <NER> . <NER> panic - depression comorbidity in <NER> . <NER> . 1998;55:801 - 808 . <NER> . <NER> , <NER> , <NER> , <NER> B , <NER> , <NER> . <NER> panic - depression comorbidity in <NER> : association with symptoms , impairment , course and help - seeking . <NER> . <NER> ; <NER> . <NER> . <NER> , <NER> , <NER> , <NER> , <NER> attacks in the community : social morbidity and health care utilization . <NER> . <NER> ; <NER> - 746 . <NER> . <NER> , <NER> , <NER> , <NER> , <NER> GL . Quality of life in panic disorder . <NER> . <NER> . <NER> . <NER> , <NER> . Epidemiology of panic disorder : progress and unresolved issues . <NER> . <NER> . <NER> . <NER> , <NER> . Panic attacks and psychopathology among youth . <NER> . 2004;109:216 - <NER> . <NER> . Reed V , <NER> . <NER> panic attacks and panic disorder in a community sample of adolescents and young adults : how specific are panic attacks ? J Psychiatr Res . <NER> . <NER> . <NER> <NER> The long - term course of panic disorder and its predictors . J <NER> . 1998;18(6)(suppl <NER> <NER> . <NER> , <NER> , <NER> A , <NER> , <NER> , <NER> , <NER> K , Schlaepfer T , <NER> , <NER> . <NER> and recovery from panic disorder in <NER> follow - up . <NER> . <NER> - <NER> . <NER> . <NER> , <NER> , <NER> , <NER> O , <NER> , Hiripi E , <NER> , <NER> , <NER> , <NER> , <NER> The <NER> <NER> ( <NER> ) : design and field procedures . Int J Methods Psychiatr Res . 2004 ; <NER> . <NER> . <NER> , <NER> . <NER> <NER> ( CIDI ) . Int J Methods Psychiatr Res . 2004;13:93 - 121 . <NER> . <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> calibration of <NER> diagnoses in <NER> ) version of <NER> ( WHO ) <NER> ( WMHCIDI ) . Int J Methods Psychiatr Res . 2004;13:122 - 139 . 18 . <NER> , <NER> , <NER> O , <NER> , <NER> . <NER> prevalence and age - of - onset distributions of <NER> disorders in <NER> . <NER> . <NER> . <NER> . <NER> , <NER> , <NER> , <NER> . <NER> I Disorders , <NER> , <NER> <NER> ) . <NER> , <NER> ; <NER> . <NER> . <NER> , <NER> , <NER> , <NER> , <NER> V , <NER> , <NER> , <NER> and validity of the Panic Disorder Severity Scale : replication and extension . J Psychiatr Res . <NER> . <NER> . <NER> , <NER> , <NER> , <NER> of the self - report version of the Panic Disorder Severity Scale . <NER> . <NER> - 185 . <NER> . <NER> , <NER> , <NER> , <NER> , Sheehan DV . <NER> psychiatric impairment in primary care with the Sheehan Disability Scale . Int J <NER> . <NER> . <NER> . <NER> , <NER> , <NER> , <NER> , <NER> , <NER> . Failure and delay in initial treatment contact after <NER> onset of mental disorders in <NER> . <NER> . 2005;62:603 - 613 . <NER> . <NER> . <NER> for <NER> . <NER> , <NER> : <NER> ; <NER> . <NER> . <NER> , <NER> , eds . <NER> . <NER> , <NER> : <NER> ; <NER> . ( <NER> , <NER> 2006 WWW.ARCHGENPSYCHIATRY.COM <NER> © <NER> <NER> . All rights reserved . Downloaded From : http://archpsyc.jamanetwork.com/ on 04/10/2014 \\x0c <NER> . <NER> , <NER> , <NER> . <NER> . <NER> , <NER> <NER> ; <NER> . <NER> . Hosmer <NER> , <NER> . <NER> ed . <NER> , <NER> : <NER> ; <NER> . <NER> . <NER> . Introduction to Variance Estimation . <NER> , <NER> : <NER> ; <NER> . <NER> . <NER> . <NER> . <NER> . Research <NER> , <NER> : <NER> ; <NER> . <NER> . <NER> , <NER> , <NER> , <NER> , <NER> . Improving the accuracy of major depression age of onset reports in <NER> . Int J Methods Psychiatr Res . <NER> . <NER> . <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> . The cross - national epidemiology of panic disorder . <NER> . <NER> . <NER> . <NER> . Epidemiology of psychiatric comorbidity . In : <NER> , Tohen M , <NER> , eds . <NER> in <NER> Epidemiology . <NER> , <NER> : <NER> ; <NER> - <NER> . <NER> . <NER> , Bushnell <NER> , <NER> , <NER> , <NER> . The epidemiology of panic symptomatology and agoraphobic avoidance . <NER> . <NER> - <NER> . <NER> . <NER> , <NER> , <NER> , <NER> , Pfister H , <NER> , <NER> , co - morbidity and correlates of mental disorders in the general population : results from <NER> ( <NER> ) . <NER> . <NER> - <NER> . <NER> . Alonso J , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , Haro JM , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> - Alonso M , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> , <NER> ; <NER> / MHEDEA 2000 Investigators , <NER> ( ESEMeD ) Project . 12-Month comorbidity patterns and associated factors in <NER> : results from <NER> ESEMeD ) project . <NER> . <NER> . <NER> . <NER> , <NER> , <NER> , <NER> , <NER> , <NER> . The phenomenon of panic . J <NER> . <NER> . <NER> . <NER> . <NER> fear and panic attacks : the same emotional states triggered by different cues ? <NER> Rev. <NER> - <NER> . <NER> . <NER> . Cognitive - behavioral approaches to panic and agoraphobia . In : <NER> , <NER> , eds . Advances in <NER> . <NER> . <NER> , <NER> : <NER> ; <NER> . <NER> . <NER> , <NER> . Panic disorder and agoraphobia . In : <NER> , ed . Anxiety and Its Disorders : The Nature and <NER> . 2nd ed . <NER> , <NER> : <NER> ; <NER> . <NER> . <NER> , <NER> , <NER> , <NER> A family study of panic disorder . <NER> . <NER> . <NER> . <NER> <NER> , <NER> of agoraphobic avoidance . <NER> . <NER> . <NER> . <NER> , <NER> . The epidemiology of panic attacks , panic disorder , and agoraphobia . In : <NER> , <NER> , <NER> , eds . <NER> and <NER> : A Comprehensive Guide for the <NER> . <NER> , <NER> : <NER> ; <NER> . <NER> . <NER> , <NER> , <NER> , <NER> of people with infrequent panic attacks . J <NER> . <NER> . <NER> . <NER> , <NER> , <NER> . <NER> associated with panic attacks in nonclinical subjects . Behav Ther . <NER> - <NER> . <NER> . <NER> , <NER> , <NER> . A modern learning theory perspective on the etiology of panic disorder . Psychol Rev. <NER> . <NER> . <NER> . A cognitive approach to panic . <NER> . <NER> - 470 . <NER> . <NER> , <NER> . A review of the relationship between panic and avoidance . <NER> Rev. <NER> - 685 . <NER> . <NER> , <NER> , <NER> , <NER> , <NER> . Role of cognitive appraisal in panic - related avoidance . <NER> . <NER> . <NER> . <NER> , <NER> , <NER> , <NER> , <NER> , <NER> . The development of agoraphobia in panic disorder : a predictable process ? J <NER> . <NER> . <NER> . <NER> , <NER> , <NER> , <NER> , <NER> , <NER> . <NER> use of mental health services in <NER> : results from <NER> . <NER> . <NER> - <NER> . <NER> . <NER> , <NER> - behavioral therapy and the treatment of panic disorder : efficacy and strategies . J <NER> . <NER> <NER> . <NER> . <NER> , <NER> A multidimensional meta - analysis of treatments for depression , panic , and generalized anxiety disorder : an empirical examination of the status of empirically supported therapies . J <NER> . <NER> ; <NER> - 899 . <NER> . <NER> , <NER> , <NER> , <NER> A , <NER> , Rudden M , <NER> , <NER> , <NER> , Richter D , <NER> . A pilot open trial of brief psychodynamic psychotherapy for panic disorder . J Psychother Pract Res . <NER> : <NER> - 245 . <NER> . <NER> . The pharmacotherapy of panic disorder . J <NER> . 2005;66 ( suppl 4):23 - 27 . <NER> . <NER> A , <NER> , <NER> . Evidence - based pharmacotherapy of panic disorder . <NER> . <NER> - 482 . ( <NER> , <NER> 2006 WWW.ARCHGENPSYCHIATRY.COM <NER> © <NER> <NER> . All rights reserved . Downloaded From : http://archpsyc.jamanetwork.com/ on 04/10/2014 \\x0c'"
      ]
     },
     "execution_count": 119,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.docF[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 116,
   "metadata": {},
   "outputs": [],
   "source": [
    "def NERtag(sents):\n",
    "    tokens = []\n",
    "    for i in doc:\n",
    "    #     print (i.ent_iob_)\n",
    "        if(i.ent_iob_ == 'O'):\n",
    "            tokens.append(i.text)\n",
    "        elif (i.ent_iob_ == 'B'):\n",
    "            tokens.append('<NER>')\n",
    "        else:\n",
    "            pass\n",
    "    return ' '.join(tokens)\n",
    "    \n",
    "        \n",
    "    \n",
    "# sents = df['sents'][0]\n",
    "# for s in sents:\n",
    "#     tokens = []\n",
    "#     for i in doc:\n",
    "#     #     print (i.ent_iob_)\n",
    "#         if(i.ent_iob_ == 'O'):\n",
    "#             tokens.append(i.text)\n",
    "#         elif (i.ent_iob_ == 'B'):\n",
    "#             tokens.append('<NER>')\n",
    "#         else:\n",
    "#             pass\n",
    "#     ' '.join(tokens)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 97,
   "metadata": {},
   "outputs": [],
   "source": [
    "df['docF'] = [for s in df.doc]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 100,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[['Panic Disorder', 'ORG', 8, 10],\n",
       " ['the National Comorbidity Survey Replication Ronald C. Kessler',\n",
       "  'ORG',\n",
       "  14,\n",
       "  22],\n",
       " ['MS Context', 'ORG', 51, 53],\n",
       " ['DSM-IV', 'ORG', 62, 65],\n",
       " ['PD', 'ORG', 74, 75],\n",
       " ['PD', 'ORG', 90, 91],\n",
       " ['AG', 'ORG', 96, 97],\n",
       " ['the US National Comorbidity Survey Replication', 'ORG', 102, 108],\n",
       " ['World Health Organization Composite International Diagnostic Interview',\n",
       "  'ORG',\n",
       "  126,\n",
       "  133],\n",
       " ['PD', 'ORG', 158, 159],\n",
       " ['AG', 'ORG', 162, 163],\n",
       " ['Lifetime', 'ORG', 166, 167],\n",
       " ['AG (PA', 'ORG', 176, 179],\n",
       " ['PA', 'ORG', 185, 186],\n",
       " ['AG', 'ORG', 187, 188],\n",
       " ['PD (PA-AG', 'ORG', 189, 194],\n",
       " ['PD', 'ORG', 199, 200],\n",
       " ['AG', 'ORG', 201, 202],\n",
       " ['PD', 'ORG', 203, 204],\n",
       " ['PD with AG (PD-AG', 'ORG', 211, 218],\n",
       " ['Persistence', 'ORG', 220, 221],\n",
       " ['DSM-IV', 'ORG', 249, 252],\n",
       " ['PD-AG', 'ORG', 259, 262],\n",
       " ['PA', 'ORG', 266, 267],\n",
       " ['the Panic Disorder Severity Scale', 'ORG', 271, 276],\n",
       " ['PD-AG', 'ORG', 280, 283],\n",
       " ['PA', 'ORG', 293, 294],\n",
       " ['PD-AG', 'ORG', 324, 327],\n",
       " ['PA', 'ORG', 331, 332],\n",
       " ['12-month', 'ORG', 336, 337],\n",
       " ['PD-AG', 'ORG', 349, 352],\n",
       " ['PA', 'ORG', 356, 357],\n",
       " ['PD', 'ORG', 372, 373],\n",
       " ['PA-AG', 'ORG', 374, 377],\n",
       " ['PD', 'ORG', 466, 467],\n",
       " ['Axis', 'ORG', 497, 498],\n",
       " ['AG', 'ORG', 543, 544],\n",
       " ['AG', 'ORG', 553, 554],\n",
       " ['PA', 'ORG', 562, 563],\n",
       " ['PD', 'ORG', 564, 565],\n",
       " ['AG', 'ORG', 570, 571],\n",
       " ['US National Comorbidity Survey Replication', 'ORG', 602, 607],\n",
       " ['NCS-R', 'ORG', 608, 611],\n",
       " ['NCS-R', 'ORG', 616, 619],\n",
       " ['Consent', 'ORG', 655, 656],\n",
       " ['Department of Health Care Policy', 'ORG', 662, 667],\n",
       " ['Harvard Medical School', 'ORG', 668, 671],\n",
       " ['the Western Psychiatric Institute', 'ORG', 692, 696],\n",
       " ['REPRINTED) ARCH GEN PSYCHIATRY/VOL 63', 'ORG', 708, 716],\n",
       " ['APR', 'ORG', 717, 718],\n",
       " ['American Medical Association', 'ORG', 723, 726],\n",
       " ['NCS', 'ORG', 744, 745],\n",
       " ['Harvard Medical School (Boston', 'ORG', 752, 757],\n",
       " ['the University of Michigan', 'ORG', 761, 765],\n",
       " ['NCS-R', 'ORG', 771, 774],\n",
       " ['NCS-R', 'ORG', 950, 953],\n",
       " ['AG Panic', 'ORG', 961, 963],\n",
       " ['AG', 'ORG', 964, 965],\n",
       " ['the World Mental Health Survey Initiatiave', 'ORG', 968, 974],\n",
       " ['the World Health Organization Composite International Diagnostic Interview',\n",
       "  'ORG',\n",
       "  976,\n",
       "  984],\n",
       " ['CIDI', 'ORG', 1013, 1014],\n",
       " ['PA', 'ORG', 1151, 1152],\n",
       " ['PA', 'ORG', 1205, 1206],\n",
       " ['PD', 'ORG', 1207, 1208],\n",
       " ['AG (PA', 'ORG', 1209, 1212],\n",
       " ['PA', 'ORG', 1215, 1216],\n",
       " ['PD and AG (PA-AG', 'ORG', 1217, 1224],\n",
       " ['PD', 'ORG', 1226, 1227],\n",
       " ['AG', 'ORG', 1228, 1229],\n",
       " ['PD', 'ORG', 1230, 1231],\n",
       " ['PD', 'ORG', 1235, 1236],\n",
       " ['AG', 'ORG', 1237, 1238],\n",
       " ['PD-AG', 'ORG', 1239, 1242],\n",
       " ['PA', 'ORG', 1245, 1246],\n",
       " ['DSM', 'ORG', 1253, 1254],\n",
       " ['PA-AG', 'ORG', 1258, 1261],\n",
       " ['the DSM-IV', 'ORG', 1265, 1269],\n",
       " ['AG', 'ORG', 1270, 1271],\n",
       " ['PD', 'ORG', 1275, 1276],\n",
       " ['AG', 'ORG', 1280, 1281],\n",
       " ['PA', 'ORG', 1285, 1286],\n",
       " ['the Structured Clinical Interview for DSM-IV', 'ORG', 1321, 1329],\n",
       " ['SCID)19', 'ORG', 1330, 1331],\n",
       " ['NCS', 'ORG', 1339, 1340],\n",
       " ['PD', 'ORG', 1356, 1357],\n",
       " ['CIDI', 'ORG', 1411, 1412],\n",
       " ['PA', 'ORG', 1443, 1444],\n",
       " ['PA', 'ORG', 1445, 1446],\n",
       " ['AG', 'ORG', 1460, 1461],\n",
       " ['AG', 'ORG', 1462, 1463],\n",
       " ['The DSM-IV', 'ORG', 1477, 1481],\n",
       " ['PD', 'ORG', 1497, 1498],\n",
       " ['CIDI', 'ORG', 1502, 1503],\n",
       " ['PA', 'ORG', 1524, 1525],\n",
       " ['CIDI', 'ORG', 1535, 1536],\n",
       " ['CIDI', 'ORG', 1555, 1556],\n",
       " ['CIDI', 'ORG', 1564, 1565],\n",
       " ['COURSE', 'ORG', 1584, 1585],\n",
       " ['IMPAIRMENT Respondents', 'ORG', 1589, 1591],\n",
       " ['DSM-IV', 'ORG', 1593, 1596],\n",
       " ['PA', 'ORG', 1599, 1600],\n",
       " ['AOO', 'ORG', 1609, 1610],\n",
       " ['AOO', 'ORG', 1616, 1617],\n",
       " ['the NCS-R. (Question', 'ORG', 1690, 1696],\n",
       " ['PDSS', 'ORG', 1708, 1709],\n",
       " ['PD', 'ORG', 1717, 1718],\n",
       " ['PDSS', 'ORG', 1727, 1728],\n",
       " ['NCS', 'ORG', 1733, 1734],\n",
       " ['CIDI', 'ORG', 1804, 1805],\n",
       " ['SDS', 'ORG', 1807, 1808],\n",
       " ['12-month', 'ORG', 1811, 1812],\n",
       " ['PA', 'ORG', 1832, 1833],\n",
       " ['Interference', 'ORG', 1898, 1899],\n",
       " ['COMORBID DSM-IV DISORDERS', 'ORG', 1941, 1946],\n",
       " ['NCS-R', 'ORG', 1947, 1950],\n",
       " ['DSM-IV', 'ORG', 1958, 1961],\n",
       " ['Organic', 'ORG', 2080, 2081],\n",
       " ['CIDI', 'ORG', 2116, 2117],\n",
       " ['APR', 'ORG', 2137, 2138],\n",
       " ['American Medical Association', 'ORG', 2143, 2146],\n",
       " [' ', 'ORG', 2169, 2170],\n",
       " ['12-month', 'ORG', 2212, 2213],\n",
       " ['12-month', 'ORG', 2339, 2340],\n",
       " ['guidelines.24 Guideline', 'ORG', 2357, 2359],\n",
       " ['PD', 'ORG', 2456, 2457],\n",
       " ['METHODS Cross', 'ORG', 2530, 2532],\n",
       " ['AOO', 'ORG', 2551, 2552],\n",
       " ['analysis27', 'ORG', 2569, 2570],\n",
       " ['DSM-IV', 'ORG', 2580, 2583],\n",
       " ['NCS', 'ORG', 2587, 2588],\n",
       " ['SUDAAN', 'ORG', 2610, 2611],\n",
       " ['PA', 'ORG', 2677, 2678],\n",
       " ['PA', 'ORG', 2686, 2687],\n",
       " ['PA', 'ORG', 2704, 2705],\n",
       " ['PD', 'ORG', 2710, 2711],\n",
       " ['12-month PD', 'ORG', 2718, 2720],\n",
       " ['PA', 'ORG', 2738, 2739],\n",
       " ['PA-AG', 'ORG', 2744, 2747],\n",
       " ['12-month PA-AG', 'ORG', 2754, 2758],\n",
       " ['PD', 'ORG', 2775, 2776],\n",
       " ['PA-AG', 'ORG', 2783, 2786],\n",
       " ['PD-AG', 'ORG', 2791, 2794],\n",
       " ['12-month PD-AG', 'ORG', 2801, 2805],\n",
       " ['COURSE OF ILLNESS', 'ORG', 2806, 2809],\n",
       " ['PA-AG', 'ORG', 2837, 2840],\n",
       " ['PD', 'ORG', 2844, 2845],\n",
       " ['PD-AG', 'ORG', 2851, 2854],\n",
       " ['PD', 'ORG', 2864, 2865],\n",
       " ['PA', 'ORG', 2869, 2870],\n",
       " ['PA-AG', 'ORG', 2875, 2878],\n",
       " ['PD', 'ORG', 2889, 2890],\n",
       " ['PD', 'ORG', 2911, 2912],\n",
       " ['PD', 'ORG', 2930, 2931],\n",
       " ['PD-AG', 'ORG', 2945, 2948],\n",
       " ['PA-AG', 'ORG', 2952, 2955],\n",
       " ['PD', 'ORG', 2963, 2964],\n",
       " ['PA', 'ORG', 3008, 3009],\n",
       " ['P=.03) AG', 'ORG', 3031, 3034],\n",
       " ['PA', 'ORG', 3050, 3051],\n",
       " ['PD', 'ORG', 3065, 3066],\n",
       " ['PA', 'ORG', 3084, 3085],\n",
       " ['PD', 'ORG', 3096, 3097],\n",
       " ['PD-AG', 'ORG', 3102, 3105],\n",
       " ['PA-AG', 'ORG', 3109, 3112],\n",
       " ['Lifetime', 'ORG', 3119, 3120],\n",
       " ['DSM-IV', 'ORG', 3123, 3126],\n",
       " ['PD', 'ORG', 3135, 3136],\n",
       " ['AG', 'ORG', 3142, 3143],\n",
       " ['PA', 'ORG', 3151, 3152],\n",
       " ['PD or AG', 'ORG', 3154, 3157],\n",
       " ['PA-AG', 'ORG', 3158, 3161],\n",
       " ['PA', 'ORG', 3165, 3166],\n",
       " ['AG', 'ORG', 3167, 3168],\n",
       " ['PD', 'ORG', 3170, 3171],\n",
       " ['PD', 'ORG', 3172, 3173],\n",
       " ['PD', 'ORG', 3178, 3179],\n",
       " ['AG', 'ORG', 3180, 3181],\n",
       " ['PD-AG', 'ORG', 3182, 3185],\n",
       " ['PD', 'ORG', 3189, 3190],\n",
       " ['AG', 'ORG', 3191, 3192],\n",
       " ['PD', 'ORG', 3197, 3198],\n",
       " ['PD-AG', 'ORG', 3204, 3207],\n",
       " ['PD', 'ORG', 3222, 3223],\n",
       " ['APR', 'ORG', 3237, 3238],\n",
       " ['American Medical Association', 'ORG', 3243, 3246],\n",
       " ['PD', 'ORG', 3279, 3280],\n",
       " ['the PD-AG', 'ORG', 3294, 3298],\n",
       " ['AOO of PA', 'ORG', 3315, 3318],\n",
       " ['P=.44', 'ORG', 3331, 3332],\n",
       " ['PA AOO', 'ORG', 3336, 3338],\n",
       " ['PD', 'ORG', 3352, 3353],\n",
       " ['AOO of PA', 'ORG', 3361, 3364],\n",
       " ['PD', 'ORG', 3371, 3372],\n",
       " ['PD-AG', 'ORG', 3375, 3378],\n",
       " ['PA', 'ORG', 3396, 3397],\n",
       " ['PA', 'ORG', 3411, 3412],\n",
       " ['PD-AG', 'ORG', 3417, 3420],\n",
       " ['PD', 'ORG', 3435, 3436],\n",
       " ['AG', 'ORG', 3443, 3444],\n",
       " ['AG', 'ORG', 3459, 3460],\n",
       " ['AG', 'ORG', 3479, 3480],\n",
       " ['PD', 'ORG', 3576, 3577],\n",
       " ['PA', 'ORG', 3579, 3580],\n",
       " ['AG', 'ORG', 3595, 3596],\n",
       " ['Respondents', 'ORG', 3659, 3660],\n",
       " ['PA', 'ORG', 3684, 3685],\n",
       " ['PD-AG', 'ORG', 3694, 3697],\n",
       " ['DSM-IV', 'ORG', 3759, 3762],\n",
       " ['PA', 'ORG', 3784, 3785],\n",
       " ['Persistence', 'ORG', 3792, 3793],\n",
       " ['Course of Panic', 'ORG', 3795, 3798],\n",
       " ['PA-AG', 'ORG', 3815, 3818],\n",
       " ['PD-AG', 'ORG', 3830, 3833],\n",
       " ['Lifetime', 'ORG', 3840, 3841],\n",
       " ['Lifetime', 'ORG', 3885, 3886],\n",
       " ['PA', 'ORG', 3910, 3911],\n",
       " ['PD', 'ORG', 3928, 3929],\n",
       " ['NA NA 23.6', 'ORG', 3930, 3933],\n",
       " ['AG', 'ORG', 3941, 3942],\n",
       " ['NA', 'ORG', 3943, 3944],\n",
       " ['Lifetime', 'ORG', 4002, 4003],\n",
       " ['Lifetime', 'ORG', 4023, 4024],\n",
       " ['NA', 'ORG', 4064, 4065],\n",
       " ['NA Abbreviations', 'ORG', 4086, 4088],\n",
       " ['AG', 'ORG', 4089, 4090],\n",
       " ['NA', 'ORG', 4093, 4094],\n",
       " ['PA', 'ORG', 4098, 4099],\n",
       " ['PD', 'ORG', 4103, 4104],\n",
       " ['PA', 'ORG', 4108, 4109],\n",
       " ['PA', 'ORG', 4114, 4115],\n",
       " ['PD or AG', 'ORG', 4118, 4121],\n",
       " ['PA-AG', 'ORG', 4122, 4125],\n",
       " ['PA', 'ORG', 4129, 4130],\n",
       " ['AG', 'ORG', 4131, 4132],\n",
       " ['PD', 'ORG', 4135, 4136],\n",
       " ['PD', 'ORG', 4137, 4138],\n",
       " ['PD', 'ORG', 4143, 4144],\n",
       " ['AG', 'ORG', 4145, 4146],\n",
       " ['PD-AG', 'ORG', 4147, 4150],\n",
       " ['PD', 'ORG', 4154, 4155],\n",
       " ['AG', 'ORG', 4156, 4157],\n",
       " ['PA-AG', 'ORG', 4212, 4215],\n",
       " ['PD-AG', 'ORG', 4217, 4220],\n",
       " ['Age of Onset', 'ORG', 4222, 4225],\n",
       " ['Cumulative Probability', 'ORG', 4227, 4229],\n",
       " ['APR', 'ORG', 4280, 4281],\n",
       " ['American Medical Association', 'ORG', 4286, 4289],\n",
       " ['PD', 'ORG', 4307, 4308],\n",
       " ['PA', 'ORG', 4341, 4342],\n",
       " ['AG', 'ORG', 4359, 4360],\n",
       " ['PD', 'ORG', 4364, 4365],\n",
       " ['PA-AG', 'ORG', 4370, 4373],\n",
       " ['PD', 'ORG', 4384, 4385],\n",
       " ['PD-AG', 'ORG', 4399, 4402],\n",
       " ['PA-AG', 'ORG', 4423, 4426],\n",
       " ['PD', 'ORG', 4436, 4437],\n",
       " ['PD-AG', 'ORG', 4448, 4451],\n",
       " ['AG', 'ORG', 4476, 4477],\n",
       " ['PD', 'ORG', 4478, 4479],\n",
       " ['CLINICAL', 'ORG', 4494, 4495],\n",
       " ['12-month', 'ORG', 4510, 4511],\n",
       " ['PD-AG', 'ORG', 4530, 4533],\n",
       " ['PA', 'ORG', 4555, 4556],\n",
       " ['Characteristic Odds Ratio', 'ORG', 4593, 4596],\n",
       " ['PA-AG', 'ORG', 4609, 4612],\n",
       " ['PD-AG', 'ORG', 4624, 4627],\n",
       " ['Race Hispanic', 'ORG', 4762, 4764],\n",
       " ['White 1.0', 'ORG', 4838, 4840],\n",
       " ['Education', 'ORG', 4848, 4849],\n",
       " ['Married/cohabitating', 'ORG', 4942, 4945],\n",
       " ['Working 1.0 1.0 1.0 1.0 Student', 'ORG', 5011, 5017],\n",
       " ['Homemaker', 'ORG', 5041, 5042],\n",
       " ['Abbreviations: AG', 'ORG', 5213, 5216],\n",
       " ['PA', 'ORG', 5219, 5220],\n",
       " ['PD', 'ORG', 5224, 5225],\n",
       " ['PA', 'ORG', 5229, 5230],\n",
       " ['PA', 'ORG', 5235, 5236],\n",
       " ['PD or AG', 'ORG', 5238, 5241],\n",
       " ['PA-AG', 'ORG', 5242, 5245],\n",
       " ['PA', 'ORG', 5249, 5250],\n",
       " ['AG', 'ORG', 5251, 5252],\n",
       " ['PD', 'ORG', 5254, 5255],\n",
       " ['PD', 'ORG', 5256, 5257],\n",
       " ['PD', 'ORG', 5262, 5263],\n",
       " ['AG', 'ORG', 5264, 5265],\n",
       " ['PD-AG', 'ORG', 5266, 5269],\n",
       " ['PD', 'ORG', 5273, 5274],\n",
       " ['AG', 'ORG', 5275, 5276],\n",
       " ['PA', 'ORG', 5322, 5323],\n",
       " ['PA-AG', 'ORG', 5326, 5329],\n",
       " ['PD', 'ORG', 5331, 5332],\n",
       " ['104 PD-AG', 'ORG', 5335, 5339],\n",
       " ['REPRINTED) ARCH GEN PSYCHIATRY/VOL 63', 'ORG', 5364, 5372],\n",
       " ['APR', 'ORG', 5373, 5374],\n",
       " ['American Medical Association', 'ORG', 5379, 5382],\n",
       " ['PA-AG', 'ORG', 5397, 5400],\n",
       " ['PD', 'ORG', 5425, 5426],\n",
       " ['Summary SDS', 'ORG', 5446, 5448],\n",
       " ['the PD-AG', 'ORG', 5461, 5465],\n",
       " ['PA', 'ORG', 5486, 5487],\n",
       " ['PA-AG', 'ORG', 5514, 5517],\n",
       " ['SDS', 'ORG', 5520, 5521],\n",
       " ['PA', 'ORG', 5573, 5574],\n",
       " ['PD', 'ORG', 5597, 5598],\n",
       " ['AG', 'ORG', 5612, 5613],\n",
       " ['the PA-AG', 'ORG', 5634, 5638],\n",
       " ['PA', 'ORG', 5643, 5644],\n",
       " ['PD', 'ORG', 5669, 5670],\n",
       " ['PD-AG', 'ORG', 5680, 5683],\n",
       " ['PA', 'ORG', 5697, 5698],\n",
       " ['PA-AG', 'ORG', 5708, 5711],\n",
       " ['PA-AG', 'ORG', 5745, 5748],\n",
       " ['PD-AG', 'ORG', 5794, 5797],\n",
       " ['PA', 'ORG', 5806, 5807],\n",
       " ['the PA-AG', 'ORG', 5818, 5822],\n",
       " ['PD', 'ORG', 5827, 5828],\n",
       " ['12-month', 'ORG', 5844, 5845],\n",
       " ['PD', 'ORG', 5859, 5860],\n",
       " ['PD-AG', 'ORG', 5870, 5873],\n",
       " ['PA', 'ORG', 5884, 5885],\n",
       " ['PA-AG', 'ORG', 5895, 5898],\n",
       " ['PA-AG PD', 'ORG', 5948, 5952],\n",
       " ['PD-AG', 'ORG', 5953, 5956],\n",
       " ['Generalized', 'ORG', 5989, 5990],\n",
       " ['Attention-', 'ORG', 6342, 6344],\n",
       " ['NA', 'ORG', 6356, 6357],\n",
       " ['NA', 'ORG', 6365, 6366],\n",
       " ['NA', 'ORG', 6378, 6379],\n",
       " ['NA 7.3 Conduct', 'ORG', 6387, 6390],\n",
       " ['NA', 'ORG', 6399, 6400],\n",
       " ['NA', 'ORG', 6408, 6409],\n",
       " ['NA', 'ORG', 6455, 6456],\n",
       " ['NA', 'ORG', 6464, 6465],\n",
       " ['Alcohol', 'ORG', 6502, 6503],\n",
       " ['NA 83.1 6.5', 'ORG', 6642, 6645],\n",
       " ['NA 5.3 Abbreviations: AG', 'ORG', 6651, 6656],\n",
       " ['NA', 'ORG', 6664, 6665],\n",
       " ['PA', 'ORG', 6674, 6675],\n",
       " ['PD', 'ORG', 6679, 6680],\n",
       " ['PA', 'ORG', 6684, 6685],\n",
       " ['PA', 'ORG', 6690, 6691],\n",
       " ['PD or AG', 'ORG', 6693, 6696],\n",
       " ['PA-AG', 'ORG', 6697, 6700],\n",
       " ['PA', 'ORG', 6704, 6705],\n",
       " ['AG', 'ORG', 6706, 6707],\n",
       " ['PD', 'ORG', 6709, 6710],\n",
       " ['PD', 'ORG', 6711, 6712],\n",
       " ['PD', 'ORG', 6717, 6718],\n",
       " ['AG', 'ORG', 6719, 6720],\n",
       " ['PD-AG', 'ORG', 6721, 6724],\n",
       " ['PD', 'ORG', 6728, 6729],\n",
       " ['AG', 'ORG', 6730, 6731],\n",
       " ['PA-AG', 'ORG', 6825, 6828],\n",
       " ['PD-AG', 'ORG', 6829, 6832],\n",
       " ['REPRINTED', 'ORG', 6834, 6835],\n",
       " ['PSYCHIATRY/VOL 63', 'ORG', 6838, 6842],\n",
       " ['APR 2006', 'ORG', 6843, 6845],\n",
       " ['American Medical Association', 'ORG', 6849, 6852],\n",
       " ['PD or AG', 'ORG', 6892, 6895],\n",
       " ['PA', 'ORG', 6916, 6917],\n",
       " ['PD and AG', 'ORG', 6930, 6933],\n",
       " ['COMMENT', 'ORG', 6939, 6940],\n",
       " ['SCID PD', 'ORG', 7045, 7047],\n",
       " ['PA or AG', 'ORG', 7057, 7060],\n",
       " ['AOO', 'ORG', 7067, 7068],\n",
       " ['NCS-R', 'ORG', 7096, 7099],\n",
       " ['AOO', 'ORG', 7114, 7115],\n",
       " ['NCS', 'ORG', 7137, 7138],\n",
       " ['DSM-IV PD', 'ORG', 7144, 7148],\n",
       " ['PD-AG', 'ORG', 7149, 7152],\n",
       " ['NCS', 'ORG', 7174, 7175],\n",
       " ['NCS', 'ORG', 7186, 7187],\n",
       " ['PD', 'ORG', 7191, 7192],\n",
       " ['NCS', 'ORG', 7205, 7206],\n",
       " ['NCS-R PD', 'ORG', 7219, 7223],\n",
       " ['AG', 'ORG', 7239, 7240],\n",
       " ['CIDI', 'ORG', 7252, 7253],\n",
       " ['the DSM-IV', 'ORG', 7262, 7266],\n",
       " ['NCS', 'ORG', 7365, 7366],\n",
       " ['the DSM-IV', 'ORG', 7382, 7386],\n",
       " ['CIDI', 'ORG', 7389, 7390],\n",
       " ['NCS', 'ORG', 7407, 7408],\n",
       " ['PD', 'ORG', 7430, 7431],\n",
       " ['AG', 'ORG', 7434, 7435],\n",
       " ['DSM-IV', 'ORG', 7454, 7457],\n",
       " ['PD', 'ORG', 7476, 7477],\n",
       " ['PD', 'ORG', 7512, 7513],\n",
       " ['cues,38,39', 'ORG', 7527, 7528],\n",
       " ['NCS', 'ORG', 7532, 7533],\n",
       " ['PD', 'ORG', 7562, 7563],\n",
       " ['AG', 'ORG', 7565, 7566],\n",
       " ['AG', 'ORG', 7581, 7582],\n",
       " ['PD', 'ORG', 7584, 7585],\n",
       " ['AG', 'ORG', 7602, 7603],\n",
       " ['AG', 'ORG', 7609, 7610],\n",
       " ['PD', 'ORG', 7611, 7612],\n",
       " ['PA and AG', 'ORG', 7626, 7629],\n",
       " ['PD', 'ORG', 7633, 7634],\n",
       " ['PA-AG', 'ORG', 7680, 7683],\n",
       " ['PD-AG', 'ORG', 7697, 7700],\n",
       " ['AG', 'ORG', 7849, 7850],\n",
       " ['NA', 'ORG', 7853, 7854],\n",
       " ['PA', 'ORG', 7858, 7859],\n",
       " ['PD', 'ORG', 7863, 7864],\n",
       " ['PA', 'ORG', 7868, 7869],\n",
       " ['PA', 'ORG', 7874, 7875],\n",
       " ['PD or AG', 'ORG', 7877, 7880],\n",
       " ['PA-AG', 'ORG', 7881, 7884],\n",
       " ['PA', 'ORG', 7888, 7889],\n",
       " ['AG', 'ORG', 7890, 7891],\n",
       " ['PD', 'ORG', 7893, 7894],\n",
       " ['PD', 'ORG', 7895, 7896],\n",
       " ['PD', 'ORG', 7901, 7902],\n",
       " ['AG', 'ORG', 7903, 7904],\n",
       " ['PD-AG', 'ORG', 7905, 7908],\n",
       " ['PD', 'ORG', 7912, 7913],\n",
       " ['AG', 'ORG', 7914, 7915],\n",
       " ['12-month', 'ORG', 7926, 7927],\n",
       " ['12-month', 'ORG', 7942, 7943],\n",
       " ['Panic Disorder Severity Scale', 'ORG', 7970, 7974],\n",
       " ['PSYCHIATRY/VOL 63', 'ORG', 8099, 8103],\n",
       " ['APR 2006', 'ORG', 8104, 8106],\n",
       " ['WWW.ARCHGENPSYCHIATRY.COM', 'ORG', 8106, 8107],\n",
       " ['American Medical Association', 'ORG', 8110, 8113],\n",
       " ['AG', 'ORG', 8127, 8128],\n",
       " ['PA-AG40', 'ORG', 8136, 8139],\n",
       " ['PD-AG', 'ORG', 8144, 8147],\n",
       " ['PD', 'ORG', 8151, 8152],\n",
       " ['AG', 'ORG', 8159, 8160],\n",
       " ['PD', 'ORG', 8161, 8162],\n",
       " ['AG', 'ORG', 8182, 8183],\n",
       " ['PD', 'ORG', 8186, 8187],\n",
       " ['PA', 'ORG', 8188, 8189],\n",
       " ['AG', 'ORG', 8196, 8197],\n",
       " ['PD', 'ORG', 8198, 8199],\n",
       " ['PA', 'ORG', 8212, 8213],\n",
       " ['PD-AG', 'ORG', 8215, 8218],\n",
       " ['PA-AG', 'ORG', 8239, 8242],\n",
       " ['PD', 'ORG', 8243, 8244],\n",
       " ['AG', 'ORG', 8255, 8256],\n",
       " ['PA', 'ORG', 8259, 8260],\n",
       " ['PA', 'ORG', 8276, 8277],\n",
       " ['PD', 'ORG', 8278, 8279],\n",
       " ['PA', 'ORG', 8324, 8325],\n",
       " ['PD', 'ORG', 8327, 8328],\n",
       " ['PA', 'ORG', 8375, 8376],\n",
       " ['PD', 'ORG', 8377, 8378],\n",
       " ['PA', 'ORG', 8388, 8389],\n",
       " ['PA', 'ORG', 8396, 8397],\n",
       " ['researchmightprofitablyattempttostudyPAonlyandevaluate', 'ORG', 8400, 8401],\n",
       " ['PD', 'ORG', 8408, 8409],\n",
       " ['NCS-R', 'ORG', 8426, 8429],\n",
       " ['PDSS', 'ORG', 8439, 8440],\n",
       " ['PD-AG', 'ORG', 8457, 8460],\n",
       " ['PA-AG', 'ORG', 8469, 8472],\n",
       " ['PD', 'ORG', 8473, 8474],\n",
       " ['PDSS', 'ORG', 8483, 8484],\n",
       " ['PDSS', 'ORG', 8495, 8496],\n",
       " ['SDS', 'ORG', 8502, 8503],\n",
       " ['AG (PA-AG', 'ORG', 8511, 8516],\n",
       " ['PD', 'ORG', 8522, 8523],\n",
       " ['PD', 'ORG', 8524, 8525],\n",
       " ['PA', 'ORG', 8527, 8528],\n",
       " ['AG', 'ORG', 8539, 8540],\n",
       " ['AG', 'ORG', 8560, 8561],\n",
       " ['PD', 'ORG', 8567, 8568],\n",
       " ['PA', 'ORG', 8569, 8570],\n",
       " ['AG', 'ORG', 8590, 8591],\n",
       " ['PA', 'ORG', 8594, 8595],\n",
       " ['PD', 'ORG', 8596, 8597],\n",
       " ['AG', 'ORG', 8607, 8608],\n",
       " ['AG', 'ORG', 8629, 8630],\n",
       " ['PD', 'ORG', 8633, 8634],\n",
       " ['AG', 'ORG', 8640, 8641],\n",
       " ['NCS-R', 'ORG', 8655, 8658],\n",
       " ['PD', 'ORG', 8663, 8664],\n",
       " ['PD and/or AG', 'ORG', 8688, 8691],\n",
       " ['Lifetime', 'ORG', 8791, 8792],\n",
       " ['PA-AG', 'ORG', 8814, 8817],\n",
       " ['PD-AG', 'ORG', 8819, 8822],\n",
       " ['Human', 'ORG', 9059, 9060],\n",
       " ['Guideline', 'ORG', 9138, 9139],\n",
       " ['AG', 'ORG', 9161, 9162],\n",
       " ['PA', 'ORG', 9165, 9166],\n",
       " ['PD', 'ORG', 9170, 9171],\n",
       " ['PA', 'ORG', 9175, 9176],\n",
       " ['PA', 'ORG', 9181, 9182],\n",
       " ['PD or AG', 'ORG', 9184, 9187],\n",
       " ['PA-AG', 'ORG', 9188, 9191],\n",
       " ['PA', 'ORG', 9195, 9196],\n",
       " ['AG', 'ORG', 9197, 9198],\n",
       " ['PD', 'ORG', 9200, 9201],\n",
       " ['PD', 'ORG', 9202, 9203],\n",
       " ['PD', 'ORG', 9208, 9209],\n",
       " ['AG', 'ORG', 9210, 9211],\n",
       " ['PD-AG', 'ORG', 9212, 9215],\n",
       " ['PD', 'ORG', 9219, 9220],\n",
       " ['AG', 'ORG', 9221, 9222],\n",
       " ['REPRINTED) ARCH GEN PSYCHIATRY/VOL 63', 'ORG', 9252, 9260],\n",
       " ['APR', 'ORG', 9261, 9262],\n",
       " ['American Medical Association', 'ORG', 9267, 9270],\n",
       " ['Submitted for Publication', 'ORG', 9308, 9311],\n",
       " ['Department of Health Care Policy', 'ORG', 9339, 9344],\n",
       " ['Harvard Medical School', 'ORG', 9345, 9348],\n",
       " ['Longwood Ave', 'ORG', 9350, 9352],\n",
       " ['The National Comorbidity Survey Replication', 'ORG', 9366, 9371],\n",
       " ['NCS-R', 'ORG', 9372, 9375],\n",
       " ['the National Institute of Mental Health', 'ORG', 9382, 9388],\n",
       " ['the National Institute of Drug Abuse', 'ORG', 9396, 9402],\n",
       " ['Substance Abuse', 'ORG', 9407, 9409],\n",
       " ['Mental Health Services Administration', 'ORG', 9410, 9414],\n",
       " ['The Robert Wood Johnson Foundation', 'ORG', 9418, 9423],\n",
       " ['Disclaimer', 'ORG', 9431, 9432],\n",
       " ['Harvard Medical School', 'ORG', 9481, 9484],\n",
       " ['Michigan State University', 'ORG', 9498, 9501],\n",
       " ['The Johns Hopkins University', 'ORG', 9509, 9513],\n",
       " ['Harvard University', 'ORG', 9528, 9530],\n",
       " ['Indiana University', 'ORG', 9539, 9541],\n",
       " ['New York State Psychiatric Institute', 'ORG', 9548, 9553],\n",
       " ['College of Physicians and Surgeons of Columbia University',\n",
       "  'ORG',\n",
       "  9554,\n",
       "  9562],\n",
       " ['University of Pittsburgh', 'ORG', 9570, 9573],\n",
       " ['Group Health Cooperative', 'ORG', 9582, 9585],\n",
       " ['Group Health Cooperative', 'ORG', 9595, 9598],\n",
       " ['Harvard Medical School', 'ORG', 9603, 9606],\n",
       " ['University of California', 'ORG', 9611, 9614],\n",
       " ['Cornell University', 'ORG', 9622, 9624],\n",
       " ['NY', 'ORG', 9627, 9628],\n",
       " ['HansUlrich Wittchen', 'ORG', 9631, 9633],\n",
       " ['Max Planck Institute of Psychiatry', 'ORG', 9634, 9639],\n",
       " ['Institute of Psychology, Technical University Dresden', 'ORG', 9645, 9652],\n",
       " ['NCS', 'ORG', 9662, 9663],\n",
       " ['NCS-R', 'ORG', 9670, 9673],\n",
       " ['NCS-R', 'ORG', 9689, 9692],\n",
       " ['the World Health Organization World Mental Health (WMH) Survey Initiative',\n",
       "  'ORG',\n",
       "  9697,\n",
       "  9709],\n",
       " ['R01', 'ORG', 9716, 9717],\n",
       " ['Catherine T. MacArthur Foundation', 'ORG', 9725, 9729],\n",
       " ['the Pfizer Foundation', 'ORG', 9730, 9733],\n",
       " ['the US Public Health Service', 'ORG', 9742, 9747],\n",
       " ['the Pan American Health Organization', 'ORG', 9757, 9762],\n",
       " ['Eli Lilly and Company', 'ORG', 9763, 9767],\n",
       " ['Ortho-McNeil Pharmaceutical, Inc', 'ORG', 9768, 9774],\n",
       " ['GlaxoSmithKline', 'ORG', 9775, 9776],\n",
       " ['Bristol-Myers Squibb', 'ORG', 9778, 9782],\n",
       " ['WMH', 'ORG', 9787, 9788],\n",
       " ['the WMH Data Collection', 'ORG', 9803, 9807],\n",
       " ['Data Analysis Coordination Centres', 'ORG', 9808, 9812],\n",
       " ['Kessler RC', 'ORG', 9828, 9830],\n",
       " ['McGonagle KA', 'ORG', 9831, 9833],\n",
       " ['Hughes M', 'ORG', 9840, 9842],\n",
       " ['Kendler KS', 'ORG', 9849, 9851],\n",
       " ['Lifetime', 'ORG', 9852, 9853],\n",
       " ['DSM-III', 'ORG', 9857, 9860],\n",
       " ['the National Comorbidity Survey', 'ORG', 9871, 9875],\n",
       " ['Magee WJ', 'ORG', 9895, 9897],\n",
       " ['the National Comorbidity Survey', 'ORG', 9934, 9938],\n",
       " ['Burke KC', 'ORG', 9949, 9951],\n",
       " ['Regier DA', 'ORG', 9956, 9958],\n",
       " ['Kessler RC', 'ORG', 9984, 9986],\n",
       " ['Wetzler S', 'ORG', 9995, 9997],\n",
       " ['Sanderson WC', 'ORG', 9998, 10000],\n",
       " ['Treatment Strategies for Patients With Psychiatric Comorbidity',\n",
       "  'ORG',\n",
       "  10003,\n",
       "  10010],\n",
       " ['John Wiley & Sons', 'ORG', 10016, 10020],\n",
       " ['Stang PE', 'ORG', 10028, 10030],\n",
       " ['HU, Ustun TB', 'ORG', 10032, 10036],\n",
       " ['Walters EE', 'ORG', 10042, 10044],\n",
       " ['Lifetime', 'ORG', 10045, 10046],\n",
       " ['the National Comorbidity Survey', 'ORG', 10051, 10055],\n",
       " ['Stang P', 'ORG', 10071, 10073],\n",
       " ['Walters EE', 'ORG', 10080, 10082],\n",
       " ['Kessler RC', 'ORG', 10083, 10085],\n",
       " ['Lifetime', 'ORG', 10086, 10087],\n",
       " ['the National Comorbidity Survey', 'ORG', 10092, 10096],\n",
       " ['Klerman GL', 'ORG', 10121, 10123],\n",
       " ['Ouellette R', 'ORG', 10127, 10129],\n",
       " ['Johnson J', 'ORG', 10130, 10132],\n",
       " ['JAMA', 'ORG', 10148, 10149],\n",
       " ['Markowitz JS', 'ORG', 10158, 10160],\n",
       " ['Ouellette R', 'ORG', 10164, 10166],\n",
       " ['DSM-IV', 'ORG', 10246, 10249],\n",
       " ['Katschnig H,', 'ORG', 10280, 10283],\n",
       " ['Eaton WW', 'ORG', 10305, 10307],\n",
       " ['Tien A', 'ORG', 10314, 10316],\n",
       " ['Onset', 'ORG', 10335, 10336],\n",
       " ['the Baltimore Epidemiologic Catchment Area', 'ORG', 10342, 10347],\n",
       " ['Heeringa S', 'ORG', 10373, 10375],\n",
       " ['NCS-R', 'ORG', 10400, 10403],\n",
       " ['Ustun TB', 'ORG', 10427, 10429],\n",
       " ['The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO)',\n",
       "  'ORG',\n",
       "  10430,\n",
       "  10448],\n",
       " ['Composite International Diagnostic Interview', 'ORG', 10448, 10452],\n",
       " ['Abelson J', 'ORG', 10471, 10473],\n",
       " ['Escobar JI', 'ORG', 10477, 10479],\n",
       " ['Vega WA', 'ORG', 10492, 10494],\n",
       " ['Walters EE', 'ORG', 10495, 10497],\n",
       " ['DSM-IV', 'ORG', 10509, 10512],\n",
       " ['the World Mental Health (WMH', 'ORG', 10514, 10520],\n",
       " ['the World Health Organization', 'ORG', 10523, 10527],\n",
       " ['Composite International Diagnostic Interview', 'ORG', 10530, 10534],\n",
       " ['Kessler RC', 'ORG', 10550, 10552],\n",
       " ['Walters EE', 'ORG', 10562, 10564],\n",
       " ['Lifetime', 'ORG', 10565, 10566],\n",
       " ['DSM-IV', 'ORG', 10575, 10578],\n",
       " ['the National Comorbidity Survey Replication', 'ORG', 10580, 10585],\n",
       " ['First MB', 'ORG', 10596, 10598],\n",
       " ['Structured Clinical Interview for DSM-IV Axis', 'ORG', 10608, 10616],\n",
       " ['Research Version', 'ORG', 10619, 10621],\n",
       " ['New York State Psychiatric Institute', 'ORG', 10640, 10645],\n",
       " ['Shear MK', 'ORG', 10650, 10652],\n",
       " ['Houck P', 'ORG', 10669, 10671],\n",
       " ['Spiegel DA', 'ORG', 10701, 10703],\n",
       " ['Shear MK', 'ORG', 10704, 10706],\n",
       " ['Depress Anxiety', 'ORG', 10723, 10725],\n",
       " ['Olfson M', 'ORG', 10735, 10737],\n",
       " ['Portera L', 'ORG', 10738, 10740],\n",
       " ['Farber L', 'ORG', 10741, 10743],\n",
       " ['Kessler RC', 'ORG', 10785, 10787],\n",
       " ['the National Comorbidity Survey Replication', 'ORG', 10802, 10807],\n",
       " ['American Psychiatric Association', 'ORG', 10818, 10821],\n",
       " ['Practice Guideline', 'ORG', 10822, 10824],\n",
       " ['the Treatment of Patients With Panic Disorder', 'ORG', 10825, 10832],\n",
       " ['American Psychiatric Association Press', 'ORG', 10837, 10841],\n",
       " ['Textbook of Psychopharmacology', 'ORG', 10854, 10857],\n",
       " ['American Psychiatric Publishing', 'ORG', 10862, 10865],\n",
       " ['REPRINTED) ARCH GEN PSYCHIATRY/VOL 63', 'ORG', 10869, 10877],\n",
       " ['APR', 'ORG', 10878, 10879],\n",
       " ['American Medical Association', 'ORG', 10884, 10887],\n",
       " ['Halli SS', 'ORG', 10901, 10903],\n",
       " ['Halli SS', 'ORG', 10907, 10909],\n",
       " ['Advanced Techniques of Population Analysis', 'ORG', 10910, 10915],\n",
       " ['NY:', 'ORG', 10919, 10921],\n",
       " ['Plenum Publishing Corp', 'ORG', 10921, 10924],\n",
       " ['DW', 'ORG', 10930, 10931],\n",
       " ['Lemeshow S. Applied Logistic Regression', 'ORG', 10932, 10937],\n",
       " ['John Wiley & Sons', 'ORG', 10946, 10950],\n",
       " ['Springer-Verlag NY Inc', 'ORG', 10968, 10973],\n",
       " ['SUDAAN', 'ORG', 10978, 10979],\n",
       " ['Professional Software for Survey Data Analysis', 'ORG', 10980, 10986],\n",
       " ['Version 8.0.1', 'ORG', 10987, 10989],\n",
       " ['Research Triangle Institute', 'ORG', 10996, 10999],\n",
       " ['Cannell CF', 'ORG', 11008, 11010],\n",
       " ['Schwarz N', 'ORG', 11011, 11013],\n",
       " ['Kessler RC', 'ORG', 11017, 11019],\n",
       " ['the US National Comorbidity Survey', 'ORG', 11031, 11036],\n",
       " ['Canino GJ', 'ORG', 11055, 11057],\n",
       " ['Hwu HG', 'ORG', 11064, 11066],\n",
       " ['Lee CK', 'ORG', 11073, 11075],\n",
       " ['Lellouch J', 'ORG', 11076, 11078],\n",
       " ['Oakley-Browne MA', 'ORG', 11085, 11089],\n",
       " ['RubioStipec M', 'ORG', 11090, 11092],\n",
       " ['Wells JE', 'ORG', 11093, 11095],\n",
       " ['Kessler RC', 'ORG', 11124, 11126],\n",
       " ['Psychiatric', 'ORG', 11147, 11148],\n",
       " ['John Wiley & Sons', 'ORG', 11155, 11159],\n",
       " ['JA', 'ORG', 11170, 11171],\n",
       " ['Oakley-Browne MA', 'ORG', 11172, 11176],\n",
       " ['Wells JE', 'ORG', 11177, 11179],\n",
       " ['Hornblow AR', 'ORG', 11180, 11182],\n",
       " ['Muller N', 'ORG', 11216, 11218],\n",
       " ['the German Health Interview and Examination Survey', 'ORG', 11238, 11245],\n",
       " ['GHS', 'ORG', 11246, 11247],\n",
       " ['Bruffaerts R', 'ORG', 11267, 11269],\n",
       " ['Bryson H', 'ORG', 11273, 11275],\n",
       " ['de Girolamo G', 'ORG', 11276, 11279],\n",
       " ['Gasquet I', 'ORG', 11286, 11288],\n",
       " ['Kessler RC', 'ORG', 11295, 11297],\n",
       " ['Kovess V', 'ORG', 11298, 11300],\n",
       " ['Ormel J', 'ORG', 11304, 11306],\n",
       " ['Autonell J', 'ORG', 11324, 11326],\n",
       " ['Bernal M', 'ORG', 11327, 11329],\n",
       " ['Buist-Bouwman MA', 'ORG', 11330, 11334],\n",
       " ['Joo SS', 'ORG', 11346, 11348],\n",
       " ['Matschinger H', 'ORG', 11354, 11356],\n",
       " ['Morgan Z', 'ORG', 11360, 11362],\n",
       " ['Taub N', 'ORG', 11372, 11374],\n",
       " ['Vollebergh WA', 'ORG', 11375, 11377],\n",
       " ['European Study of the Epidemiology of Mental Disorders',\n",
       "  'ORG',\n",
       "  11384,\n",
       "  11392],\n",
       " ['the European Study of the Epidemiology of Mental Disorders (',\n",
       "  'ORG',\n",
       "  11408,\n",
       "  11418],\n",
       " ['Barlow DH', 'ORG', 11433, 11435],\n",
       " ['Phobic', 'ORG', 11470, 11471],\n",
       " ['Cognitive-Behavioral Therapy', 'ORG', 11518, 11522],\n",
       " ['Sage Publications', 'ORG', 11531, 11533],\n",
       " ['White KS', 'ORG', 11540, 11542],\n",
       " ['Barlow DH', 'ORG', 11543, 11545],\n",
       " ['Barlow DH', 'ORG', 11553, 11555],\n",
       " ['Treatment of Anxiety and Panic', 'ORG', 11566, 11571],\n",
       " ['Guilford Publications', 'ORG', 11580, 11582],\n",
       " ['Crowe RR', 'ORG', 11589, 11591],\n",
       " ['Murrell E. Predictors', 'ORG', 11620, 11623],\n",
       " ['Norton GR', 'ORG', 11662, 11664],\n",
       " ['Panic Disorder', 'ORG', 11670, 11672],\n",
       " ['Practitioner', 'ORG', 11680, 11681],\n",
       " ['Norton GR', 'ORG', 11695, 11697],\n",
       " ['Harrison B', 'ORG', 11698, 11700],\n",
       " ['Norton GR', 'ORG', 11724, 11726],\n",
       " ['Dorward J', 'ORG', 11727, 11729],\n",
       " ['Bouton ME', 'ORG', 11751, 11753],\n",
       " ['Mineka S', 'ORG', 11754, 11756],\n",
       " ['Clark DM', 'ORG', 11780, 11782],\n",
       " ['Barlow DH', 'ORG', 11802, 11804],\n",
       " ['Telch MJ', 'ORG', 11824, 11826],\n",
       " ['Fabisch H', 'ORG', 11871, 11873],\n",
       " ['Lane M', 'ORG', 11902, 11904],\n",
       " ['Olfson M', 'ORG', 11905, 11907],\n",
       " ['Kessler RC', 'ORG', 11914, 11916],\n",
       " ['the National Comorbidity Survey Replication', 'ORG', 11932, 11937],\n",
       " ['Deveney C. Cognitive', 'ORG', 11951, 11954],\n",
       " ['Busch F', 'ORG', 12028, 12030],\n",
       " ['Roiphe J', 'ORG', 12037, 12039],\n",
       " ['Singer M', 'ORG', 12043, 12045],\n",
       " ['Goldman H', 'ORG', 12049, 12051],\n",
       " ['Shear MK', 'ORG', 12055, 12057],\n",
       " ['Pollack MH', 'ORG', 12083, 12085],\n",
       " ['REPRINTED) ARCH GEN PSYCHIATRY/VOL 63', 'ORG', 12132, 12140],\n",
       " ['APR', 'ORG', 12141, 12142],\n",
       " ['American Medical Association', 'ORG', 12147, 12150]]"
      ]
     },
     "execution_count": 100,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['NERF'][0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 83,
   "metadata": {},
   "outputs": [],
   "source": [
    "df['sents'] = [[s for s in i.sents] for i in df.doc]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 84,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0    [(ORIGINAL, ARTICLE), (The, Epidemiology, of, ...\n",
       "1    [(ORIGINAL, ARTICLE, Lifetime, Prevalence, and...\n",
       "2    [(MarketWatch, Medicaid, Cost, Containment, An...\n",
       "3    [(Unmet, Need, for, Personal, Assistance, Serv...\n",
       "4    [(ANNALS, OF, FAMILY, MEDICINE,  , WWW.ANNFAMM...\n",
       "Name: sents, dtype: object"
      ]
     },
     "execution_count": 84,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.sents"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>filename</th>\n",
       "      <th>rawContent</th>\n",
       "      <th>doc</th>\n",
       "      <th>NC</th>\n",
       "      <th>NER</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1003.txt</td>\n",
       "      <td>ORIGINAL ARTICLE The Epidemiology of Panic Att...</td>\n",
       "      <td>(ORIGINAL, ARTICLE, The, Epidemiology, of, Pan...</td>\n",
       "      <td>[[ORIGINAL ARTICLE, ARTICLE, ROOT, ARTICLE], [...</td>\n",
       "      <td>[[Panic Disorder, ORG, 8, 10], [Agoraphobia, G...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   filename                                         rawContent  \\\n",
       "0  1003.txt  ORIGINAL ARTICLE The Epidemiology of Panic Att...   \n",
       "\n",
       "                                                 doc  \\\n",
       "0  (ORIGINAL, ARTICLE, The, Epidemiology, of, Pan...   \n",
       "\n",
       "                                                  NC  \\\n",
       "0  [[ORIGINAL ARTICLE, ARTICLE, ROOT, ARTICLE], [...   \n",
       "\n",
       "                                                 NER  \n",
       "0  [[Panic Disorder, ORG, 8, 10], [Agoraphobia, G...  "
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head(1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "2443 2209\n",
      "8 10\n",
      "['Panic', 'Disorder,'] Panic Disorder\n",
      "12 13\n",
      "['in'] Agoraphobia\n",
      "14 22\n",
      "['National', 'Comorbidity', 'Survey', 'Replication', 'Ronald', 'C.', 'Kessler,', 'PhD;'] the National Comorbidity Survey Replication Ronald C. Kessler\n",
      "23 24\n",
      "['Tat'] PhD\n",
      "25 28\n",
      "['AM;', 'Robert', 'Jin,'] Wai Tat Chiu\n",
      "31 33\n",
      "['Ruscio,', 'PhD;'] Robert Jin\n",
      "34 35\n",
      "['Shear,'] MA\n",
      "36 39\n",
      "['Ellen', 'E.', 'Walters,'] Ayelet Meron Ruscio\n",
      "40 41\n",
      "['Context:'] PhD\n",
      "42 44\n",
      "['limited', 'information'] Katherine Shear\n",
      "45 46\n",
      "['about'] MD\n",
      "47 50\n",
      "['epidemiology', 'of', 'DSM-IV'] Ellen E. Walters\n",
      "51 53\n",
      "['attacks', '(PAs)'] MS Context\n",
      "62 65\n",
      "['data', 'about', 'the'] DSM-IV\n",
      "74 75\n",
      "['(AG)'] PD\n",
      "90 91\n",
      "['representative'] PD\n",
      "96 97\n",
      "['the'] AG\n",
      "102 108\n",
      "['Composite', 'International', 'Diagnostic', 'Interview.', 'Participants:', 'English-speaking'] the US National Comorbidity Survey Replication\n",
      "126 133\n",
      "['without', 'AG.', 'Results:', 'Lifetime', 'prevalence', 'estimates', 'are'] World Health Organization Composite International Diagnostic Interview\n",
      "136 137\n",
      "['panic'] English\n",
      "143 147\n",
      "['PA', 'with', 'AG', 'without'] 18 years or older\n",
      "158 159\n",
      "['for'] PD\n",
      "162 163\n",
      "['(PD-AG).'] AG\n",
      "166 167\n",
      "['of'] Lifetime\n",
      "170 172\n",
      "['of', 'years'] 22.7%\n",
      "176 179\n",
      "['across', 'these', '4'] AG (PA\n",
      "182 184\n",
      "['subgroups', 'are'] 0.8%\n",
      "185 186\n",
      "['comorbid'] PA\n",
      "187 188\n",
      "['other'] AG\n",
      "189 194\n",
      "['DSM-IV', 'disorders,', 'with', 'the', 'highest'] PD (PA-AG\n",
      "196 198\n",
      "['PD-AG', 'and'] 3.7%\n",
      "199 200\n",
      "['lowest'] PD\n",
      "201 202\n",
      "['PA'] AG\n",
      "203 204\n",
      "['Scores'] PD\n",
      "208 210\n",
      "['Severity', 'Scale'] 1.1%\n",
      "211 218\n",
      "['also', 'highest', 'for', 'PD-AG', '(86.3%', 'moderate', 'or'] PD with AG (PD-AG\n",
      "220 221\n",
      "['lowest'] Persistence\n",
      "230 231\n",
      "['associated'] years\n",
      "237 238\n",
      "['Lifetime'] 4\n",
      "241 242\n",
      "['(from'] 4\n",
      "249 252\n",
      "['only),', 'but', '12-month'] DSM-IV\n",
      "259 262\n",
      "['(from', '54.9%', 'for'] PD-AG\n",
      "266 267\n",
      "['PA'] PA\n",
      "271 276\n",
      "['major', 'societal', 'burden', 'of', 'panic'] the Panic Disorder Severity Scale\n",
      "280 283\n",
      "['and', 'PA-AG,', 'isolated'] PD-AG\n",
      "284 286\n",
      "['also', 'have'] 86.3%\n",
      "293 294\n",
      "['Gen'] PA\n",
      "296 298\n",
      "['EPIDEMIOLOGICAL', 'SURVEY'] 6.7%\n",
      "303 304\n",
      "['of'] Agoraphobia\n",
      "315 316\n",
      "['with'] Lifetime\n",
      "321 323\n",
      "['Despite', 'these'] 96.1%\n",
      "324 327\n",
      "['important', 'questions', 'remain'] PD-AG\n",
      "328 330\n",
      "['about', 'the'] 61.1%\n",
      "331 332\n",
      "['of'] PA\n",
      "336 337\n",
      "['important'] 12-month\n",
      "346 348\n",
      "['isolated', 'panic'] 54.9%\n",
      "349 352\n",
      "['(PAs)', 'that', 'do'] PD-AG\n",
      "353 355\n",
      "['meet', 'criteria'] 18.2%\n",
      "356 357\n",
      "['panic'] PA\n",
      "372 373\n",
      "['use'] PD\n",
      "374 377\n",
      "['psychotropic', 'medication,', 'and'] PA-AG\n",
      "389 392\n",
      "['led', 'to', 'the'] Arch Gen Psychiatry\n",
      "393 394\n",
      "['that'] 2006;63:415\n",
      "412 413\n",
      "['It'] 3\n",
      "419 422\n",
      "['persistent', 'course', 'and'] disorders,5-7\n",
      "466 467\n",
      "['community'] PD\n",
      "497 498\n",
      "['English-speaking'] Axis\n",
      "543 544\n",
      "['and'] AG\n",
      "553 554\n",
      "['Shear).'] AG\n",
      "562 563\n",
      "['415'] PA\n",
      "564 565\n",
      "['American'] PD\n",
      "570 571\n",
      "['Downloaded'] AG\n",
      "602 607\n",
      "['NCS-R', 'recruitment', 'and', 'consent', 'procedures.'] US National Comorbidity Survey Replication\n",
      "608 611\n",
      "['were', 'interviewed', 'in'] NCS-R\n",
      "616 619\n",
      "['interview,', 'administered', 'to'] NCS-R\n",
      "625 626\n",
      "['assessment.'] 9282\n",
      "626 627\n",
      "['The'] English\n",
      "641 644\n",
      "['lifetime', 'core', 'disorder'] between February 2001\n",
      "645 647\n",
      "['a', 'probability'] April 2003\n",
      "652 654\n",
      "['total', 'of'] 70.9%\n",
      "655 656\n",
      "['part'] Consent\n",
      "662 667\n",
      "['correlates', 'and', 'disorders', 'of', 'secondary'] Department of Health Care Policy\n",
      "668 671\n",
      "['The', 'part', '1'] Harvard Medical School\n",
      "672 673\n",
      "['is'] Boston\n",
      "674 675\n",
      "['here'] Mass\n",
      "676 678\n",
      "['examine', 'prevalence'] Drs Kessler\n",
      "679 680\n",
      "['course,'] Ruscio\n",
      "681 683\n",
      "['severity', 'and'] Messrs Chiu\n",
      "684 685\n",
      "['impairment,'] Jin\n",
      "687 689\n",
      "['aspects', 'of'] Ms Walters\n",
      "692 696\n",
      "['2', 'sample', 'is', 'used'] the Western Psychiatric Institute\n",
      "699 700\n",
      "['with'] Pittsburgh\n",
      "708 716\n",
      "['correlates,', 'and', 'treatment.', 'The', 'part', '1', 'sample', 'was'] REPRINTED) ARCH GEN PSYCHIATRY/VOL 63\n",
      "717 718\n",
      "['to'] APR\n",
      "720 721\n",
      "['differential'] 415\n",
      "722 723\n",
      "['of'] 2006\n",
      "723 726\n",
      "['selection', 'and', 'discrepancies'] American Medical Association\n",
      "744 745\n",
      "['weighted'] NCS\n",
      "752 757\n",
      "['selection', 'from', 'the', 'part', '1'] Harvard Medical School (Boston\n",
      "758 759\n",
      "['More'] Mass\n",
      "761 765\n",
      "['NCS-R', 'sampling', 'and', 'weights'] the University of Michigan\n",
      "766 768\n",
      "['reported', 'elsewhere.15'] Ann Arbor\n",
      "771 774\n",
      "['Panic', 'and', 'AG'] NCS-R\n",
      "783 784\n",
      "['version'] 2\n",
      "788 789\n",
      "['Organization'] 1\n",
      "804 805\n",
      "['assessment'] 2\n",
      "811 812\n",
      "['in'] 1\n",
      "832 833\n",
      "['blue\"'] 5692\n",
      "834 835\n",
      "['no'] 2\n",
      "851 852\n",
      "['2'] 1\n",
      "876 877\n",
      "['medical'] 2\n",
      "886 887\n",
      "['concern'] secondary\n",
      "900 901\n",
      "['behavior'] 1\n",
      "918 919\n",
      "['include'] US\n",
      "929 930\n",
      "['or'] 2\n",
      "944 945\n",
      "['that'] 1\n",
      "950 953\n",
      "['embarrassing', 'to', 'escape.'] NCS-R\n",
      "961 963\n",
      "['the', 'feared'] AG Panic\n",
      "964 965\n",
      "['distress'] AG\n",
      "968 974\n",
      "['these', 'situations,', 'or', 'the', 'necessity', 'of'] the World Mental Health Survey Initiatiave\n",
      "976 984\n",
      "['during', 'these', 'situations.', 'We', 'used', 'these', 'classifications', 'to'] the World Health Organization Composite International Diagnostic Interview\n",
      "1013 1014\n",
      "['The'] CIDI\n",
      "1067 1068\n",
      "['elsewhere,17,18'] 4\n",
      "1084 1086\n",
      "['(SCID)19', 'were'] 1 month\n",
      "1112 1113\n",
      "['receiver'] Agoraphobia\n",
      "1118 1119\n",
      "['a'] 2\n",
      "1151 1152\n",
      "['in'] PA\n",
      "1199 1200\n",
      "['analysis'] 4\n",
      "1205 1206\n",
      "['recurrent'] PA\n",
      "1207 1208\n",
      "['PAs,'] PD\n",
      "1209 1212\n",
      "['could', 'be', 'interpreted'] AG (PA\n",
      "1215 1216\n",
      "['more,'] PA\n",
      "1217 1224\n",
      "['a', 'PD', 'diagnosis.', 'However,', 'CIDI', 'respondents', 'who'] PD and AG (PA-AG\n",
      "1226 1227\n",
      "['or'] PD\n",
      "1228 1229\n",
      "['lifetime'] AG\n",
      "1230 1231\n",
      "['PAs'] PD\n",
      "1235 1236\n",
      "['the'] PD\n",
      "1237 1238\n",
      "['to'] AG\n",
      "1239 1242\n",
      "['had', 'only', '1'] PD-AG\n",
      "1245 1246\n",
      "['additional'] PA\n",
      "1253 1254\n",
      "['relation'] DSM\n",
      "1258 1261\n",
      "['was', 'improved', 'when'] PA-AG\n",
      "1265 1269\n",
      "['4', 'lifetime', 'uncued', 'attacks'] the DSM-IV\n",
      "1270 1271\n",
      "['the'] AG\n",
      "1275 1276\n",
      "['result'] PD\n",
      "1280 1281\n",
      "['PD'] AG\n",
      "1285 1286\n",
      "['differ'] PA\n",
      "1321 1329\n",
      "['first', 'attack', 'and', 'AOO', 'of', 'having', '4', 'uncued'] the Structured Clinical Interview for DSM-IV\n",
      "1330 1331\n",
      "['with'] SCID)19\n",
      "1338 1339\n",
      "['were'] 325\n",
      "1339 1340\n",
      "['asked'] NCS\n",
      "1356 1357\n",
      "['and'] PD\n",
      "1368 1369\n",
      "['assessed'] 0.72\n",
      "1379 1380\n",
      "['of'] 0.45\n",
      "1381 1382\n",
      "['7-question'] 0.15\n",
      "1393 1394\n",
      "['NCS-R.'] 56.3\n",
      "1395 1397\n",
      "['wording', 'is'] 95%\n",
      "1400 1401\n",
      "['The'] 15.5\n",
      "1411 1412\n",
      "['assessment'] CIDI\n",
      "1423 1424\n",
      "['the'] McNemar\n",
      "1426 1428\n",
      "['independently', 'of'] 2 1\n",
      "1429 1430\n",
      "['NCS-R'] 0\n",
      "1443 1444\n",
      "['PDSS'] PA\n",
      "1445 1446\n",
      "['points'] PA\n",
      "1460 1461\n",
      "['7'] AG\n",
      "1462 1463\n",
      "['questions'] AG\n",
      "1477 1481\n",
      "['(SDS),22', 'also', 'was', 'included'] The DSM-IV\n",
      "1491 1492\n",
      "['with'] 2\n",
      "1497 1498\n",
      "['the'] PD\n",
      "1502 1503\n",
      "['past'] CIDI\n",
      "1506 1509\n",
      "['panic,', 'their', 'worry'] 2 or 3\n",
      "1521 1523\n",
      "['worry', 'interfered'] only 1\n",
      "1524 1525\n",
      "['with'] PA\n",
      "1535 1536\n",
      "['a'] CIDI\n",
      "1547 1550\n",
      "['(0),', 'mild', '(1-3),'] at least 4\n",
      "1555 1556\n",
      "['very'] CIDI\n",
      "1558 1559\n",
      "['Interference'] McNemar\n",
      "1564 1565\n",
      "['role'] CIDI\n",
      "1574 1575\n",
      "['Responses'] SCID\n",
      "1580 1582\n",
      "['highest', 'score'] only 2\n",
      "1584 1585\n",
      "['4'] COURSE\n",
      "1589 1591\n",
      "['severe', 'and'] IMPAIRMENT Respondents\n",
      "1593 1596\n",
      "['response', 'categories.', 'COMORBID'] DSM-IV\n",
      "1599 1600\n",
      "['NCS-R'] PA\n",
      "1609 1610\n",
      "['disorders:'] AOO\n",
      "1613 1614\n",
      "['(generalized'] first\n",
      "1616 1617\n",
      "['specific'] AOO\n",
      "1619 1620\n",
      "['phobia,'] 4\n",
      "1623 1625\n",
      "['obsessive-compulsive', 'disorder,'] a month\n",
      "1654 1655\n",
      "['dependence,'] years\n",
      "1656 1659\n",
      "['which', 'abuse', 'and'] at least 1\n",
      "1677 1678\n",
      "['and'] 7-question\n",
      "1690 1696\n",
      "['conduct', 'disorder).', 'Organic', 'exclusion', 'rules', 'and'] the NCS-R. (Question\n",
      "1708 1709\n",
      "['more'] PDSS\n",
      "1717 1718\n",
      "['nonpatient'] PD\n",
      "1727 1728\n",
      "['CIDI'] PDSS\n",
      "1733 1734\n",
      "['mood,'] NCS\n",
      "1772 1773\n",
      "['to'] 2\n",
      "1775 1776\n",
      "['ORs'] 7\n",
      "1804 1805\n",
      "['12-month'] CIDI\n",
      "1807 1808\n",
      "['panic'] SDS\n",
      "1811 1812\n",
      "['the'] 12-month\n",
      "1816 1819\n",
      "['section.', 'Part', '2'] the 1 month\n",
      "1820 1823\n",
      "['additionally', 'were', 'asked'] the past year\n",
      "1832 1833\n",
      "['for'] PA\n",
      "1857 1858\n",
      "['distinguished'] 0\n",
      "1859 1860\n",
      "['5'] 10\n",
      "1874 1875\n",
      "['treatment'] 1\n",
      "1881 1882\n",
      "['asked'] 46\n",
      "1886 1889\n",
      "['of', 'visits;', 'number'] 7-9\n",
      "1895 1896\n",
      "['name,'] 10\n",
      "1898 1899\n",
      "['duration'] Interference\n",
      "1903 1904\n",
      "['No'] 4\n",
      "1929 1930\n",
      "['of'] 4\n",
      "1941 1946\n",
      "['(at', 'least', '2', 'months', 'of'] COMORBID DSM-IV DISORDERS\n",
      "1947 1950\n",
      "['appropriate', 'medication,', 'defined'] NCS-R\n",
      "1958 1961\n",
      "['visits', 'to', 'any'] DSM-IV\n",
      "2056 2057\n",
      "['course'] 3\n",
      "2080 2081\n",
      "['treatment'] Organic\n",
      "2116 2117\n",
      "['used'] CIDI\n",
      "2128 2129\n",
      "['was'] dis(REPRINTED\n",
      "2137 2138\n",
      "['comorbid'] APR\n",
      "2140 2141\n",
      "['Because'] 416\n",
      "2142 2143\n",
      "['NCS-R'] 2006\n",
      "2143 2146\n",
      "['sample', 'design', 'featured'] American Medical Association\n",
      "2165 2166\n",
      "['of'] 0.65\n",
      "2167 2168\n",
      "['of'] 0.81\n",
      "2169 2170\n",
      "['in']  \n",
      "2174 2175\n",
      "['were'] 0.33\n",
      "2176 2177\n",
      "['using'] 0.70\n",
      "2184 2185\n",
      "['variance-covariance'] 6.3\n",
      "2186 2187\n",
      "['Statistical'] 877.0\n",
      "2207 2208\n",
      "['for'] Two\n",
      "2212 2213\n",
      "['(0.5)'] 12-month\n",
      "2227 2228\n",
      "['lifetime'] 2\n",
      "2265 2267\n",
      "['PA-AG,', 'whereas'] seen.23 Treatment\n",
      "2270 2271\n",
      "['respondents'] 5\n",
      "2293 2296\n",
      "['(0.1)', 'for', '12-month'] the 12 months\n",
      "2339 2340\n",
      "['only'] 12-month\n",
      "2357 2359\n",
      "['of', '31.0'] guidelines.24 Guideline\n",
      "2369 2373\n",
      "['other', 'requirements', 'for', 'a'] at least 2 months\n",
      "2384 2387\n",
      "['subgroups,', 'the', 'exception'] at least 4\n",
      "2398 2401\n",
      "['67.9%', 'in', 'PD-AG'] at least 8\n",
      "2414 2418\n",
      "['cued', 'lifetime', 'attack.', 'Mean'] at least 30 minutes\n",
      "2424 2427\n",
      "['with', 'any', 'varies'] at least 4\n",
      "2437 2440\n",
      "['with', 'a', 'significantly'] at least 4\n",
      "2456 2457\n",
      "['and'] PD\n",
      "2463 2466\n",
      "['P=.03)', 'AG.', 'Agoraphobia'] at least 8\n",
      "2481 2484\n",
      "['(78.2', 'vs', '38.3,'] at least 8\n",
      "2485 2486\n",
      "['P=.02)'] visits.24\n",
      "2509 2512\n",
      "['PAs', '(28.3%)', 'PD'] at least 2\n",
      "2530 2532\n",
      "['disorder', '(PD)'] METHODS Cross\n",
      "2546 2547\n",
      "['PD'] method26\n",
      "2551 2552\n",
      "['history'] AOO\n",
      "2569 2570\n",
      "['history'] analysis27\n",
      "2580 2583\n",
      "['(3.7%)', 'and', 'PD-AG'] DSM-IV\n",
      "2587 2588\n",
      "['than'] NCS\n",
      "2601 2602\n",
      "['PSYCHIATRY/VOL'] Taylor\n",
      "2610 2611\n",
      "['Association.'] SUDAAN\n",
      "2612 2614\n",
      "['rights', 'reserved.'] system.29 Significance\n",
      "2627 2629\n",
      "['such', 'attacks'] Wald 2\n",
      "2646 2647\n",
      "['and'] 2-sided\n",
      "2656 2660\n",
      "['No', 'meaningful', 'difference', 'exists'] Twenty-eight percent\n",
      "2665 2667\n",
      "['among', 'the'] 28.3%\n",
      "2668 2669\n",
      "['subgroups'] 1.0\n",
      "2677 2678\n",
      "['distribution'] PA\n",
      "2679 2681\n",
      "['similar', 'across'] 11.2%\n",
      "2682 2683\n",
      "['subgroups'] 0.5\n",
      "2686 2687\n",
      "['AOO'] PA\n",
      "2689 2691\n",
      "['is', 'only'] 4.7%\n",
      "2692 2693\n",
      "['1'] 0.3\n",
      "2697 2700\n",
      "['AOO', 'of', 'PA'] roughly one sixth\n",
      "2704 2705\n",
      "['significantly'] PA\n",
      "2710 2711\n",
      "['subgroups'] PD\n",
      "2712 2714\n",
      "['vs', '22.9,'] 2.8%\n",
      "2718 2720\n",
      "['(12month', 'prevalence'] 12-month PD\n",
      "2721 2722\n",
      "['PA'] Eight\n",
      "2722 2723\n",
      "['among'] tenths\n",
      "2724 2726\n",
      "['cases),', 'however,'] 1%\n",
      "2730 2733\n",
      "['in', 'PA', 'only'] roughly 3%\n",
      "2738 2739\n",
      "['3'] PA\n",
      "2744 2747\n",
      "['higher', 'in', 'the'] PA-AG\n",
      "2748 2750\n",
      "['than', 'PA'] 0.4%\n",
      "2751 2752\n",
      "['in'] 0.1\n",
      "2754 2758\n",
      "['of', 'AG', '(57.4%', 'vs'] 12-month PA-AG\n",
      "2760 2762\n",
      "['P.001)', 'and'] 1.1%\n",
      "2763 2764\n",
      "['presence'] 0.1\n",
      "2768 2771\n",
      "['41.1%,', 'z=3.0,', 'P=.002)'] approximately one fifth\n",
      "2775 2776\n",
      "['as'] PD\n",
      "2777 2779\n",
      "['function', 'of'] 60%\n",
      "2783 2786\n",
      "['2', 'PA', 'subgroups'] PA-AG\n",
      "2791 2794\n",
      "['or', 'in', 'the'] PD-AG\n",
      "2795 2797\n",
      "['PD', 'subgroups'] 0.4%\n",
      "2798 2799\n",
      "['vs'] 0.1\n",
      "2801 2805\n",
      "['P=.36).', 'Mean', 'number', 'of'] 12-month PD-AG\n",
      "2806 2809\n",
      "['with', 'attacks', 'also'] COURSE OF ILLNESS\n",
      "2819 2820\n",
      "['same'] 4\n",
      "2825 2826\n",
      "['CORRELATES'] 1\n",
      "2831 2833\n",
      "['variation', 'in'] 22.7%\n",
      "2837 2840\n",
      "['correlates', 'of', 'lifetime'] PA-AG\n",
      "2841 2843\n",
      "['across', 'the'] 0.8%\n",
      "2844 2845\n",
      "['subgroups,'] PD\n",
      "2847 2849\n",
      "['ORs', 'associated'] 3.7%\n",
      "2851 2854\n",
      "['female', 'are', 'noticeably'] PD-AG\n",
      "2855 2857\n",
      "['for', 'the'] 1.1%\n",
      "2864 2865\n",
      "['ORs'] PD\n",
      "2866 2868\n",
      "['with', 'other'] 12.0%\n",
      "2869 2870\n",
      "['status'] PA\n",
      "2872 2874\n",
      "['higher', 'for'] 10.7%\n",
      "2875 2878\n",
      "['AG', 'than', 'non-AG'] PA-AG\n",
      "2889 2890\n",
      "['ages)'] PD\n",
      "2894 2895\n",
      "['nonHispanic'] 31.0\n",
      "2896 2897\n",
      "['have'] 131.4\n",
      "2911 2912\n",
      "['and'] PD\n",
      "2915 2916\n",
      "['have'] 1\n",
      "2921 2922\n",
      "['in'] 3\n",
      "2924 2925\n",
      "['subgroups.'] 4\n",
      "2930 2931\n",
      "['employment'] PD\n",
      "2934 2937\n",
      "['largely', 'of', 'the'] at least 1\n",
      "2938 2939\n",
      "['and'] lifetime\n",
      "2942 2944\n",
      "['odds', 'of'] 67.9%\n",
      "2945 2948\n",
      "['outcomes', 'other', 'than'] PD-AG\n",
      "2949 2951\n",
      "['only,', 'whereas'] 87.6%\n",
      "2952 2955\n",
      "['people', 'have', 'elevated'] PA-AG\n",
      "2960 2962\n",
      "['the', 'other'] 46.8%\n",
      "2963 2964\n",
      "['outcomes.'] PD\n",
      "2970 2971\n",
      "['in'] lifetime\n",
      "2989 2990\n",
      "['quite'] 18.2\n",
      "2991 2992\n",
      "['(in'] P.001\n",
      "3008 3009\n",
      "['odds'] PA\n",
      "3013 3014\n",
      "['lifetime'] 121.8\n",
      "3015 3016\n",
      "['disorders'] 38.3\n",
      "3017 3018\n",
      "['in'] z=6.6\n",
      "3019 3020\n",
      "['survey'] P.001\n",
      "3025 3026\n",
      "['comorbid'] 134.4\n",
      "3027 3028\n",
      "['are'] 78.2\n",
      "3031 3034\n",
      "['of', 'the', 'PA-only'] P=.03) AG\n",
      "3035 3036\n",
      "['1.'] Agoraphobia\n",
      "3050 3051\n",
      "['Subgroups'] PA\n",
      "3052 3054\n",
      "['PA', 'Only'] 78.2 vs\n",
      "3054 3055\n",
      "['(n'] 38.3\n",
      "3058 3059\n",
      "['(n'] P=.02\n",
      "3065 3066\n",
      "['344)'] PD\n",
      "3067 3068\n",
      "['(n'] 134.4\n",
      "3069 3070\n",
      "['105)'] 121.8\n",
      "3071 3072\n",
      "['3'] z=0.53\n",
      "3073 3074\n",
      "['prevalence'] P=.60\n",
      "3084 3085\n",
      "['(0.1)'] PA\n",
      "3087 3089\n",
      "['Lifetime', 'cued'] 22.7%\n",
      "3093 3095\n",
      "['(4.4)', '46.8'] 28.3%\n",
      "3096 3097\n",
      "['67.9'] PD\n",
      "3099 3101\n",
      "['4', 'Lifetime'] 3.7%\n",
      "3102 3105\n",
      "['attacks', '12.0', '(1.1)'] PD-AG\n",
      "3106 3108\n",
      "['(4.1)', '100.0'] 1.1%\n",
      "3109 3112\n",
      "['100.0', '(0)', '0.1'] PA-AG\n",
      "3113 3115\n",
      "['Age', 'of'] 0.8%\n",
      "3117 3118\n",
      "['PA'] 1\n",
      "3119 3120\n",
      "['(0.5)'] Lifetime\n",
      "3123 3126\n",
      "['(0.8)', '21.5', '(1.0)'] DSM-IV\n",
      "3135 3136\n",
      "['0.5'] PD\n",
      "3142 3143\n",
      "['17.0'] AG\n",
      "3151 3152\n",
      "['persistence*'] PA\n",
      "3154 3157\n",
      "['41.1', '(5.5)', '57.4'] PD or AG\n",
      "3158 3161\n",
      "['62.6', '(4.4)', '48.7'] PA-AG\n",
      "3165 3166\n",
      "['4.7'] PA\n",
      "3167 3168\n",
      "['6.6'] AG\n",
      "3170 3171\n",
      "['(0.6)'] PD\n",
      "3172 3173\n",
      "['(1.1)'] PD\n",
      "3178 3179\n",
      "['38.3'] PD\n",
      "3180 3181\n",
      "['78.2'] AG\n",
      "3182 3185\n",
      "['121.8', '(11.9)', '134.4'] PD-AG\n",
      "3189 3190\n",
      "['uncued'] PD\n",
      "3191 3192\n",
      "['31.0'] AG\n",
      "3197 3198\n",
      "['46.0'] PD\n",
      "3200 3202\n",
      "['Median', '1'] 3.7%\n",
      "3204 3207\n",
      "['attacks', '6.0', '(0.3)'] PD-AG\n",
      "3208 3210\n",
      "['(2.2)', '17.2'] 1.1%\n",
      "3217 3219\n",
      "['uncued', 'attacks'] 4.7%\n",
      "3222 3223\n",
      "['(48.3)'] PD\n",
      "3237 3238\n",
      "['PD,'] APR\n",
      "3240 3242\n",
      "['PA', 'only,'] 417 ©\n",
      "3242 3243\n",
      "['lifetime'] 2006\n",
      "3243 3246\n",
      "['history', 'of', 'PA'] American Medical Association\n",
      "3257 3258\n",
      "['with'] \f",
      "\n",
      "3279 3280\n",
      "['are'] PD\n",
      "3284 3285\n",
      "['error).'] 121.8\n",
      "3286 3287\n",
      "['are'] 31.3\n",
      "3290 3291\n",
      "['(standard'] P.001\n",
      "3294 3298\n",
      "['indicated.', '', 'Significant', 'at'] the PD-AG\n",
      "3300 3301\n",
      "['test.'] 134.4\n",
      "3306 3307\n",
      "['30'] P.001\n",
      "3315 3318\n",
      "['30', '50', '70'] AOO of PA\n",
      "3320 3321\n",
      "['60'] 4\n",
      "3323 3326\n",
      "['PA-AG', 'PD', 'Only'] 21.5-22.7\n",
      "3329 3330\n",
      "['Age'] 0.9\n",
      "3331 3332\n",
      "['Onset,'] P=.44\n",
      "3336 3338\n",
      "['Lifetime', 'Prevalence'] PA AOO\n",
      "3346 3347\n",
      "['panic'] 2\n",
      "3352 3353\n",
      "['lifetime'] PD\n",
      "3354 3359\n",
      "['subgroups', '(2', '3', '=6.9,', 'P=.07).'] only about 1 year later\n",
      "3361 3364\n",
      "['to', 'Figure', '1'] AOO of PA\n",
      "3371 3372\n",
      "['GEN'] PD\n",
      "3375 3378\n",
      "['2006', 'WWW.ARCHGENPSYCHIATRY.COM', '418'] PD-AG\n",
      "3380 3381\n",
      "['Medical'] 23.6\n",
      "3382 3383\n",
      "['All'] 22.9\n",
      "3386 3387\n",
      "['From:'] 0.5\n",
      "3393 3394\n",
      "['the'] 12month\n",
      "3396 3397\n",
      "['and'] PA\n",
      "3408 3410\n",
      "['conditions', 'differ'] 35.7%\n",
      "3411 3412\n",
      "['across'] PA\n",
      "3414 3416\n",
      "['subgroups,', 'with'] 62.6%\n",
      "3417 3420\n",
      "['lowest', 'ORs', 'consistently'] PD-AG\n",
      "3421 3422\n",
      "['the'] 2\n",
      "3422 3423\n",
      "['PA-only'] 3\n",
      "3424 3425\n",
      "['In'] 48.7\n",
      "3426 3427\n",
      "['case'] P.001\n",
      "3435 3436\n",
      "['depression,'] PD\n",
      "3443 3444\n",
      "['shown'] AG\n",
      "3445 3447\n",
      "['the', 'PA-AG'] 57.4%\n",
      "3448 3450\n",
      "['(4.4-24.0)', 'consistently'] 35.7%\n",
      "3453 3454\n",
      "['the'] P.001\n",
      "3459 3460\n",
      "['as'] AG\n",
      "3461 3463\n",
      "['as', 'the'] 62.6%\n",
      "3464 3466\n",
      "['ORs', '(2.5-25.8).'] 41.1%\n",
      "3467 3468\n",
      "['the'] z=3.0\n",
      "3479 3480\n",
      "['PA-AG'] AG\n",
      "3483 3484\n",
      "['comparable'] 2\n",
      "3487 3489\n",
      "['ORs', '(3.5-5.4),'] 41.1%\n",
      "3490 3492\n",
      "['the', 'PD-AG'] 35.7%\n",
      "3500 3501\n",
      "['for'] 2\n",
      "3504 3506\n",
      "['for', 'the'] 62.6%\n",
      "3507 3509\n",
      "['is', 'associated'] 57.4%\n",
      "3518 3519\n",
      "['comparable'] years\n",
      "3530 3531\n",
      "['ratings'] 46.7\n",
      "3532 3533\n",
      "['clinical'] P.001\n",
      "3561 3562\n",
      "['42.4%'] 4\n",
      "3576 3577\n",
      "['severe'] PD\n",
      "3579 3580\n",
      "['0.3%'] PA\n",
      "3595 3596\n",
      "['Subgroups*'] AG\n",
      "3606 3612\n",
      "['5172)', 'PA-AG', '(n', '=', '3572)', 'PD'] Age of 60 years or older\n",
      "3620 3621\n",
      "['Age,'] Hispanic\n",
      "3634 3635\n",
      "['1.7'] 4\n",
      "3656 3657\n",
      "['4.0'] 4\n",
      "3659 3660\n",
      "['Sex'] Respondents\n",
      "3684 3685\n",
      "['(0.3-3.2)'] PA\n",
      "3694 3697\n",
      "['0.4', '(0.3-0.6)', '0.5'] PD-AG\n",
      "3701 3702\n",
      "['2.1'] 3\n",
      "3720 3721\n",
      "['1.0'] Pearson\n",
      "3738 3741\n",
      "['1.2', '(0.8-1.9)', '0.8'] 0.01 to 0.02\n",
      "3747 3748\n",
      "['0.8'] 4\n",
      "3759 3762\n",
      "['1.0', '1.0', '1.0'] DSM-IV\n",
      "3769 3770\n",
      "['(1.2-2.1)'] 3\n",
      "3772 3773\n",
      "['Never'] One\n",
      "3780 3782\n",
      "['0.9', '(0.4-2.0)'] 71.9%\n",
      "3784 3785\n",
      "['6.3'] PA\n",
      "3787 3789\n",
      "['Employment', 'status'] Table 1\n",
      "3792 3793\n",
      "['1.0'] Persistence\n",
      "3795 3798\n",
      "['0.8', '(0.5-1.4)', '0.8'] Course of Panic\n",
      "3813 3814\n",
      "['1.0'] 1672\n",
      "3815 3818\n",
      "['1.2', '(0.2-6.6)', '1.0'] PA-AG\n",
      "3821 3822\n",
      "['Other'] 71\n",
      "3828 3829\n",
      "['3.8'] 344\n",
      "3830 3833\n",
      "['2', '1.7', '18.4'] PD-AG\n",
      "3836 3837\n",
      "['family'] 105\n",
      "3838 3840\n",
      "['Low', '1.2'] 2 3\n",
      "3840 3841\n",
      "['(0.9-1.6)'] Lifetime\n",
      "3846 3847\n",
      "['(0.6-3.2)'] 22.7\n",
      "3848 3849\n",
      "['1.0'] 1.0\n",
      "3850 3851\n",
      "['0.9'] 0.8\n",
      "3852 3853\n",
      "['1.4'] 0.1\n",
      "3856 3857\n",
      "['High-average'] 0.2\n",
      "3858 3859\n",
      "['(1.0-1.4)'] 1.1\n",
      "3860 3861\n",
      "['(0.3-1.7)'] 0.1\n",
      "3862 3864\n",
      "['(0.8-2.1)', '0.9'] NA 1\n",
      "3867 3868\n",
      "['1.0'] 76.2\n",
      "3869 3870\n",
      "['1.0'] 1.2\n",
      "3871 3872\n",
      "['8.4'] 87.6\n",
      "3873 3874\n",
      "['2.5'] 4.4\n",
      "3877 3878\n",
      "['agoraphobia;'] 3.0\n",
      "3879 3880\n",
      "['panic'] 67.9\n",
      "3881 3882\n",
      "['PD,'] 5.5\n",
      "3883 3885\n",
      "['disorder;', 'PA'] 90.7 4\n",
      "3885 3886\n",
      "['only,'] Lifetime\n",
      "3888 3889\n",
      "['of'] 12.0\n",
      "3890 3891\n",
      "['but'] 1.1\n",
      "3892 3893\n",
      "['PD'] 10.7\n",
      "3894 3895\n",
      "['AG;'] 4.1\n",
      "3896 3897\n",
      "['lifetime'] 100.0\n",
      "3898 3899\n",
      "['of'] 0\n",
      "3900 3901\n",
      "['with'] 100.0\n",
      "3902 3903\n",
      "['but'] 0\n",
      "3904 3905\n",
      "['PD;'] 0.1\n",
      "3910 3911\n",
      "['PD'] PA\n",
      "3911 3912\n",
      "['without'] 22.7\n",
      "3913 3914\n",
      "['PD-AG,'] 0.5\n",
      "3915 3916\n",
      "['history'] 22.1\n",
      "3917 3918\n",
      "['PD'] 1.7\n",
      "3919 3920\n",
      "['AG.'] 22.7\n",
      "3921 3922\n",
      "['on'] 0.8\n",
      "3923 3924\n",
      "['logistic'] 21.5\n",
      "3925 3926\n",
      "['analyses'] 1.0\n",
      "3927 3928\n",
      "['separately'] 0.9\n",
      "3928 3929\n",
      "['compare'] PD\n",
      "3930 3933\n",
      "['in', 'each', 'of'] NA NA 23.6\n",
      "3934 3935\n",
      "['4'] 0.9\n",
      "3936 3937\n",
      "['subgroups'] 22.9\n",
      "3938 3939\n",
      "['respondents'] 1.0\n",
      "3940 3941\n",
      "['have'] 0.5\n",
      "3941 3942\n",
      "['no'] AG\n",
      "3943 3944\n",
      "['history'] NA\n",
      "3946 3947\n",
      "['the'] 1.8\n",
      "3948 3950\n",
      "['sizes', 'differ'] NA 17.0\n",
      "3951 3952\n",
      "['respondents'] 1.4\n",
      "3958 3959\n",
      "['exclusive'] 2\n",
      "3959 3960\n",
      "['panic'] 3\n",
      "3960 3961\n",
      "['subgroups'] 12-mo\n",
      "3963 3964\n",
      "['only,'] 35.7\n",
      "3965 3966\n",
      "['PA-AG,'] 1.5\n",
      "3967 3968\n",
      "['PD'] 41.1\n",
      "3969 3970\n",
      "['and'] 5.5\n",
      "3971 3972\n",
      "['PD-AG)'] 57.4\n",
      "3973 3974\n",
      "['compared'] 3.7\n",
      "3975 3976\n",
      "['with'] 62.6\n",
      "3977 3978\n",
      "['3500'] 4.4\n",
      "3981 3982\n",
      "['no'] Years\n",
      "3984 3985\n",
      "['panic.'] 4.7\n",
      "3986 3987\n",
      "['at'] 0.2\n",
      "3988 3989\n",
      "['P.05'] 6.6\n",
      "3990 3991\n",
      "['2-sided'] 1.1\n",
      "3992 3993\n",
      "['(REPRINTED)'] 8.3\n",
      "3994 3995\n",
      "['GEN'] 0.6\n",
      "3996 3997\n",
      "['63,'] 10.7\n",
      "3998 3999\n",
      "['2006'] 1.1\n",
      "4000 4001\n",
      "['419'] 20.4\n",
      "4001 4002\n",
      "['©2006'] 1\n",
      "4002 4003\n",
      "['American'] Lifetime\n",
      "4005 4006\n",
      "['All'] 38.3\n",
      "4007 4008\n",
      "['reserved.'] 4.5\n",
      "4009 4010\n",
      "['From:'] 78.2\n",
      "4011 4012\n",
      "['on'] 16.0\n",
      "4013 4014\n",
      "['\\x0cspondents'] 121.8\n",
      "4015 4016\n",
      "['the'] 11.9\n",
      "4017 4018\n",
      "['subgroup'] 134.4\n",
      "4019 4020\n",
      "['higher'] 20.7\n",
      "4021 4023\n",
      "['ratings', '(45.3%'] 18.2 4\n",
      "4023 4024\n",
      "['with'] Lifetime\n",
      "4026 4027\n",
      "['severe'] 31.0\n",
      "4028 4029\n",
      "['and'] 4.5\n",
      "4030 4031\n",
      "['with'] 131.4\n",
      "4032 4033\n",
      "['rating)'] 29.4\n",
      "4034 4035\n",
      "['those'] 31.3\n",
      "4036 4037\n",
      "['the'] 2.7\n",
      "4038 4039\n",
      "['subgroup'] 46.0\n",
      "4040 4041\n",
      "['with'] 7.8\n",
      "4042 4043\n",
      "['or'] 4.3\n",
      "4044 4045\n",
      "['rating,'] 1\n",
      "4048 4049\n",
      "['severe'] 6.0\n",
      "4050 4051\n",
      "['Summary'] 0.3\n",
      "4052 4053\n",
      "['ratings'] 9.2\n",
      "4054 4055\n",
      "['role'] 2.2\n",
      "4056 4057\n",
      "['are'] 17.2\n",
      "4058 4059\n",
      "['to'] 8.8\n",
      "4060 4061\n",
      "['ratings'] 34.1\n",
      "4062 4063\n",
      "['being'] 70.4\n",
      "4064 4065\n",
      "['in'] NA\n",
      "4066 4067\n",
      "['PD-AG'] 4\n",
      "4067 4068\n",
      "['subgroup'] lifetime\n",
      "4070 4071\n",
      "['moderate'] 11.5\n",
      "4072 4073\n",
      "['severe'] 0.9\n",
      "4074 4075\n",
      "['and'] 100.2\n",
      "4076 4077\n",
      "['with'] 48.3\n",
      "4078 4079\n",
      "['rating)'] 10.0\n",
      "4080 4081\n",
      "['lowest'] 0.7\n",
      "4084 4085\n",
      "['subgroup'] 3.5\n",
      "4086 4088\n",
      "['with', 'moderate'] NA Abbreviations\n",
      "4089 4090\n",
      "['severe'] AG\n",
      "4093 4094\n",
      "['with'] NA\n",
      "4098 4099\n",
      "['ratings,'] PA\n",
      "4103 4104\n",
      "['has'] PD\n",
      "4108 4109\n",
      "['with'] PA\n",
      "4114 4115\n",
      "['39.0%'] PA\n",
      "4118 4121\n",
      "['than', 'the', 'PDonly'] PD or AG\n",
      "4122 4125\n",
      "['(76.8%', 'with', 'moderate'] PA-AG\n",
      "4129 4130\n",
      "['56.2%'] PA\n",
      "4131 4132\n",
      "['severe'] AG\n",
      "4135 4136\n",
      "['modal'] PD\n",
      "4137 4138\n",
      "['is'] PD\n",
      "4143 4144\n",
      "['other'] PD\n",
      "4145 4146\n",
      "['in'] AG\n",
      "4147 4150\n",
      "['PA-only', 'subgroup.', 'In'] PD-AG\n",
      "4154 4155\n",
      "['rating'] PD\n",
      "4156 4157\n",
      "['no'] AG\n",
      "4187 4188\n",
      "['are'] 2-sided\n",
      "4190 4191\n",
      "['the'] 100\n",
      "4194 4195\n",
      "['PA-only'] 50\n",
      "4195 4196\n",
      "['(61.1%)'] 30\n",
      "4196 4197\n",
      "['subgroups.'] 10\n",
      "4198 4200\n",
      "['proportions', 'that'] 40 20\n",
      "4209 4210\n",
      "['treatment'] 60\n",
      "4212 4215\n",
      "['PD-only', '(70.3%', 'vs'] PA-AG\n",
      "4217 4220\n",
      "['PD-AG', '(85.0%', 'vs'] PD-AG\n",
      "4221 4222\n",
      "['subgroups,'] 100\n",
      "4222 4225\n",
      "['but', 'substantially', 'lower'] Age of Onset\n",
      "4227 4229\n",
      "['PA-only', '(16.2%'] Cumulative Probability\n",
      "4233 4234\n",
      "['(37.6%'] 2\n",
      "4239 4240\n",
      "['common'] first\n",
      "4244 4245\n",
      "['the'] 4\n",
      "4247 4248\n",
      "['sector'] lifetime\n",
      "4251 4253\n",
      "['the', '4'] 2 3\n",
      "4254 4255\n",
      "['(32.3%-70.4%).'] 6.9\n",
      "4256 4257\n",
      "['exception'] P=.07\n",
      "4263 4264\n",
      "['health'] 1\n",
      "4278 4279\n",
      "['treatment,'] 63\n",
      "4280 4281\n",
      "['proportion'] APR\n",
      "4283 4284\n",
      "['cases'] 418\n",
      "4285 4286\n",
      "['received'] 2006\n",
      "4286 4289\n",
      "['treatment', 'in', 'the'] American Medical Association\n",
      "4300 4301\n",
      "['in'] \f",
      "\n",
      "4303 4305\n",
      "['subgroup', '(45.7%),'] 83.1%\n",
      "4307 4308\n",
      "['in'] PD\n",
      "4313 4315\n",
      "['(66.9%)', 'subgroups.'] 100%\n",
      "4318 4319\n",
      "['the'] 2\n",
      "4331 4332\n",
      "['all'] 4\n",
      "4341 4342\n",
      "['(52.7%'] PA\n",
      "4359 4360\n",
      "['treatment'] AG\n",
      "4364 4365\n",
      "['general'] PD\n",
      "4370 4373\n",
      "['in', 'any', 'other'] PA-AG\n",
      "4375 4378\n",
      "['each', 'Table', '3.'] 4.4-24.0\n",
      "4384 4385\n",
      "['Panic'] PD\n",
      "4389 4392\n",
      "['Disorders*', 'Disorder', 'PA'] 2.0-5.4\n",
      "4399 4402\n",
      "['Percentage', 'OR', '(95%'] PD-AG\n",
      "4404 4407\n",
      "['OR', '(95%', 'CI)'] 2.5-25.8\n",
      "4423 4426\n",
      "['(1.7-3.2)', '31.9', '8.5'] PA-AG\n",
      "4428 4431\n",
      "['4.4', '(2.9-6.8)', '15.0'] 3.2-5.1\n",
      "4436 4437\n",
      "['21.0'] PD\n",
      "4441 4444\n",
      "['(13.8-41.4)', '34.3', '3.8'] 3.5-5.4\n",
      "4448 4451\n",
      "['153.8', 'Social', 'phobia'] PD-AG\n",
      "4453 4454\n",
      "['(1.6-2.4)'] 5.6\n",
      "4475 4476\n",
      "['(3.4-7.5)'] 3\n",
      "4476 4477\n",
      "['39.6'] AG\n",
      "4478 4479\n",
      "['(6.8-19.7)'] PD\n",
      "4486 4489\n",
      "['NA', '8.2', '5.4'] 3.4-5.8\n",
      "4491 4494\n",
      "['20.2', '(5.5-73.9)', '20.8'] TWELVE-MONTH\n",
      "4494 4495\n",
      "['Separation'] CLINICAL\n",
      "4498 4500\n",
      "['3.1', '(2.3-4.0)'] IMPAIRMENT Summary\n",
      "4509 4510\n",
      "['40.6'] four\n",
      "4510 4511\n",
      "['Any'] 12-month\n",
      "4514 4516\n",
      "['45.0', '3.2'] 2 3\n",
      "4517 4520\n",
      "['94.9', '77.9', '(24.9-244.1)'] 34.3-102.9\n",
      "4521 4522\n",
      "['7.2'] P.001\n",
      "4530 4533\n",
      "['depressive', 'disorder', '28.2'] PD-AG\n",
      "4535 4537\n",
      "['48.7', '4.4'] 86.3%\n",
      "4544 4546\n",
      "['8.2', 'Dysthymia'] 42.4%\n",
      "4555 4556\n",
      "['14.6'] PA\n",
      "4560 4562\n",
      "['disorder', 'I'] 6.7%\n",
      "4569 4571\n",
      "['(2.7-9.6)', '14.4'] 0.3%\n",
      "4577 4578\n",
      "['Any'] 4\n",
      "4581 4582\n",
      "['2.5'] 2\n",
      "4586 4587\n",
      "['50.0'] 4\n",
      "4593 4596\n",
      "['Impulse-control', 'disorders', 'Attention-deficit/hyperactivity'] Characteristic Odds Ratio\n",
      "4597 4599\n",
      "['11.7', '2.3'] 95%\n",
      "4607 4608\n",
      "['20.0'] 5172\n",
      "4609 4612\n",
      "['defiant', 'disorder', '13.6'] PA-AG\n",
      "4615 4616\n",
      "['NA'] 3572\n",
      "4622 4623\n",
      "['Conduct'] 3844\n",
      "4624 4627\n",
      "['12.3', '1.9', '(1.4-2.6)'] PD-AG\n",
      "4630 4631\n",
      "['4.2'] 3604\n",
      "4635 4638\n",
      "['Intermittent', 'explosive', 'disorder'] 18-29\n",
      "4638 4639\n",
      "['7.8'] 1.0\n",
      "4639 4642\n",
      "['1.7', '(1.3-2.2)', '21.8'] 1.0 1.0 1.0\n",
      "4647 4650\n",
      "['9.0', '1.7', '(0.8-3.6)'] 0.7-1.3\n",
      "4651 4653\n",
      "['Any', 'impulse-control'] 1.6 (\n",
      "4653 4658\n",
      "['disorder', '33.7', '2.3', '(1.8-2.8)', '63.2'] 0.6-4.4) 1.5\n",
      "4659 4662\n",
      "['47.2', '4.3', '(2.8-6.6)'] 1.1-2.1\n",
      "4663 4664\n",
      "['NA'] 1.7\n",
      "4665 4668\n",
      "['Substance', 'use', 'disorders'] 1.0-2.8\n",
      "4669 4670\n",
      "['abuse'] 45\n",
      "4674 4677\n",
      "['(1.8-2.7)', '27.0', '3.2'] 0.7-1.2\n",
      "4678 4679\n",
      "['25.0'] 1.7\n",
      "4680 4683\n",
      "['(2.5-4.9)', '37.3', '5.6'] 0.5-6.0\n",
      "4686 4689\n",
      "['dependence', '8.5', '2.4'] 0.9-1.8\n",
      "4690 4692\n",
      "['14.2', '4.0'] 1.3 (\n",
      "4692 4695\n",
      "['(1.6-9.7)', '12.8', '4.1'] 0.7-2.4\n",
      "4696 4698\n",
      "['23.4', '7.3'] 60 0.4\n",
      "4699 4704\n",
      "['12.1', 'Illicit', 'drug', 'abuse', 'or'] 0.2-0.6) 0.5\n",
      "4705 4706\n",
      "['13.0'] 0.1\n",
      "4711 4714\n",
      "['17.5', '3.6', '(2.3-5.4)'] 0.2-0.7\n",
      "4715 4716\n",
      "['3.9'] 0.1\n",
      "4721 4722\n",
      "['5.6'] 2\n",
      "4722 4723\n",
      "['3.0'] 29.2\n",
      "4723 4724\n",
      "['(2.0-4.4)'] 4.0\n",
      "4724 4728\n",
      "['10.6', '5.8', '(2.1-16.0)', '9.1'] 24.2 35.5 Sex Male\n",
      "4728 4729\n",
      "['5.2'] 1.0\n",
      "4729 4730\n",
      "['(3.1-8.7)'] 1.0\n",
      "4730 4733\n",
      "['9.3', '4.6', '(1.9-10.9)'] 1.0 1.0 Female\n",
      "4733 4734\n",
      "['6.0'] 1.4\n",
      "4735 4738\n",
      "['substance', 'use', 'disorder'] 1.2-1.7\n",
      "4741 4745\n",
      "['31.4', '3.5', '(1.8-6.9)', '27.0'] 0.8-2.3)\n",
      "4745 4746\n",
      "['3.3'] 2.3\n",
      "4747 4750\n",
      "['37.3', '4.8', '(2.4-9.5)'] 1.8-3.0\n",
      "4751 4752\n",
      "['Any'] 2.0\n",
      "4753 4756\n",
      "['71.9', '3.3', '(2.8-4.1)'] 1.3-3.2\n",
      "4757 4758\n",
      "['NA'] 2\n",
      "4758 4759\n",
      "['83.1'] 16.5\n",
      "4759 4760\n",
      "['6.5'] 1.2\n",
      "4760 4761\n",
      "['(3.7-11.7)'] 38.6\n",
      "4761 4762\n",
      "['100.0'] 9.1\n",
      "4762 4764\n",
      "['NA', '5.3'] Race Hispanic\n",
      "4766 4767\n",
      "['agoraphobia;'] 0.4\n",
      "4770 4771\n",
      "['NA,'] 1.0\n",
      "4772 4773\n",
      "['applicable;'] 0.3\n",
      "4776 4778\n",
      "['PA,', 'panic'] 0.8 (\n",
      "4778 4779\n",
      "['attack;'] 0.5\n",
      "4784 4787\n",
      "['lifetime', 'history', 'of'] 0.3-2.1\n",
      "4791 4795\n",
      "['or', 'AG;', 'PA-AG,', 'lifetime'] 0.5-0.8)\n",
      "4795 4796\n",
      "['history'] 0.6\n",
      "4797 4800\n",
      "['PA', 'with', 'AG'] 0.3-1.5\n",
      "4803 4807\n",
      "['PD', 'only,', 'lifetime', 'history'] 0.3-0.6)\n",
      "4807 4808\n",
      "['of'] 0.5\n",
      "4809 4812\n",
      "['without', 'AG;', 'PD-AG,'] 0.2-1.0\n",
      "4814 4815\n",
      "['of'] 1.0\n",
      "4816 4819\n",
      "['with', 'AG.', '*Based'] 0.6-1.5\n",
      "4822 4825\n",
      "['multivariate', 'logistic', 'regression'] 0.6-7.0\n",
      "4826 4827\n",
      "['for'] 1.1\n",
      "4828 4831\n",
      "['row', 'of', 'the'] 0.6-2.0\n",
      "4834 4836\n",
      "['dummy', 'variables'] 0.2-\n",
      "4838 4840\n",
      "['4', 'panic'] White 1.0\n",
      "4840 4841\n",
      "['subgroups'] 1.0\n",
      "4841 4842\n",
      "['are'] 1.0\n",
      "4843 4845\n",
      "['to', 'predict'] 2 27.7\n",
      "4845 4847\n",
      "['lifetime', 'occurrence'] 2.5 23.5\n",
      "4848 4849\n",
      "['the'] Education\n",
      "4851 4854\n",
      "['controlling', 'for', 'age'] 0-11\n",
      "4856 4857\n",
      "['(in'] 1.0\n",
      "4858 4860\n",
      "['age', 'intervals),'] 12 1.0\n",
      "4861 4864\n",
      "['and', 'race-ethnicity.', 'The'] 0.7-1.3\n",
      "4867 4871\n",
      "['in', 'each', 'of', 'the'] 0.3-1.7)\n",
      "4873 4876\n",
      "['subgroups', 'with', 'respondents'] 0.6-1.3\n",
      "4877 4878\n",
      "['have'] 0.9\n",
      "4879 4882\n",
      "['lifetime', 'history', 'of'] 0.4-2.1\n",
      "4883 4886\n",
      "['Significant', 'at', 'the'] 13-15\n",
      "4888 4891\n",
      "['2-sided', 'test.', 'Insufficient'] 0.7-1.2\n",
      "4892 4893\n",
      "['for'] 0.9\n",
      "4894 4897\n",
      "['because', 'of', 'the'] 0.4-2.0\n",
      "4898 4899\n",
      "['prevalence'] 1.2\n",
      "4900 4902\n",
      "['PA-AG', 'and'] 0.8-\n",
      "4906 4908\n",
      "['PSYCHIATRY/VOL', '63,'] 0.3-\n",
      "4913 4916\n",
      "['American', 'Medical', 'Association.'] 0.7-1.2\n",
      "4917 4918\n",
      "['rights'] 0.5\n",
      "4919 4922\n",
      "['Downloaded', 'From:', 'http://archpsyc.jamanetwork.com/'] 0.2-1.5\n",
      "4923 4925\n",
      "['04/10/2014', '\\x0cof'] 0.8 (\n",
      "4925 4926\n",
      "['the'] 0.5\n",
      "4929 4930\n",
      "['The'] 0.7\n",
      "4931 4934\n",
      "['that', 'obtained', 'treatment'] 0.3-2.1\n",
      "4935 4936\n",
      "['with'] 2\n",
      "4937 4938\n",
      "['treatment'] 1.9\n",
      "4938 4939\n",
      "['guidelines'] 10.3\n",
      "4939 4941\n",
      "['did', 'not'] 0.7 Marital\n",
      "4942 4945\n",
      "['markedly', 'across', 'the'] Married/cohabitating\n",
      "4945 4950\n",
      "['3', 'subgroups', 'with', 'PD', 'or'] 1.0 1.0 1.0 1.0 Separated\n",
      "4954 4955\n",
      "['meeting'] 1.1\n",
      "4956 4959\n",
      "['guidelines', 'was', 'received'] 0.8-1.4\n",
      "4960 4961\n",
      "['a'] 2.2\n",
      "4962 4965\n",
      "['lower', 'proportion', 'of'] 1.1-4.2\n",
      "4968 4971\n",
      "['PA-only', 'subgroup', '(18.2%),'] 1.2-2.1\n",
      "4972 4973\n",
      "['treatment'] 1.3\n",
      "4974 4977\n",
      "['apply', 'to', 'PD'] 0.7-2.3\n",
      "4980 4981\n",
      "['to'] 1.0\n",
      "4982 4985\n",
      "['PAs.', 'COMMENT', 'These'] 0.8-1.2\n",
      "4986 4987\n",
      "['should'] 1.2\n",
      "4988 4989\n",
      "['interpreted'] 0.5\n",
      "4992 4993\n",
      "['several'] 1.2\n",
      "4994 4997\n",
      "['First,', 'the', 'response'] 0.8-1.8\n",
      "4998 4999\n",
      "['was'] 0.9\n",
      "5000 5003\n",
      "['70%.', 'As', 'described'] 0.4-2.0\n",
      "5004 5005\n",
      "['more'] 2\n",
      "5006 5007\n",
      "['elsewhere,15'] 6.3\n",
      "5007 5008\n",
      "['we'] 10.3\n",
      "5011 5017\n",
      "['in', 'a', 'nonrespondent', 'survey', 'in', 'which'] Working 1.0 1.0 1.0 1.0 Student\n",
      "5019 5022\n",
      "['of', 'initial', 'nonrespondents'] 0.5-1.4\n",
      "5023 5025\n",
      "['offered', 'a'] 0.8 (\n",
      "5025 5028\n",
      "['large', 'financial', 'incentive'] 0.2-3.5\n",
      "5029 5030\n",
      "['to'] 0.4\n",
      "5035 5036\n",
      "['interview'] 1.5\n",
      "5037 5038\n",
      "['included'] 0.5\n",
      "5041 5042\n",
      "['questions.'] Homemaker\n",
      "5044 5047\n",
      "['difference', 'was', 'found'] 0.5-1.3\n",
      "5048 5049\n",
      "['panic'] 2.0\n",
      "5050 5053\n",
      "['question', 'endorsement', 'compared'] 0.8-5.1\n",
      "5054 5055\n",
      "['responses'] 1.1\n",
      "5056 5059\n",
      "['the', 'main', 'survey'] 0.7-1.7\n",
      "5060 5062\n",
      "['indirectly', 'arguing'] 1.3 (\n",
      "5062 5063\n",
      "['against'] 0.5\n",
      "5066 5068\n",
      "['on', 'the'] Retired 1.0\n",
      "5069 5072\n",
      "['of', 'panic.', 'Second,'] 0.6-1.5\n",
      "5075 5078\n",
      "['with', 'SCID', 'PD'] 0.2-6.6\n",
      "5079 5080\n",
      "['was'] 1.0\n",
      "5081 5082\n",
      "['no'] 0.5\n",
      "5085 5086\n",
      "['obtained'] 4.3\n",
      "5087 5090\n",
      "['PA', 'or', 'AG.'] 1.6-11.3\n",
      "5092 5093\n",
      "['biased'] 1.1\n",
      "5094 5097\n",
      "['about', 'AOO,', 'persistence,'] 0.9-1.5\n",
      "5098 5099\n",
      "['other'] 3.6\n",
      "5100 5103\n",
      "['course', 'and', 'treatment'] 1.8-7.1\n",
      "5104 5105\n",
      "['were'] 1.5\n",
      "5106 5107\n",
      "['retrospectively.'] 1.0\n",
      "5110 5111\n",
      "['more'] 3.8\n",
      "5112 5115\n",
      "['elsewhere,16', 'a', 'number'] 2.1-6.8\n",
      "5116 5117\n",
      "['strategies'] 2\n",
      "5118 5119\n",
      "['used'] 18.4\n",
      "5120 5121\n",
      "['the'] 30.9\n",
      "5121 5122\n",
      "['NCS-R'] Annual\n",
      "5127 5128\n",
      "['exists'] 0.9\n",
      "5133 5136\n",
      "['accuracy', 'of', 'retrospective'] 0.5-2.3\n",
      "5137 5138\n",
      "['reports,30'] 1.3\n",
      "5139 5140\n",
      "['we'] 0.9\n",
      "5143 5144\n",
      "['about'] 1.4\n",
      "5145 5148\n",
      "['on', 'other', 'aspects'] 0.6-3.2\n",
      "5152 5153\n",
      "['limitations'] 1.0\n",
      "5154 5157\n",
      "['a', 'backdrop,', 'the'] 0.8-1.2\n",
      "5158 5159\n",
      "['lifetime'] 0.9\n",
      "5160 5163\n",
      "['estimates', 'of', 'DSM-IV'] 0.4-2.0\n",
      "5164 5165\n",
      "['and'] 1.4\n",
      "5166 5169\n",
      "['(4.7%', 'and', '1.1%,'] 0.9-2.1\n",
      "5170 5172\n",
      "['are', 'similar'] 0.8 (\n",
      "5172 5175\n",
      "['to', 'the', 'DSM-III-R1'] 0.4-1.7\n",
      "5179 5180\n",
      "['NCS'] 1.2\n",
      "5181 5184\n",
      "['and', '1.5%,', 'respectively).'] 1.0-1.4\n",
      "5185 5186\n",
      "['NCS-R'] 0.7\n",
      "5187 5188\n",
      "['of'] 0.3\n",
      "5193 5196\n",
      "['higher', 'than', 'in'] 0.8-2.1\n",
      "5197 5198\n",
      "['NCS'] 0.9\n",
      "5199 5202\n",
      "['Although', 'higher', 'than'] 0.5-1.6\n",
      "5204 5205\n",
      "['epidemiological'] 1.0\n",
      "5206 5207\n",
      "['the'] 1.0\n",
      "5207 5209\n",
      "['concordance', 'of'] 1.0 2\n",
      "5210 5211\n",
      "['NCS-R'] 0.9\n",
      "5211 5213\n",
      "['PD', 'prevalence'] 2.5 2.2\n",
      "5213 5216\n",
      "['estimate', 'with', 'an'] Abbreviations: AG\n",
      "5219 5220\n",
      "['argues'] PA\n",
      "5224 5225\n",
      "['the'] PD\n",
      "5229 5230\n",
      "['concern'] PA\n",
      "5235 5236\n",
      "['upward'] PA\n",
      "5238 5241\n",
      "['the', 'CIDI', 'requirement'] PD or AG\n",
      "5242 5245\n",
      "['anxiety', 'about', 'multiple'] PA-AG\n",
      "5249 5250\n",
      "['the'] PA\n",
      "5251 5252\n",
      "['requirement.'] AG\n",
      "5254 5255\n",
      "['persistence,'] PD\n",
      "5256 5257\n",
      "['correlates,'] PD\n",
      "5262 5263\n",
      "['consistent'] PD\n",
      "5264 5265\n",
      "['the'] AG\n",
      "5266 5269\n",
      "['NCS1,2,32', 'and', 'other'] PD-AG\n",
      "5273 5274\n",
      "['direct'] PD\n",
      "5275 5276\n",
      "['is'] AG\n",
      "5292 5293\n",
      "['prevalence'] 4\n",
      "5315 5316\n",
      "['survey'] 4\n",
      "5321 5322\n",
      "['a'] 1672\n",
      "5322 5323\n",
      "['much'] PA\n",
      "5325 5326\n",
      "['lifetime'] 72\n",
      "5326 5329\n",
      "['prevalence', 'of', 'PAs'] PA-AG\n",
      "5330 5331\n",
      "['the'] 344\n",
      "5331 5332\n",
      "['NCS-R'] PD\n",
      "5335 5339\n",
      "['the', 'NCS', '(7.3%),', 'a'] 104 PD-AG\n",
      "5345 5346\n",
      "['detailed'] 3500\n",
      "5357 5358\n",
      "['the'] P.05\n",
      "5360 5361\n",
      "['that'] 2-sided\n",
      "5364 5372\n",
      "['underestimated', 'in', 'the', 'baseline', 'NCS.', 'We', 'are', 'aware'] REPRINTED) ARCH GEN PSYCHIATRY/VOL 63\n",
      "5373 5374\n",
      "['no'] APR\n",
      "5376 5377\n",
      "['population'] 419\n",
      "5377 5378\n",
      "['research'] ©\n",
      "5378 5379\n",
      "['in'] 2006\n",
      "5379 5382\n",
      "['which', 'investigators', 'compared'] American Medical Association\n",
      "5393 5394\n",
      "['without'] \f",
      "\n",
      "5397 5400\n",
      "['striking', 'results', 'of'] PA-AG\n",
      "5406 5408\n",
      "['are', 'common'] 45.3%\n",
      "5415 5417\n",
      "['These', 'results'] 20.2%\n",
      "5425 5426\n",
      "['people'] PD\n",
      "5430 5432\n",
      "['to', 'meet'] 46.1%\n",
      "5439 5441\n",
      "['uncued', 'attacks,'] 6.0%\n",
      "5446 5448\n",
      "['cued', 'attacks.'] Summary SDS\n",
      "5461 5465\n",
      "['attacks', 'even', 'among', 'people'] the PD-AG\n",
      "5467 5469\n",
      "['This', 'finding'] 95.0%\n",
      "5476 5478\n",
      "['uncovers', 'initially'] 84.7%\n",
      "5486 5487\n",
      "['probably'] PA\n",
      "5491 5493\n",
      "['proportion', 'of'] 21.3%\n",
      "5500 5502\n",
      "['that', 'persistence'] 11.1%\n",
      "5514 5517\n",
      "['to', 'AG;', 'that'] PA-AG\n",
      "5520 5521\n",
      "['other'] SDS\n",
      "5523 5525\n",
      "['is', 'more'] 58.8%\n",
      "5532 5534\n",
      "['and', 'that'] 39.0%\n",
      "5543 5545\n",
      "['they', 'occur'] 76.8%\n",
      "5552 5554\n",
      "['suggest', 'that'] 56.2%\n",
      "5567 5568\n",
      "['respondents'] 3\n",
      "5573 5574\n",
      "['met'] PA\n",
      "5589 5591\n",
      "['4.', 'Clinical'] 70.6%\n",
      "5597 5598\n",
      "['in'] PD\n",
      "5612 5613\n",
      "['(n'] AG\n",
      "5614 5616\n",
      "['701)*', 'PA-AG'] 96.1%\n",
      "5620 5622\n",
      "['Only', '(n'] 84.8%\n",
      "5625 5626\n",
      "['(n'] 5\n",
      "5628 5629\n",
      "['Clinical'] Lifetime\n",
      "5634 5638\n",
      "['(7.1)', '6.0', '(2.5)', '42.4'] the PA-AG\n",
      "5639 5641\n",
      "['34.3', 'Moderate'] 74.7%\n",
      "5643 5644\n",
      "['25.1'] PA\n",
      "5647 5649\n",
      "['43.9', '(10.1)'] 61.1%\n",
      "5669 5670\n",
      "['Impairment§'] PD\n",
      "5673 5675\n",
      "['39.0', '(7.9)'] 70.3%\n",
      "5676 5678\n",
      "['(5.0)', '84.7'] 84.8%\n",
      "5680 5683\n",
      "['Moderate', '10.2', '(1.5)'] PD-AG\n",
      "5684 5686\n",
      "['(8.0)', '20.6'] 85.0%\n",
      "5687 5689\n",
      "['10.3', '(5.0)'] 96.1%\n",
      "5697 5698\n",
      "['5.0'] PA\n",
      "5701 5703\n",
      "['70.6', '(2.0)'] 16.2%\n",
      "5704 5706\n",
      "['(8.8)', '9.4'] 61.1%\n",
      "5708 5711\n",
      "['62.9', 'Abbreviations:', 'AG,'] PA-AG\n",
      "5712 5714\n",
      "['NA,', 'not'] 37.6%\n",
      "5715 5717\n",
      "['PA,', 'panic'] 74.7%\n",
      "5732 5733\n",
      "['PA-AG,'] 3\n",
      "5735 5736\n",
      "['of'] 4\n",
      "5738 5740\n",
      "['AG', 'but'] 32.3%-70.4%\n",
      "5745 5748\n",
      "['history', 'of', 'PD'] PA-AG\n",
      "5756 5758\n",
      "['AG.', '*The'] 46.1%\n",
      "5768 5770\n",
      "['does', 'not'] 42.7%\n",
      "5780 5781\n",
      "['estimate'] 12month\n",
      "5786 5788\n",
      "['table', 'because'] the year\n",
      "5794 5797\n",
      "['and', 'the', 'sample'] PD-AG\n",
      "5799 5801\n",
      "['the', 'actual'] 72.6%\n",
      "5806 5807\n",
      "['original'] PA\n",
      "5811 5813\n",
      "['categories', 'of'] 45.7%\n",
      "5818 5822\n",
      "['collapsed', 'to', 'define', 'the'] the PA-AG\n",
      "5823 5825\n",
      "['category', 'reported'] 60.8%\n",
      "5827 5828\n",
      "['at'] PD\n",
      "5831 5833\n",
      "['2-sided', 'test.'] 66.9%\n",
      "5844 5845\n",
      "['home,'] 12-month\n",
      "5859 5860\n",
      "['across'] PD\n",
      "5863 5868\n",
      "['original', 'Sheehan', 'Disability', 'Scale', 'categories'] 43.9% vs 66.9%\n",
      "5870 5873\n",
      "['and', 'very', 'severe'] PD-AG\n",
      "5874 5876\n",
      "['collapsed', 'to'] 52.7%\n",
      "5877 5879\n",
      "['the', 'severe'] 72.6%\n",
      "5884 5885\n",
      "['number'] PA\n",
      "5888 5890\n",
      "['at', 'least'] 14.7%\n",
      "5891 5893\n",
      "['impairment', 'is'] 45.7%\n",
      "5895 5898\n",
      "['inverse', 'of', 'the'] PA-AG\n",
      "5899 5901\n",
      "['with', 'no'] 29.7%\n",
      "5902 5904\n",
      "['the', '2'] 60.8%\n",
      "5907 5910\n",
      "['this', 'row', 'is'] Twelve-month\n",
      "5928 5929\n",
      "['American'] 3\n",
      "5932 5933\n",
      "['rights'] 4\n",
      "5948 5952\n",
      "['people', 'with', 'PA-AG40', 'and'] PA-AG PD\n",
      "5953 5956\n",
      "['of', 'people', 'with'] PD-AG\n",
      "5956 5957\n",
      "['PD-AG'] 2\n",
      "5957 5958\n",
      "['compared'] 3\n",
      "5961 5963\n",
      "['PD', 'only.39,41'] 95%\n",
      "5963 5964\n",
      "['Family'] CI\n",
      "5968 5970\n",
      "['that', 'AG'] 95%\n",
      "5970 5971\n",
      "['and'] CI\n",
      "5975 5977\n",
      "['least', 'some'] 95%\n",
      "5977 5978\n",
      "['distinct'] CI\n",
      "5982 5984\n",
      "['same', 'time,'] 95%\n",
      "5984 5985\n",
      "['our'] CI\n",
      "5989 5990\n",
      "['prevalence'] Generalized\n",
      "5992 5993\n",
      "['among'] 10.0\n",
      "5993 5994\n",
      "['people'] 2.4\n",
      "5995 5998\n",
      "['PD', 'than', 'PA'] 1.7-3.2\n",
      "5999 6001\n",
      "['consistent', 'with'] 31.9 8.5\n",
      "6002 6005\n",
      "['strong', 'association', 'between'] 4.9-14.6\n",
      "6006 6008\n",
      "['and', 'PD'] 21.3 4.4\n",
      "6009 6012\n",
      "['observed', 'in', 'clinical'] 2.9-6.8\n",
      "6013 6015\n",
      "['The', 'subgroup'] 15.0 2.6\n",
      "6016 6019\n",
      "['document', 'monotonic', 'increases'] 1.4-4.8\n",
      "6020 6021\n",
      "['PA'] 33.6\n",
      "6023 6024\n",
      "['PD-AG'] 21.0\n",
      "6024 6025\n",
      "['in'] 2.4\n",
      "6026 6029\n",
      "['of', 'attacks,', 'comorbidity,'] 2.0-3.0\n",
      "6030 6032\n",
      "['severity,', 'role'] 73.7 24.0\n",
      "6033 6036\n",
      "['and', 'treatment', 'seeking,'] 13.8-41.4\n",
      "6037 6039\n",
      "['intermediate', 'values'] 34.3 3.8\n",
      "6040 6045\n",
      "['PA-AG', 'and', 'PD', 'only.', 'Together'] 2.7-5.3) 75.2\n",
      "6047 6050\n",
      "['finding', 'that', 'a'] 14.3-46.6\n",
      "6051 6052\n",
      "['proportion'] 153.8\n",
      "6054 6055\n",
      "['is'] 18.8\n",
      "6055 6056\n",
      "['associated'] 1.9\n",
      "6057 6060\n",
      "['PA,', 'these', 'results'] 1.6-2.4\n",
      "6061 6062\n",
      "['be'] 65.5\n",
      "6064 6067\n",
      "['suggesting', 'that', 'panic'] 7.7-35.8\n",
      "6068 6069\n",
      "['along'] 31.1\n",
      "6071 6074\n",
      "['in', 'which', 'PA'] 2.3-4.2\n",
      "6076 6077\n",
      "['differ'] 15.5\n",
      "6078 6079\n",
      "['degree'] 9.3\n",
      "6082 6083\n",
      "['kind.'] 82.4\n",
      "6086 6088\n",
      "['consistent', 'with'] 12.0 3.0\n",
      "6089 6092\n",
      "['findings', 'that', 'infrequent,'] 2.3-3.9\n",
      "6096 6097\n",
      "['in'] 2.3\n",
      "6100 6101\n",
      "['that'] 21.6\n",
      "6101 6106\n",
      "['these', 'attacks', 'typically', 'include', 'fewer'] 5.0 (3.4-7.5\n",
      "6107 6108\n",
      "['less'] 39.6\n",
      "6110 6113\n",
      "['than', 'those', 'in'] 6.8-19.7\n",
      "6114 6115\n",
      "['with'] 40.7\n",
      "6119 6121\n",
      "['PA', 'aggregates'] 2.1 1.5\n",
      "6122 6125\n",
      "['PD', 'in', 'families.40,44'] 0.5-4.3\n",
      "6126 6127\n",
      "['distinction'] 0\n",
      "6128 6130\n",
      "['cued', 'and'] 8.2 5.4\n",
      "6131 6134\n",
      "['attacks', 'might', 'be'] 1.8-16.1\n",
      "6135 6137\n",
      "['into', 'question'] 19.6 20.2\n",
      "6138 6139\n",
      "['part'] 5.5\n",
      "6142 6144\n",
      "['line', 'of'] 20.8 Separation\n",
      "6146 6147\n",
      "['on'] 7.7\n",
      "6147 6148\n",
      "['the'] 3.1\n",
      "6149 6152\n",
      "['that', 'most', 'PAs'] 2.3-4.0\n",
      "6154 6155\n",
      "['some'] 6.3\n",
      "6160 6162\n",
      "['premature', 'to'] 11.0 4.4\n",
      "6167 6168\n",
      "['the'] 23.5\n",
      "6170 6171\n",
      "['PA'] 7.1\n",
      "6174 6175\n",
      "['arbitrary.'] 40.6\n",
      "6179 6180\n",
      "['prevalence'] 45.0\n",
      "6182 6183\n",
      "['only'] 2.7\n",
      "6186 6188\n",
      "['outcomes', 'associated'] 94.9 77.9\n",
      "6189 6192\n",
      "['PA', 'only,', 'future'] 24.9-244.1\n",
      "6193 6194\n",
      "['whether'] 66.0\n",
      "6196 6197\n",
      "['or'] 5.5\n",
      "6200 6202\n",
      "['PD', 'should'] 93.6 56.2\n",
      "6203 6206\n",
      "['modified', 'to', 'improve'] 22.4-141.0\n",
      "6207 6208\n",
      "['between'] 143.7\n",
      "6208 6209\n",
      "['pathological'] Mood\n",
      "6213 6215\n",
      "['An', 'innovation'] 28.2 2.1\n",
      "6216 6219\n",
      "['the', 'NCS-R', 'was'] 1.8-2.4\n",
      "6221 6222\n",
      "['of'] 4.4\n",
      "6223 6226\n",
      "['fully', 'structured', 'version'] 2.6-7.4\n",
      "6227 6229\n",
      "['the', 'PDSS'] 34.7 2.0\n",
      "6230 6233\n",
      "['assess', 'clinical', 'severity.'] 1.5-2.7\n",
      "6234 6235\n",
      "['lower'] 38.5\n",
      "6237 6240\n",
      "['clinical', 'samples,', '86.3%'] 1.5-4.0\n",
      "6241 6242\n",
      "['respondents'] 8.2\n",
      "6242 6244\n",
      "['with', 'PD-AG'] Dysthymia 5.0\n",
      "6246 6249\n",
      "['to', '46.1%', 'of'] 2.4-4.3\n",
      "6250 6252\n",
      "['with', 'PA-AG'] 10.0 5.0\n",
      "6253 6256\n",
      "['PD', 'only', 'were'] 2.1-12.0\n",
      "6257 6259\n",
      "['the', 'clinically'] 9.6 5.0\n",
      "6260 6263\n",
      "['range', 'on', 'the'] 2.9-8.8\n",
      "6264 6266\n",
      "['A', 'related'] 14.6 8.9\n",
      "6267 6270\n",
      "['is', 'that', 'clinical'] 4.2-18.8\n",
      "6271 6272\n",
      "['assessed'] 6.9\n",
      "6278 6279\n",
      "['assessed'] 2.8\n",
      "6280 6283\n",
      "['the', 'SDS', 'appear'] 2.3-3.5\n",
      "6287 6290\n",
      "['as', 'much', 'by'] 2.7-9.6\n",
      "6291 6293\n",
      "['(PA-AG', 'vs'] 14.4 5.4\n",
      "6294 6297\n",
      "['only)', 'as', 'by'] 3.6-7.9\n",
      "6298 6300\n",
      "['(PD', 'only'] 33.0 13.6\n",
      "6301 6304\n",
      "['PA', 'only).', 'This'] 8.0-23.2\n",
      "6305 6306\n",
      "['is'] 52.3\n",
      "6309 6311\n",
      "['findings', 'that'] 36.0 2.5\n",
      "6312 6315\n",
      "['is', 'associated', 'with'] 2.2-2.8\n",
      "6317 6318\n",
      "['anticipatory'] 7.1\n",
      "6319 6322\n",
      "['and', 'cognitive', 'correlates'] 4.1-12.3\n",
      "6323 6325\n",
      "['severity41,47-49', 'and'] 50.0 3.3\n",
      "6326 6329\n",
      "['finding', 'that', 'AG'] 2.4-4.5\n",
      "6330 6332\n",
      "['more', 'common'] 73.3 10.0\n",
      "6333 6336\n",
      "['people', 'with', 'PD'] 5.0-19.9\n",
      "6337 6338\n",
      "['PA.'] 35.3\n",
      "6342 6344\n",
      "['pattern', 'is'] Attention-\n",
      "6348 6350\n",
      "['number', 'of'] 11.7 2.3\n",
      "6351 6354\n",
      "['among', 'respondents', 'with'] 1.6-3.3\n",
      "6355 6356\n",
      "['those'] 28.8\n",
      "6356 6357\n",
      "['without'] NA\n",
      "6357 6359\n",
      "['AG', 'in'] 13.0 2.6\n",
      "6360 6363\n",
      "['the', 'PA', 'and'] 1.5-4.5\n",
      "6364 6365\n",
      "['samples.'] 36.2\n",
      "6365 6366\n",
      "['One'] NA\n",
      "6370 6372\n",
      "['pattern', 'is'] 13.6 2.5\n",
      "6373 6376\n",
      "['AG', 'is', 'a'] 1.8-3.5\n",
      "6377 6378\n",
      "['marker'] 12.2\n",
      "6378 6379\n",
      "['of'] NA\n",
      "6379 6381\n",
      "['panic,', 'although'] 13.0 2.4\n",
      "6382 6385\n",
      "['is', 'at', 'least'] 1.5-3.7\n",
      "6386 6387\n",
      "['inconsistent'] 27.6\n",
      "6387 6390\n",
      "['with', 'the', 'notion'] NA 7.3 Conduct\n",
      "6391 6393\n",
      "['previous', 'paragraphs'] 12.3 1.9\n",
      "6394 6397\n",
      "['AG', 'is', 'distinct'] 1.4-2.6\n",
      "6398 6399\n",
      "['PD'] 12.4\n",
      "6399 6400\n",
      "['disorder.'] NA\n",
      "6401 6402\n",
      "['possibility'] 4.2\n",
      "6403 6404\n",
      "['that'] 2.8\n",
      "6407 6408\n",
      "['direct'] 22.5\n",
      "6408 6409\n",
      "['effect'] NA\n",
      "6409 6410\n",
      "['on'] 18.8\n",
      "6413 6414\n",
      "['results'] 7.8\n",
      "6416 6419\n",
      "['with', 'previous', 'NCS-R'] 1.3-2.2\n",
      "6420 6422\n",
      "['that', 'most'] 21.8 5.3\n",
      "6423 6426\n",
      "['with', 'PD', 'eventually'] 2.4-11.6\n",
      "6427 6429\n",
      "['treatment,23', 'that'] 11.8 2.5\n",
      "6430 6433\n",
      "['active', 'cases', 'receive'] 1.4-4.4\n",
      "6434 6436\n",
      "['in', 'a'] 9.0 1.7\n",
      "6441 6442\n",
      "['current'] 9.5\n",
      "6447 6449\n",
      "['PD', 'and/or'] 33.7 2.3\n",
      "6450 6453\n",
      "['subgroups)', 'fails', 'to'] 1.8-2.8\n",
      "6454 6455\n",
      "['basic'] 63.2\n",
      "6455 6456\n",
      "['treatment'] NA\n",
      "6456 6458\n",
      "['guidelines.50', 'The'] 47.2 4.3\n",
      "6459 6462\n",
      "['result', 'is', 'all'] 2.8-6.6\n",
      "6463 6464\n",
      "['more'] 59.5\n",
      "6464 6465\n",
      "['striking'] NA\n",
      "6465 6466\n",
      "['in'] 24.6\n",
      "6473 6475\n",
      "['liberal.', 'For'] 19.3 2.2\n",
      "6476 6479\n",
      "['no', 'distinction', 'was'] 1.8-2.7\n",
      "6480 6481\n",
      "['among'] 27.0\n",
      "6483 6486\n",
      "['much', 'more', 'evidence'] 1.5-6.7\n",
      "6487 6489\n",
      "['the', 'effectiveness'] 25.0 3.5\n",
      "6490 6493\n",
      "['some', 'types', 'of'] 2.5-4.9\n",
      "6494 6496\n",
      "['than', 'others'] 37.3 5.6\n",
      "6497 6500\n",
      "['treating', 'panic,51-53', 'nor'] 2.7-11.5\n",
      "6501 6502\n",
      "['a'] 11.5\n",
      "6502 6503\n",
      "['distinction'] Alcohol\n",
      "6504 6506\n",
      "['among', 'antidepressants'] 8.5 2.4\n",
      "6507 6510\n",
      "['anxiolytics', 'despite', 'much'] 1.8-3.2\n",
      "6511 6512\n",
      "['evidence'] 14.2\n",
      "6514 6517\n",
      "['effectiveness', 'of', 'some'] 1.6-9.7\n",
      "6518 6520\n",
      "['others.54,55', 'In'] 12.8 4.1\n",
      "6521 6524\n",
      "['the', 'finding', 'that'] 2.6-6.3\n",
      "6526 6527\n",
      "['fail'] 7.3\n",
      "6528 6531\n",
      "['receive', 'guideline-concordant', 'treatment,'] 3.0-17.6\n",
      "6532 6533\n",
      "['patients'] 12.1\n",
      "6538 6540\n",
      "['dropped', 'Table'] 13.0 2.4\n",
      "6541 6544\n",
      "['Lifetime', 'and', '12-Month'] 1.8-3.0\n",
      "6545 6547\n",
      "['of', 'Respondents'] 17.7 3.4\n",
      "6548 6551\n",
      "['4', 'Mutually', 'Exclusive'] 1.6-7.3\n",
      "6552 6553\n",
      "['Subgroups'] 17.5\n",
      "6553 6554\n",
      "['Treatment'] 3.6\n",
      "6555 6558\n",
      "['(Standard', 'Error)', '2'] 2.3-5.4\n",
      "6559 6561\n",
      "['*', 'PA'] 20.6 3.9\n",
      "6562 6565\n",
      "['PA-AG', 'PD', 'Only'] 2.1-7.2\n",
      "6566 6567\n",
      "['Lifetime'] 7.3\n",
      "6567 6568\n",
      "['treatment'] Illicit\n",
      "6570 6572\n",
      "['1672)', '(n'] 5.6 3.0\n",
      "6573 6576\n",
      "['71)', '(n', '='] 2.0-4.4\n",
      "6578 6579\n",
      "['='] 5.8\n",
      "6580 6583\n",
      "['Psychiatrist', '24.2', '(1.2)'] 2.1-16.0\n",
      "6584 6586\n",
      "['(6.6)', '37.9'] 9.1 5.2\n",
      "6587 6590\n",
      "['58.4', '(4.9)', '58.5'] 3.1-8.7\n",
      "6594 6597\n",
      "['(1.3)', '46.1', '(7.1)'] 1.9-10.9\n",
      "6598 6599\n",
      "['(2.8)'] 6.0\n",
      "6603 6604\n",
      "['medical'] 21.4\n",
      "6604 6605\n",
      "['32.3'] 2.2\n",
      "6606 6609\n",
      "['42.7', '(6.4)', '56.0'] 1.8-2.6\n",
      "6611 6612\n",
      "['(4.9)'] 3.5\n",
      "6613 6616\n",
      "['Human', 'services', '15.1'] 1.8-6.9\n",
      "6617 6619\n",
      "['26.6', '(6.1)'] 27.0 3.3\n",
      "6624 6626\n",
      "['Complementary-alternative', '15.9'] 37.3 4.8\n",
      "6627 6630\n",
      "['35.5', '(7.1)', '19.1'] 2.4-9.5\n",
      "6631 6632\n",
      "['28.3'] 9.8\n",
      "6634 6636\n",
      "['Panic-specific', 'treatment'] 71.9 3.3\n",
      "6637 6640\n",
      "['(1.2)', '37.6', '(6.6)'] 2.8-4.1\n",
      "6641 6642\n",
      "['(2.8)'] 100.0\n",
      "6642 6645\n",
      "['85.0', '(4.3)', '101.1'] NA 83.1 6.5\n",
      "6646 6649\n",
      "['treatment', '61.1', '(1.3)'] 3.7-11.7\n",
      "6650 6651\n",
      "['(5.4)'] 100.0\n",
      "6651 6656\n",
      "['84.8', '(1.8)', '96.1', '(1.7)', '107.5'] NA 5.3 Abbreviations: AG\n",
      "6659 6660\n",
      "['='] CI\n",
      "6664 6665\n",
      "['(n'] NA\n",
      "6669 6670\n",
      "['42)'] OR\n",
      "6674 6675\n",
      "['(7.4)'] PA\n",
      "6679 6680\n",
      "['24.7'] PD\n",
      "6684 6685\n",
      "['(1.4)'] PA\n",
      "6690 6691\n",
      "['(6.4)'] PA\n",
      "6693 6696\n",
      "['medical', '25.5', '(1.7)'] PD or AG\n",
      "6697 6700\n",
      "['(7.9)', '46.0', '(5.0)'] PA-AG\n",
      "6704 6705\n",
      "['services'] PA\n",
      "6706 6707\n",
      "['(1.2)'] AG\n",
      "6709 6710\n",
      "['12.7'] PD\n",
      "6711 6712\n",
      "['14.3'] PD\n",
      "6717 6718\n",
      "['11.7'] PD\n",
      "6719 6720\n",
      "['9.7'] AG\n",
      "6721 6724\n",
      "['15.9', '(5.8)', '7.5'] PD-AG\n",
      "6728 6729\n",
      "['29.7'] PD\n",
      "6730 6731\n",
      "['43.9'] AG\n",
      "6753 6754\n",
      "['(5.0)'] 4\n",
      "6773 6775\n",
      "['not', 'PD'] 5-year age\n",
      "6793 6794\n",
      "['without'] 4\n",
      "6809 6810\n",
      "['of'] P.05\n",
      "6812 6813\n",
      "['among'] 2-sided\n",
      "6825 6828\n",
      "['test.', '(REPRINTED)', 'ARCH'] PA-AG\n",
      "6829 6832\n",
      "['PSYCHIATRY/VOL', '63,', 'APR'] PD-AG\n",
      "6834 6835\n",
      "['422'] REPRINTED\n",
      "6838 6842\n",
      "['Association.', 'All', 'rights', 'reserved.'] PSYCHIATRY/VOL 63\n",
      "6843 6845\n",
      "['From:', 'http://archpsyc.jamanetwork.com/'] APR 2006\n",
      "6846 6847\n",
      "['04/10/2014'] 420\n",
      "6848 6849\n",
      "['of'] 2006\n",
      "6849 6852\n",
      "['treatment', 'prematurely', 'rather'] American Medical Association\n",
      "6866 6867\n",
      "['future'] 4\n",
      "6869 6871\n",
      "['Submitted', 'for'] 25.5%-46.0%\n",
      "6889 6890\n",
      "['PhD,'] 3\n",
      "6892 6895\n",
      "['Health', 'Care', 'Policy,'] PD or AG\n",
      "6896 6898\n",
      "['Medical', 'School,'] 40.6%-54.9%\n",
      "6916 6917\n",
      "['grant'] PA\n",
      "6921 6923\n",
      "['Institute', 'of'] 18.2%\n",
      "6930 6933\n",
      "['the', 'National', 'Institute'] PD and AG\n",
      "6939 6940\n",
      "['Abuse'] COMMENT\n",
      "6951 6952\n",
      "['Johnson'] First\n",
      "6957 6960\n",
      "['Alden', 'Trust.', 'Disclaimer:'] only 70%\n",
      "6990 6991\n",
      "['US'] 100\n",
      "7039 7040\n",
      "['Mark'] Second\n",
      "7045 7047\n",
      "['Institute,', 'College'] SCID PD\n",
      "7057 7060\n",
      "['Pincus', '(University', 'of'] PA or AG\n",
      "7061 7062\n",
      "['Pittsburgh,'] Third\n",
      "7067 7068\n",
      "['Cooperative,'] AOO\n",
      "7096 7099\n",
      "['Wittchen', '(Max', 'Planck'] NCS-R\n",
      "7114 7115\n",
      "['complete'] AOO\n",
      "7137 7138\n",
      "['The'] NCS\n",
      "7144 7148\n",
      "['the', 'World', 'Health', 'Organization'] DSM-IV PD\n",
      "7149 7152\n",
      "['Mental', 'Health', '(WMH)'] PD-AG\n",
      "7153 7155\n",
      "['Initiative.', 'These'] 4.7%\n",
      "7156 7158\n",
      "['were', 'supported'] 1.1%\n",
      "7174 7175\n",
      "['Foundation;'] NCS\n",
      "7176 7178\n",
      "['R13-MH066849,', 'R01-MH069864,'] 3.5%\n",
      "7179 7181\n",
      "['R01-DA016558', 'from'] 1.5%\n",
      "7186 7187\n",
      "['grant'] NCS\n",
      "7191 7192\n",
      "['Fogarty'] PD\n",
      "7196 7198\n",
      "['American', 'Health'] 3.7%\n",
      "7205 7206\n",
      "['Inc;'] NCS\n",
      "7207 7208\n",
      "['and'] 2.0%).2\n",
      "7214 7215\n",
      "['WMH'] surveys,31\n",
      "7219 7223\n",
      "['http://www', '.hcp.med.harvard.edu/wmh/.', 'Acknowledgment:', 'We'] NCS-R PD\n",
      "7239 7240\n",
      "['instrumentation,'] AG\n",
      "7252 7253\n",
      "['Zhao'] CIDI\n",
      "7262 7266\n",
      "['Kendler', 'KS.', 'Lifetime', 'and'] the DSM-IV\n",
      "7284 7285\n",
      "['Psychiatry.'] NCS1,2,32\n",
      "7307 7308\n",
      "['3.'] 4\n",
      "7341 7342\n",
      "['onset'] One\n",
      "7354 7358\n",
      "['5.', 'Kessler', 'RC.', 'The'] the NCS-R\n",
      "7359 7361\n",
      "['of', 'psychiatric'] 28.3%\n",
      "7365 7366\n",
      "['Sanderson'] NCS\n",
      "7367 7369\n",
      "['eds.', 'Treatment'] 7.3%\n",
      "7382 7386\n",
      "['1997.', '6.', 'Kessler', 'RC,'] the DSM-IV\n",
      "7389 7390\n",
      "['HU,'] CIDI\n",
      "7407 7408\n",
      "['1998;55:801-808.'] NCS\n",
      "7430 7431\n",
      "['with'] PD\n",
      "7434 7435\n",
      "['and'] AG\n",
      "7454 7457\n",
      "['in', 'the', 'community:'] DSM-IV\n",
      "7476 7477\n",
      "['GL.'] PD\n",
      "7512 7513\n",
      "['and'] PD\n",
      "7527 7528\n",
      "['attacks'] cues,38,39\n",
      "7532 7533\n",
      "['a'] NCS\n",
      "7562 7563\n",
      "['predictors.'] PD\n",
      "7565 7566\n",
      "['Psychopharmacol.'] AG\n",
      "7581 7582\n",
      "['Neufeld'] AG\n",
      "7584 7585\n",
      "['T,'] PD\n",
      "7602 7603\n",
      "['Br'] AG\n",
      "7609 7610\n",
      "['Berglund'] AG\n",
      "7611 7612\n",
      "['Chiu'] PD\n",
      "7618 7622\n",
      "['E,', 'Jin', 'R,', 'Pennell'] as about 40%\n",
      "7626 7629\n",
      "['A,', 'Zheng', 'H.'] PA and AG\n",
      "7633 7634\n",
      "['Survey'] PD\n",
      "7647 7649\n",
      "['16.', 'Kessler'] Table 4\n",
      "7658 7659\n",
      "['Initiative'] 4\n",
      "7677 7678\n",
      "['17.'] 701\n",
      "7680 7683\n",
      "['Abelson', 'J,', 'Demler'] PA-AG\n",
      "7686 7687\n",
      "['Gibbon'] 37\n",
      "7694 7695\n",
      "['Vega'] 120\n",
      "7697 7700\n",
      "['EE,', 'Wang', 'P,'] PD-AG\n",
      "7703 7704\n",
      "['H.'] 41\n",
      "7709 7710\n",
      "['in'] 0.3\n",
      "7711 7712\n",
      "['World'] 0.2\n",
      "7713 7714\n",
      "['Health'] 20.2\n",
      "7715 7716\n",
      "['version'] 7.1\n",
      "7719 7720\n",
      "['Health'] 2.5\n",
      "7721 7722\n",
      "['(WHO)'] 42.4\n",
      "7723 7724\n",
      "['International'] 8.0\n",
      "7725 7726\n",
      "['Interview'] 34.3\n",
      "7727 7728\n",
      "['Int'] 6.4\n",
      "7729 7730\n",
      "['Methods'] 0.8\n",
      "7731 7732\n",
      "['Res.'] 25.1\n",
      "7733 7734\n",
      "['18.'] 7.9\n",
      "7735 7736\n",
      "['RC,'] 40.1\n",
      "7737 7738\n",
      "['P,'] 4.8\n",
      "7739 7740\n",
      "['O,'] 43.9\n",
      "7741 7742\n",
      "['R,'] 10.1\n",
      "7743 7744\n",
      "['EE.'] 102.9\n",
      "7745 7746\n",
      "['prevalence'] 14.9\n",
      "7747 7748\n",
      "['age-of-onset'] 2.0\n",
      "7749 7750\n",
      "['of'] 25.1\n",
      "7751 7752\n",
      "['disorders'] 5.6\n",
      "7753 7754\n",
      "['the'] 37.8\n",
      "7755 7756\n",
      "['Comorbidity'] 5.7\n",
      "7757 7758\n",
      "['Replication.'] 13.7\n",
      "7759 7760\n",
      "['Gen'] 4.5\n",
      "7761 7762\n",
      "['2005;62:593-602.'] 61.9\n",
      "7765 7766\n",
      "['Spitzer'] 2.2\n",
      "7767 7768\n",
      "['Gibbon'] 29.6\n",
      "7769 7770\n",
      "['Williams'] 8.3\n",
      "7771 7772\n",
      "['Structured'] 16.1\n",
      "7773 7774\n",
      "['Interview'] 4.4\n",
      "7781 7782\n",
      "['Non-patient'] 1.1\n",
      "7783 7784\n",
      "['(SCID-I/NP).'] 39.0\n",
      "7785 7786\n",
      "['York:'] 7.9\n",
      "7787 7788\n",
      "['Research,'] 56.2\n",
      "7789 7790\n",
      "['York'] 5.0\n",
      "7791 7792\n",
      "['Psychiatric'] 84.7\n",
      "7793 7794\n",
      "['2002.'] 5.3\n",
      "7795 7796\n",
      "['Shear'] 108.4\n",
      "7797 7798\n",
      "['Rucci'] 10.2\n",
      "7799 7800\n",
      "['Williams'] 1.5\n",
      "7801 7802\n",
      "['Frank'] 19.8\n",
      "7803 7804\n",
      "['Grochocinski'] 8.0\n",
      "7805 7806\n",
      "['Vander'] 20.6\n",
      "7807 7808\n",
      "['J,'] 4.4\n",
      "7811 7812\n",
      "['T.'] 5.0\n",
      "7813 7814\n",
      "['and'] 119.8\n",
      "7815 7816\n",
      "['of'] 8.1\n",
      "7817 7818\n",
      "['Panic'] 1.2\n",
      "7819 7820\n",
      "['Severity'] 11.7\n",
      "7821 7822\n",
      "['replication'] 5.9\n",
      "7825 7826\n",
      "['Psychiatr'] 3.1\n",
      "7827 7828\n",
      "['2001;35:293-296.'] 5.0\n",
      "7829 7830\n",
      "['Houck'] 3.0\n",
      "7831 7832\n",
      "['Spiegel'] 62.9\n",
      "7835 7836\n",
      "['Rucci'] 2.0\n",
      "7837 7838\n",
      "['Reliability'] 29.4\n",
      "7839 7840\n",
      "['the'] 8.8\n",
      "7841 7842\n",
      "['version'] 9.4\n",
      "7843 7844\n",
      "['the'] 3.3\n",
      "7849 7850\n",
      "['Anxiety.'] AG\n",
      "7853 7854\n",
      "['AC,'] NA\n",
      "7858 7859\n",
      "['Farber'] PA\n",
      "7863 7864\n",
      "['psychiatric'] PD\n",
      "7868 7869\n",
      "['with'] PA\n",
      "7874 7875\n",
      "['J'] PA\n",
      "7877 7880\n",
      "['1997;27:93-105.', '23.', 'Wang'] PD or AG\n",
      "7881 7884\n",
      "['Berglund', 'P,', 'Olfson'] PA-AG\n",
      "7888 7889\n",
      "['KB,'] PA\n",
      "7890 7891\n",
      "['RC.'] AG\n",
      "7893 7894\n",
      "['delay'] PD\n",
      "7895 7896\n",
      "['initial'] PD\n",
      "7901 7902\n",
      "['of'] PD\n",
      "7903 7904\n",
      "['disorders'] AG\n",
      "7905 7908\n",
      "['the', 'National', 'Comorbidity'] PD-AG\n",
      "7912 7913\n",
      "['Psychiatry.'] PD\n",
      "7914 7915\n",
      "['24.'] AG\n",
      "7926 7927\n",
      "['Panic'] 12-month\n",
      "7935 7937\n",
      "['25.', 'Schatzberg'] Table 1\n",
      "7942 7943\n",
      "['of'] 12-month\n",
      "7970 7974\n",
      "['04/10/2014', '\\x0c26.', 'Halli', 'SS,'] Panic Disorder Severity Scale\n",
      "7993 7994\n",
      "['Lemeshow'] P.05\n",
      "7996 7997\n",
      "['Logistic'] 2-sided\n",
      "8003 8004\n",
      "['John'] 4\n",
      "8033 8034\n",
      "['Triangle'] 4\n",
      "8037 8039\n",
      "['Triangle', 'Institute;'] Sheehan Disability\n",
      "8078 8080\n",
      "['RC,', 'Canino'] 2 3\n",
      "8090 8093\n",
      "['EG,', 'Lee', 'CK,'] the preceding row\n",
      "8099 8103\n",
      "['Oakley-Browne', 'MA,', 'RubioStipec', 'M,'] PSYCHIATRY/VOL 63\n",
      "8104 8106\n",
      "['JE,', 'Wickramaratne'] APR 2006\n",
      "8106 8107\n",
      "['PJ,'] WWW.ARCHGENPSYCHIATRY.COM\n",
      "8107 8108\n",
      "['Wittchen'] 421\n",
      "8109 8110\n",
      "['Yeh'] 2006\n",
      "8110 8113\n",
      "['EK.', 'The', 'cross-national'] American Medical Association\n",
      "8124 8125\n",
      "['Epidemiology'] \f",
      "\n",
      "8127 8128\n",
      "['comorbidity.'] AG\n",
      "8136 8139\n",
      "['Textbook', 'in', 'Psychiatric'] PA-AG40\n",
      "8144 8147\n",
      "['Wiley', '&', 'Sons;'] PD-AG\n",
      "8151 8152\n",
      "['Bushnell'] PD\n",
      "8159 8160\n",
      "['The'] AG\n",
      "8161 8162\n",
      "['of'] PD\n",
      "8182 8183\n",
      "['N,'] AG\n",
      "8186 8187\n",
      "['co-morbidity'] PD\n",
      "8188 8189\n",
      "['correlates'] PA\n",
      "8196 8197\n",
      "['results'] AG\n",
      "8198 8199\n",
      "['the'] PD\n",
      "8212 8213\n",
      "['Angermeyer'] PA\n",
      "8215 8218\n",
      "['S,', 'Bruffaerts', 'R,'] PD-AG\n",
      "8239 8242\n",
      "['Lepine', 'JP,', 'Ormel'] PA-AG\n",
      "8243 8244\n",
      "['Polidori'] PD\n",
      "8255 8256\n",
      "['Bernal'] AG\n",
      "8259 8260\n",
      "['Codony'] PA\n",
      "8276 8277\n",
      "['P,'] PA\n",
      "8278 8279\n",
      "['C,'] PD\n",
      "8324 8325\n",
      "['36.'] PA\n",
      "8327 8328\n",
      "['Vermilyea'] PD\n",
      "8375 8376\n",
      "['In:'] PA\n",
      "8377 8378\n",
      "['KS,'] PD\n",
      "8388 8389\n",
      "['Oaks,'] PA\n",
      "8396 8397\n",
      "['Barlow'] PA\n",
      "8400 8401\n",
      "['and'] researchmightprofitablyattempttostudyPAonlyandevaluate\n",
      "8408 8409\n",
      "['Its'] PD\n",
      "8426 8429\n",
      "['40.', 'Crowe', 'RR,'] NCS-R\n",
      "8439 8440\n",
      "['panic'] PDSS\n",
      "8452 8454\n",
      "['agoraphobic', 'avoidance.'] 86.3%\n",
      "8457 8460\n",
      "['1988;2:203-217.', '42.', 'Wittchen'] PD-AG\n",
      "8461 8463\n",
      "['Essau', 'CA.'] 45.3%\n",
      "8464 8466\n",
      "['epidemiology', 'of'] 46.1%\n",
      "8469 8472\n",
      "['disorder,', 'and', 'agoraphobia.'] PA-AG\n",
      "8473 8474\n",
      "['Walker'] PD\n",
      "8483 8484\n",
      "['Agoraphobia:'] PDSS\n",
      "8495 8496\n",
      "['43.'] PDSS\n",
      "8502 8503\n",
      "['Rhodes'] SDS\n",
      "8511 8516\n",
      "['J', 'Abnorm', 'Psychol.', '1985;94:216-221.', '44.'] AG (PA-AG\n",
      "8522 8523\n",
      "['Factors'] PD\n",
      "8524 8525\n",
      "['with'] PD\n",
      "8527 8528\n",
      "['in'] PA\n",
      "8539 8540\n",
      "['DH.'] AG\n",
      "8553 8556\n",
      "['2001;108:4-32.', '46.', 'Clark'] severity41,47-49\n",
      "8560 8561\n",
      "['to'] AG\n",
      "8567 8568\n",
      "['Craske'] PD\n",
      "8569 8570\n",
      "['Barlow'] PA\n",
      "8590 8591\n",
      "['CF,'] AG\n",
      "8594 8595\n",
      "['CB.'] PA\n",
      "8596 8597\n",
      "['of'] PD\n",
      "8599 8600\n",
      "['in'] One\n",
      "8607 8608\n",
      "['Langs'] AG\n",
      "8629 8630\n",
      "['J'] AG\n",
      "8633 8634\n",
      "['50.'] PD\n",
      "8640 8641\n",
      "['Pincus'] AG\n",
      "8655 8658\n",
      "['States:', 'results', 'from'] NCS-R\n",
      "8663 8664\n",
      "['Arch'] PD\n",
      "8683 8685\n",
      "['J', 'Clin'] 45%-60%\n",
      "8687 8688\n",
      "['4):28-32.'] 3\n",
      "8688 8691\n",
      "['52.', 'Westen', 'D,'] PD and/or AG\n",
      "8698 8699\n",
      "['for'] guidelines.50\n",
      "8744 8745\n",
      "['A'] 53\n",
      "8789 8790\n",
      "['J'] 5\n",
      "8791 8792\n",
      "['2005;8:473-482.'] Lifetime\n",
      "8793 8795\n",
      "['ARCH', 'GEN'] 12-Month Treatment\n",
      "8798 8799\n",
      "['2006'] 4\n",
      "8809 8811\n",
      "['From:', 'http://archpsyc.jamanetwork.com/'] 2 3\n",
      "8814 8817\n",
      "[] PA-AG\n",
      "8819 8822\n",
      "[] PD-AG\n",
      "8822 8823\n",
      "[] Lifetime\n",
      "8827 8828\n",
      "[] 1672\n",
      "8832 8833\n",
      "[] 71\n",
      "8837 8838\n",
      "[] 344\n",
      "8842 8843\n",
      "[] 105\n",
      "8844 8845\n",
      "[] Psychiatrist\n",
      "8845 8846\n",
      "[] 24.2\n",
      "8847 8848\n",
      "[] 1.2\n",
      "8849 8850\n",
      "[] 39.4\n",
      "8851 8852\n",
      "[] 6.6\n",
      "8853 8854\n",
      "[] 37.9\n",
      "8855 8856\n",
      "[] 2.5\n",
      "8857 8858\n",
      "[] 58.4\n",
      "8859 8860\n",
      "[] 4.9\n",
      "8861 8862\n",
      "[] 58.5\n",
      "8865 8866\n",
      "[] 26.5\n",
      "8867 8868\n",
      "[] 1.3\n",
      "8869 8870\n",
      "[] 46.1\n",
      "8871 8872\n",
      "[] 7.1\n",
      "8875 8876\n",
      "[] 2.8\n",
      "8877 8878\n",
      "[] 48.1\n",
      "8879 8880\n",
      "[] 4.2\n",
      "8881 8882\n",
      "[] 32.7\n",
      "8884 8885\n",
      "[] 32.3\n",
      "8886 8887\n",
      "[] 1.2\n",
      "8888 8889\n",
      "[] 42.7\n",
      "8890 8891\n",
      "[] 6.4\n",
      "8892 8893\n",
      "[] 56.0\n",
      "8894 8895\n",
      "[] 2.9\n",
      "8896 8897\n",
      "[] 70.4\n",
      "8898 8899\n",
      "[] 4.9\n",
      "8900 8901\n",
      "[] 88.1\n",
      "8903 8904\n",
      "[] 15.1\n",
      "8905 8906\n",
      "[] 1.3\n",
      "8907 8908\n",
      "[] 26.6\n",
      "8909 8910\n",
      "[] 6.1\n",
      "8911 8912\n",
      "[] 17.6\n",
      "8913 8914\n",
      "[] 2.3\n",
      "8915 8916\n",
      "[] 16.5\n",
      "8917 8918\n",
      "[] 4.1\n",
      "8919 8920\n",
      "[] 4.7\n",
      "8923 8924\n",
      "[] 15.9\n",
      "8925 8926\n",
      "[] 1.0\n",
      "8927 8928\n",
      "[] 35.5\n",
      "8929 8930\n",
      "[] 7.1\n",
      "8931 8932\n",
      "[] 19.1\n",
      "8933 8934\n",
      "[] 1.9\n",
      "8935 8936\n",
      "[] 28.3\n",
      "8937 8938\n",
      "[] 4.7\n",
      "8939 8940\n",
      "[] 31.0\n",
      "8944 8945\n",
      "[] 16.2\n",
      "8946 8947\n",
      "[] 1.2\n",
      "8948 8949\n",
      "[] 37.6\n",
      "8950 8951\n",
      "[] 6.6\n",
      "8952 8953\n",
      "[] 70.3\n",
      "8954 8955\n",
      "[] 2.8\n",
      "8956 8957\n",
      "[] 85.0\n",
      "8958 8959\n",
      "[] 4.3\n",
      "8960 8961\n",
      "[] 101.1\n",
      "8963 8964\n",
      "[] 61.1\n",
      "8965 8966\n",
      "[] 1.3\n",
      "8967 8968\n",
      "[] 74.7\n",
      "8969 8970\n",
      "[] 5.4\n",
      "8971 8972\n",
      "[] 84.8\n",
      "8973 8974\n",
      "[] 1.8\n",
      "8975 8976\n",
      "[] 96.1\n",
      "8977 8978\n",
      "[] 1.7\n",
      "8979 8980\n",
      "[] 107.5\n",
      "8985 8986\n",
      "[] 701\n",
      "8990 8991\n",
      "[] 36\n",
      "8995 8996\n",
      "[] 120\n",
      "9000 9001\n",
      "[] 42\n",
      "9002 9003\n",
      "[] Psychiatrist\n",
      "9009 9010\n",
      "[] 7.4\n",
      "9011 9012\n",
      "[] 27.2\n",
      "9013 9014\n",
      "[] 4.7\n",
      "9015 9016\n",
      "[] 34.6\n",
      "9017 9018\n",
      "[] 7.1\n",
      "9019 9020\n",
      "[] 24.7\n",
      "9023 9024\n",
      "[] 15.2\n",
      "9025 9026\n",
      "[] 1.4\n",
      "9027 9028\n",
      "[] 21.1\n",
      "9029 9030\n",
      "[] 8.1\n",
      "9033 9034\n",
      "[] 4.7\n",
      "9035 9036\n",
      "[] 41.0\n",
      "9037 9038\n",
      "[] 6.4\n",
      "9039 9040\n",
      "[] 33.8\n",
      "9042 9043\n",
      "[] 25.5\n",
      "9044 9045\n",
      "[] 1.7\n",
      "9046 9047\n",
      "[] 30.6\n",
      "9048 9049\n",
      "[] 7.9\n",
      "9050 9051\n",
      "[] 46.0\n",
      "9052 9053\n",
      "[] 5.0\n",
      "9054 9055\n",
      "[] 45.1\n",
      "9056 9057\n",
      "[] 7.4\n",
      "9058 9059\n",
      "[] 25.1\n",
      "9059 9060\n",
      "[] Human\n",
      "9061 9062\n",
      "[] 8.5\n",
      "9063 9064\n",
      "[] 1.2\n",
      "9065 9066\n",
      "[] 21.6\n",
      "9067 9068\n",
      "[] 7.3\n",
      "9069 9070\n",
      "[] 12.7\n",
      "9071 9072\n",
      "[] 3.0\n",
      "9073 9074\n",
      "[] 14.3\n",
      "9075 9076\n",
      "[] 6.1\n",
      "9077 9078\n",
      "[] 7.7\n",
      "9078 9080\n",
      "[] Complementary-\n",
      "9081 9082\n",
      "[] 6.2\n",
      "9083 9084\n",
      "[] 1.0\n",
      "9087 9088\n",
      "[] 5.7\n",
      "9089 9090\n",
      "[] 9.7\n",
      "9091 9092\n",
      "[] 3.0\n",
      "9093 9094\n",
      "[] 15.9\n",
      "9095 9096\n",
      "[] 5.8\n",
      "9097 9098\n",
      "[] 7.5\n",
      "9102 9103\n",
      "[] 14.7\n",
      "9104 9105\n",
      "[] 1.4\n",
      "9106 9107\n",
      "[] 29.7\n",
      "9108 9109\n",
      "[] 8.9\n",
      "9110 9111\n",
      "[] 43.9\n",
      "9112 9113\n",
      "[] 4.5\n",
      "9114 9115\n",
      "[] 52.7\n",
      "9116 9117\n",
      "[] 7.3\n",
      "9118 9119\n",
      "[] 123.7\n",
      "9121 9122\n",
      "[] 45.7\n",
      "9123 9124\n",
      "[] 2.4\n",
      "9125 9126\n",
      "[] 60.8\n",
      "9127 9128\n",
      "[] 8.4\n",
      "9129 9130\n",
      "[] 66.9\n",
      "9131 9132\n",
      "[] 4.6\n",
      "9133 9134\n",
      "[] 72.6\n",
      "9135 9136\n",
      "[] 6.5\n",
      "9137 9138\n",
      "[] 24.3\n",
      "9138 9139\n",
      "[] Guideline\n",
      "9142 9143\n",
      "[] 18.2\n",
      "9144 9145\n",
      "[] 1.7\n",
      "9146 9147\n",
      "[] 40.6\n",
      "9148 9149\n",
      "[] 9.0\n",
      "9150 9151\n",
      "[] 45.1\n",
      "9152 9153\n",
      "[] 5.0\n",
      "9154 9155\n",
      "[] 54.9\n",
      "9156 9157\n",
      "[] 6.3\n",
      "9161 9162\n",
      "[] AG\n",
      "9165 9166\n",
      "[] PA\n",
      "9170 9171\n",
      "[] PD\n",
      "9175 9176\n",
      "[] PA\n",
      "9181 9182\n",
      "[] PA\n",
      "9184 9187\n",
      "[] PD or AG\n",
      "9188 9191\n",
      "[] PA-AG\n",
      "9195 9196\n",
      "[] PA\n",
      "9197 9198\n",
      "[] AG\n",
      "9200 9201\n",
      "[] PD\n",
      "9202 9203\n",
      "[] PD\n",
      "9208 9209\n",
      "[] PD\n",
      "9210 9211\n",
      "[] AG\n",
      "9212 9215\n",
      "[] PD-AG\n",
      "9219 9220\n",
      "[] PD\n",
      "9221 9222\n",
      "[] AG\n",
      "9236 9237\n",
      "[] 4\n",
      "9245 9246\n",
      "[] P.05\n",
      "9248 9249\n",
      "[] 2-sided\n",
      "9252 9260\n",
      "[] REPRINTED) ARCH GEN PSYCHIATRY/VOL 63\n",
      "9261 9262\n",
      "[] APR\n",
      "9264 9265\n",
      "[] 422\n",
      "9266 9267\n",
      "[] 2006\n",
      "9267 9270\n",
      "[] American Medical Association\n",
      "9308 9311\n",
      "[] Submitted for Publication\n",
      "9312 9316\n",
      "[] April 5, 2005\n",
      "9320 9324\n",
      "[] July 13, 2005\n",
      "9326 9330\n",
      "[] September 15, 2005\n",
      "9333 9336\n",
      "[] Ronald C. Kessler\n",
      "9337 9338\n",
      "[] PhD\n",
      "9339 9344\n",
      "[] Department of Health Care Policy\n",
      "9345 9348\n",
      "[] Harvard Medical School\n",
      "9349 9350\n",
      "[] 180\n",
      "9350 9352\n",
      "[] Longwood Ave\n",
      "9353 9354\n",
      "[] Boston\n",
      "9355 9357\n",
      "[] MA 02115\n",
      "9366 9371\n",
      "[] The National Comorbidity Survey Replication\n",
      "9372 9375\n",
      "[] NCS-R\n",
      "9382 9388\n",
      "[] the National Institute of Mental Health\n",
      "9396 9402\n",
      "[] the National Institute of Drug Abuse\n",
      "9407 9409\n",
      "[] Substance Abuse\n",
      "9410 9414\n",
      "[] Mental Health Services Administration\n",
      "9416 9417\n",
      "[] 044708\n",
      "9418 9423\n",
      "[] The Robert Wood Johnson Foundation\n",
      "9425 9430\n",
      "[] the John W. Alden Trust\n",
      "9431 9432\n",
      "[] Disclaimer\n",
      "9465 9466\n",
      "[] US\n",
      "9474 9477\n",
      "[] Ronald C. Kessler\n",
      "9481 9484\n",
      "[] Harvard Medical School\n",
      "9486 9488\n",
      "[] Kathleen Merikangas\n",
      "9492 9493\n",
      "[] NIMH\n",
      "9495 9497\n",
      "[] James Anthony\n",
      "9498 9501\n",
      "[] Michigan State University\n",
      "9502 9504\n",
      "[] East Lansing\n",
      "9506 9508\n",
      "[] William Eaton\n",
      "9509 9513\n",
      "[] The Johns Hopkins University\n",
      "9514 9515\n",
      "[] Baltimore\n",
      "9516 9517\n",
      "[] Md\n",
      "9519 9521\n",
      "[] Meyer Glantz\n",
      "9525 9527\n",
      "[] Doreen Koretz\n",
      "9528 9530\n",
      "[] Harvard University\n",
      "9531 9532\n",
      "[] Cambridge\n",
      "9533 9534\n",
      "[] Mass\n",
      "9536 9538\n",
      "[] Jane McLeod\n",
      "9539 9541\n",
      "[] Indiana University\n",
      "9542 9543\n",
      "[] Bloomington\n",
      "9545 9547\n",
      "[] Mark Olfson\n",
      "9548 9553\n",
      "[] New York State Psychiatric Institute\n",
      "9554 9562\n",
      "[] College of Physicians and Surgeons of Columbia University\n",
      "9563 9565\n",
      "[] New York\n",
      "9567 9569\n",
      "[] Harold Pincus\n",
      "9570 9573\n",
      "[] University of Pittsburgh\n",
      "9574 9575\n",
      "[] Pittsburgh\n",
      "9579 9581\n",
      "[] Greg Simon\n",
      "9582 9585\n",
      "[] Group Health Cooperative\n",
      "9586 9587\n",
      "[] Seattle\n",
      "9588 9589\n",
      "[] Wash\n",
      "9591 9594\n",
      "[] Michael Von Korff\n",
      "9595 9598\n",
      "[] Group Health Cooperative\n",
      "9600 9602\n",
      "[] Philip Wang\n",
      "9603 9606\n",
      "[] Harvard Medical School\n",
      "9608 9610\n",
      "[] Kenneth Wells\n",
      "9611 9614\n",
      "[] University of California\n",
      "9615 9617\n",
      "[] Los Angeles\n",
      "9619 9621\n",
      "[] Elaine Wethington\n",
      "9622 9624\n",
      "[] Cornell University\n",
      "9625 9626\n",
      "[] Ithaca\n",
      "9627 9628\n",
      "[] NY\n",
      "9631 9633\n",
      "[] HansUlrich Wittchen\n",
      "9634 9639\n",
      "[] Max Planck Institute of Psychiatry\n",
      "9640 9641\n",
      "[] Munich\n",
      "9642 9643\n",
      "[] Germany\n",
      "9645 9652\n",
      "[] Institute of Psychology, Technical University Dresden\n",
      "9653 9654\n",
      "[] Dresden\n",
      "9655 9656\n",
      "[] Germany\n",
      "9662 9663\n",
      "[] NCS\n",
      "9670 9673\n",
      "[] NCS-R\n",
      "9685 9686\n",
      "[] ncs@hcp.med.harvard\n",
      "9689 9692\n",
      "[] NCS-R\n",
      "9697 9709\n",
      "[] the World Health Organization World Mental Health (WMH) Survey Initiative\n",
      "9716 9717\n",
      "[] R01\n",
      "9717 9718\n",
      "[] MH070884\n",
      "9719 9720\n",
      "[] NIMH\n",
      "9722 9724\n",
      "[] John D.\n",
      "9725 9729\n",
      "[] Catherine T. MacArthur Foundation\n",
      "9730 9733\n",
      "[] the Pfizer Foundation\n",
      "9735 9736\n",
      "[] R13-MH066849\n",
      "9737 9738\n",
      "[] R01-MH069864\n",
      "9740 9741\n",
      "[] R01-DA016558\n",
      "9742 9747\n",
      "[] the US Public Health Service\n",
      "9752 9756\n",
      "[] the Fogarty International Center\n",
      "9757 9762\n",
      "[] the Pan American Health Organization\n",
      "9763 9767\n",
      "[] Eli Lilly and Company\n",
      "9768 9774\n",
      "[] Ortho-McNeil Pharmaceutical, Inc\n",
      "9775 9776\n",
      "[] GlaxoSmithKline\n",
      "9778 9782\n",
      "[] Bristol-Myers Squibb\n",
      "9787 9788\n",
      "[] WMH\n",
      "9796 9797\n",
      "[] Acknowledgment\n",
      "9803 9807\n",
      "[] the WMH Data Collection\n",
      "9808 9812\n",
      "[] Data Analysis Coordination Centres\n",
      "9825 9827\n",
      "[] REFERENCES 1\n",
      "9828 9830\n",
      "[] Kessler RC\n",
      "9831 9833\n",
      "[] McGonagle KA\n",
      "9834 9836\n",
      "[] Zhao S\n",
      "9837 9839\n",
      "[] Nelson CB\n",
      "9840 9842\n",
      "[] Hughes M\n",
      "9843 9845\n",
      "[] Eshleman S\n",
      "9846 9848\n",
      "[] Wittchen HU\n",
      "9849 9851\n",
      "[] Kendler KS\n",
      "9852 9853\n",
      "[] Lifetime\n",
      "9854 9855\n",
      "[] 12-month\n",
      "9857 9860\n",
      "[] DSM-III\n",
      "9865 9868\n",
      "[] the United States\n",
      "9871 9875\n",
      "[] the National Comorbidity Survey\n",
      "9876 9879\n",
      "[] Arch Gen Psychiatry\n",
      "9880 9883\n",
      "[] 1994;51:8-19\n",
      "9884 9885\n",
      "[] 2\n",
      "9886 9888\n",
      "[] Eaton WW\n",
      "9889 9891\n",
      "[] Kessler RC\n",
      "9892 9894\n",
      "[] Wittchen HU\n",
      "9895 9897\n",
      "[] Magee WJ\n",
      "9903 9906\n",
      "[] the United States\n",
      "9911 9914\n",
      "[] 1994;151:413-420\n",
      "9915 9916\n",
      "[] 3\n",
      "9917 9919\n",
      "[] Sheikh JI\n",
      "9920 9922\n",
      "[] Leskin GA\n",
      "9923 9925\n",
      "[] Klein DF\n",
      "9934 9938\n",
      "[] the National Comorbidity Survey\n",
      "9940 9942\n",
      "[] J Psychiatry\n",
      "9943 9946\n",
      "[] 2002;159:55-58\n",
      "9947 9948\n",
      "[] 4\n",
      "9949 9951\n",
      "[] Burke KC\n",
      "9956 9958\n",
      "[] Regier DA\n",
      "9959 9961\n",
      "[] Rae DS\n",
      "9970 9971\n",
      "[] five\n",
      "9974 9977\n",
      "[] Arch Gen Psychiatry\n",
      "9978 9981\n",
      "[] 1990;47:511-518\n",
      "9982 9983\n",
      "[] 5\n",
      "9984 9986\n",
      "[] Kessler RC\n",
      "9995 9997\n",
      "[] Wetzler S\n",
      "9998 10000\n",
      "[] Sanderson WC\n",
      "10003 10010\n",
      "[] Treatment Strategies for Patients With Psychiatric Comorbidity\n",
      "10011 10013\n",
      "[] New York\n",
      "10014 10015\n",
      "[] NY\n",
      "10016 10020\n",
      "[] John Wiley & Sons\n",
      "10021 10022\n",
      "[] 1997\n",
      "10023 10024\n",
      "[] 6\n",
      "10025 10027\n",
      "[] Kessler RC\n",
      "10028 10030\n",
      "[] Stang PE\n",
      "10031 10032\n",
      "[] Wittchen\n",
      "10032 10036\n",
      "[] HU, Ustun TB\n",
      "10037 10038\n",
      "[] Roy\n",
      "10039 10041\n",
      "[] Byrne PP\n",
      "10042 10044\n",
      "[] Walters EE\n",
      "10045 10046\n",
      "[] Lifetime\n",
      "10051 10055\n",
      "[] the National Comorbidity Survey\n",
      "10056 10059\n",
      "[] Arch Gen Psychiatry\n",
      "10064 10065\n",
      "[] 7\n",
      "10066 10070\n",
      "[] Roy-Byrne PP\n",
      "10071 10073\n",
      "[] Stang P\n",
      "10074 10076\n",
      "[] Wittchen HU\n",
      "10077 10078\n",
      "[] Ustun\n",
      "10080 10082\n",
      "[] Walters EE\n",
      "10083 10085\n",
      "[] Kessler RC\n",
      "10086 10087\n",
      "[] Lifetime\n",
      "10092 10096\n",
      "[] the National Comorbidity Survey\n",
      "10109 10112\n",
      "[] Br J Psychiatry\n",
      "10113 10114\n",
      "[] 2000\n",
      "10115 10118\n",
      "[] 176:229-235\n",
      "10119 10120\n",
      "[] 8\n",
      "10121 10123\n",
      "[] Klerman GL\n",
      "10124 10126\n",
      "[] Weissman MM\n",
      "10127 10129\n",
      "[] Ouellette R\n",
      "10130 10132\n",
      "[] Johnson J\n",
      "10133 10136\n",
      "[] Greenwald S. Panic\n",
      "10148 10149\n",
      "[] JAMA\n",
      "10150 10151\n",
      "[] 1991\n",
      "10152 10153\n",
      "[] 265:742\n",
      "10156 10157\n",
      "[] 9\n",
      "10158 10160\n",
      "[] Markowitz JS\n",
      "10161 10163\n",
      "[] Weissman MM\n",
      "10164 10166\n",
      "[] Ouellette R\n",
      "10167 10169\n",
      "[] Lish JD\n",
      "10170 10171\n",
      "[] Klerman\n",
      "10180 10183\n",
      "[] Arch Gen Psychiatry\n",
      "10184 10187\n",
      "[] 1989;46:984-992\n",
      "10188 10189\n",
      "[] 10\n",
      "10190 10192\n",
      "[] Wittchen HU\n",
      "10193 10195\n",
      "[] Essau CA\n",
      "10206 10209\n",
      "[] J Psychiatr Res\n",
      "10210 10214\n",
      "[] 1993;27(suppl 1):47-68\n",
      "10215 10216\n",
      "[] 11\n",
      "10217 10219\n",
      "[] Goodwin RD\n",
      "10220 10222\n",
      "[] Gotlib IH\n",
      "10230 10233\n",
      "[] Acta Psychiatr Scand\n",
      "10236 10237\n",
      "[] 221\n",
      "10238 10239\n",
      "[] 12\n",
      "10243 10245\n",
      "[] Wittchen HU\n",
      "10246 10249\n",
      "[] DSM-IV\n",
      "10274 10277\n",
      "[] 1998;32:335-345\n",
      "10278 10279\n",
      "[] 13\n",
      "10280 10283\n",
      "[] Katschnig H,\n",
      "10283 10285\n",
      "[] Amering M.\n",
      "10298 10300\n",
      "[] Clin Psychopharmacol\n",
      "10302 10303\n",
      "[] 2):6S-11S.\n",
      "10303 10304\n",
      "[] 14\n",
      "10305 10307\n",
      "[] Eaton WW\n",
      "10308 10310\n",
      "[] Anthony JC\n",
      "10311 10312\n",
      "[] Romanoski\n",
      "10314 10316\n",
      "[] Tien A\n",
      "10317 10319\n",
      "[] Gallo J\n",
      "10320 10322\n",
      "[] Cai G\n",
      "10323 10324\n",
      "[] Neufeld\n",
      "10329 10331\n",
      "[] Laugharne J\n",
      "10332 10334\n",
      "[] Chen LS\n",
      "10335 10336\n",
      "[] Onset\n",
      "10342 10347\n",
      "[] the Baltimore Epidemiologic Catchment Area\n",
      "10351 10354\n",
      "[] Br J Psychiatry\n",
      "10355 10356\n",
      "[] 1998;173:501\n",
      "10357 10358\n",
      "[] 507\n",
      "10359 10360\n",
      "[] 15\n",
      "10361 10363\n",
      "[] Kessler RC\n",
      "10364 10366\n",
      "[] Berglund P\n",
      "10367 10369\n",
      "[] Chiu WT\n",
      "10370 10371\n",
      "[] Demler\n",
      "10373 10375\n",
      "[] Heeringa S\n",
      "10379 10381\n",
      "[] Jin R\n",
      "10382 10384\n",
      "[] Pennell BE\n",
      "10385 10387\n",
      "[] Walters EE\n",
      "10388 10390\n",
      "[] Zaslavsky A\n",
      "10391 10393\n",
      "[] Zheng H.\n",
      "10394 10395\n",
      "[] US\n",
      "10395 10399\n",
      "[] National Comorbidity Survey Replication\n",
      "10400 10403\n",
      "[] NCS-R\n",
      "10418 10421\n",
      "[] 13:69-92\n",
      "10422 10423\n",
      "[] 16\n",
      "10424 10426\n",
      "[] Kessler RC\n",
      "10427 10429\n",
      "[] Ustun TB\n",
      "10430 10448\n",
      "[] The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO)\n",
      "10448 10452\n",
      "[] Composite International Diagnostic Interview\n",
      "10466 10467\n",
      "[] 17\n",
      "10468 10470\n",
      "[] Kessler RC\n",
      "10471 10473\n",
      "[] Abelson J\n",
      "10474 10476\n",
      "[] Demler O\n",
      "10477 10479\n",
      "[] Escobar JI\n",
      "10480 10485\n",
      "[] Gibbon M, Guyer ME\n",
      "10486 10488\n",
      "[] Howes MJ\n",
      "10489 10491\n",
      "[] Jin R\n",
      "10492 10494\n",
      "[] Vega WA\n",
      "10495 10497\n",
      "[] Walters EE\n",
      "10498 10500\n",
      "[] Wang P\n",
      "10501 10503\n",
      "[] Zaslavsky A\n",
      "10504 10507\n",
      "[] Zheng H. Clinical\n",
      "10509 10512\n",
      "[] DSM-IV\n",
      "10514 10520\n",
      "[] the World Mental Health (WMH\n",
      "10523 10527\n",
      "[] the World Health Organization\n",
      "10530 10534\n",
      "[] Composite International Diagnostic Interview\n",
      "10550 10552\n",
      "[] Kessler RC\n",
      "10553 10555\n",
      "[] Berglund P\n",
      "10556 10557\n",
      "[] Demler\n",
      "10559 10561\n",
      "[] Jin R\n",
      "10562 10564\n",
      "[] Walters EE\n",
      "10565 10566\n",
      "[] Lifetime\n",
      "10575 10578\n",
      "[] DSM-IV\n",
      "10580 10585\n",
      "[] the National Comorbidity Survey Replication\n",
      "10586 10589\n",
      "[] Arch Gen Psychiatry\n",
      "10590 10593\n",
      "[] 2005;62:593-602\n",
      "10594 10595\n",
      "[] 19\n",
      "10596 10598\n",
      "[] First MB\n",
      "10599 10601\n",
      "[] Spitzer RL\n",
      "10602 10604\n",
      "[] Gibbon M\n",
      "10605 10607\n",
      "[] Williams JBW\n",
      "10608 10616\n",
      "[] Structured Clinical Interview for DSM-IV Axis\n",
      "10619 10621\n",
      "[] Research Version\n",
      "10622 10625\n",
      "[] Non-patient\n",
      "10625 10632\n",
      "[] Edition (SCID-I/NP\n",
      "10634 10639\n",
      "[] New York: Biometrics Research\n",
      "10640 10645\n",
      "[] New York State Psychiatric Institute\n",
      "10646 10647\n",
      "[] 2002\n",
      "10648 10649\n",
      "[] 20\n",
      "10650 10652\n",
      "[] Shear MK\n",
      "10653 10655\n",
      "[] Rucci P\n",
      "10656 10658\n",
      "[] Williams J\n",
      "10659 10661\n",
      "[] Frank E\n",
      "10662 10663\n",
      "[] Grochocinski\n",
      "10665 10668\n",
      "[] Vander Bilt J\n",
      "10669 10671\n",
      "[] Houck P\n",
      "10672 10675\n",
      "[] Wang T. Reliability\n",
      "10692 10695\n",
      "[] 2001;35:293-296\n",
      "10696 10697\n",
      "[] 21\n",
      "10698 10700\n",
      "[] Houck PR\n",
      "10701 10703\n",
      "[] Spiegel DA\n",
      "10704 10706\n",
      "[] Shear MK\n",
      "10707 10710\n",
      "[] Rucci P. Reliability\n",
      "10723 10725\n",
      "[] Depress Anxiety\n",
      "10726 10727\n",
      "[] 2002;15:183\n",
      "10730 10731\n",
      "[] 22\n",
      "10732 10734\n",
      "[] Leon AC\n",
      "10735 10737\n",
      "[] Olfson M\n",
      "10738 10740\n",
      "[] Portera L\n",
      "10741 10743\n",
      "[] Farber L\n",
      "10747 10748\n",
      "[] Assessing\n",
      "10761 10763\n",
      "[] Psychiatry Med\n",
      "10764 10767\n",
      "[] 1997;27:93-105\n",
      "10768 10769\n",
      "[] 23\n",
      "10770 10772\n",
      "[] Wang PS\n",
      "10773 10775\n",
      "[] Berglund P\n",
      "10776 10778\n",
      "[] Olfson M\n",
      "10779 10781\n",
      "[] Pincus HA\n",
      "10782 10784\n",
      "[] Wells KB\n",
      "10785 10787\n",
      "[] Kessler RC\n",
      "10796 10797\n",
      "[] first\n",
      "10802 10807\n",
      "[] the National Comorbidity Survey Replication\n",
      "10808 10811\n",
      "[] Arch Gen Psychiatry\n",
      "10816 10817\n",
      "[] 24\n",
      "10818 10821\n",
      "[] American Psychiatric Association\n",
      "10822 10824\n",
      "[] Practice Guideline\n",
      "10825 10832\n",
      "[] the Treatment of Patients With Panic Disorder\n",
      "10833 10834\n",
      "[] Washington\n",
      "10835 10836\n",
      "[] DC\n",
      "10837 10841\n",
      "[] American Psychiatric Association Press\n",
      "10842 10843\n",
      "[] 1998\n",
      "10844 10845\n",
      "[] 25\n",
      "10846 10848\n",
      "[] Schatzberg AF\n",
      "10849 10851\n",
      "[] Nemeroff CB\n",
      "10854 10857\n",
      "[] Textbook of Psychopharmacology\n",
      "10858 10859\n",
      "[] Washington\n",
      "10860 10861\n",
      "[] DC\n",
      "10862 10865\n",
      "[] American Psychiatric Publishing\n",
      "10866 10867\n",
      "[] 2004\n",
      "10869 10877\n",
      "[] REPRINTED) ARCH GEN PSYCHIATRY/VOL 63\n",
      "10878 10879\n",
      "[] APR\n",
      "10881 10882\n",
      "[] 423\n",
      "10883 10884\n",
      "[] 2006\n",
      "10884 10887\n",
      "[] American Medical Association\n",
      "10899 10900\n",
      "[] 26\n",
      "10901 10903\n",
      "[] Halli SS\n",
      "10904 10906\n",
      "[] Rao KV\n",
      "10907 10909\n",
      "[] Halli SS\n",
      "10910 10915\n",
      "[] Advanced Techniques of Population Analysis\n",
      "10916 10918\n",
      "[] New York\n",
      "10919 10921\n",
      "[] NY:\n",
      "10921 10924\n",
      "[] Plenum Publishing Corp\n",
      "10925 10926\n",
      "[] 1992\n",
      "10927 10928\n",
      "[] 27\n",
      "10930 10931\n",
      "[] DW\n",
      "10932 10937\n",
      "[] Lemeshow S. Applied Logistic Regression\n",
      "10938 10939\n",
      "[] 2nd\n",
      "10941 10943\n",
      "[] New York\n",
      "10944 10945\n",
      "[] NY\n",
      "10946 10950\n",
      "[] John Wiley & Sons\n",
      "10951 10952\n",
      "[] 2000\n",
      "10953 10954\n",
      "[] 28\n",
      "10955 10957\n",
      "[] Wolter KM\n",
      "10963 10965\n",
      "[] New York\n",
      "10966 10967\n",
      "[] NY\n",
      "10968 10973\n",
      "[] Springer-Verlag NY Inc\n",
      "10974 10975\n",
      "[] 1985\n",
      "10976 10977\n",
      "[] 29\n",
      "10978 10979\n",
      "[] SUDAAN\n",
      "10980 10986\n",
      "[] Professional Software for Survey Data Analysis\n",
      "10987 10989\n",
      "[] Version 8.0.1\n",
      "10991 10993\n",
      "[] Triangle Park\n",
      "10994 10995\n",
      "[] NC\n",
      "10996 10999\n",
      "[] Research Triangle Institute\n",
      "11000 11001\n",
      "[] 2002\n",
      "11002 11003\n",
      "[] 30\n",
      "11004 11007\n",
      "[] Kna ¨uper B\n",
      "11008 11010\n",
      "[] Cannell CF\n",
      "11011 11013\n",
      "[] Schwarz N\n",
      "11014 11016\n",
      "[] Bruce ML\n",
      "11017 11019\n",
      "[] Kessler RC\n",
      "11031 11036\n",
      "[] the US National Comorbidity Survey\n",
      "11043 11046\n",
      "[] 1999;8:39-48\n",
      "11047 11048\n",
      "[] 31\n",
      "11049 11051\n",
      "[] Weissman MM\n",
      "11052 11054\n",
      "[] Bland RC\n",
      "11055 11057\n",
      "[] Canino GJ\n",
      "11058 11060\n",
      "[] Faravelli C\n",
      "11061 11063\n",
      "[] Greenwald S\n",
      "11064 11066\n",
      "[] Hwu HG\n",
      "11067 11069\n",
      "[] Joyce PR\n",
      "11070 11072\n",
      "[] Karam EG\n",
      "11073 11075\n",
      "[] Lee CK\n",
      "11076 11078\n",
      "[] Lellouch J\n",
      "11079 11081\n",
      "[] Lepine JP\n",
      "11082 11084\n",
      "[] Newman SC\n",
      "11085 11089\n",
      "[] Oakley-Browne MA\n",
      "11090 11092\n",
      "[] RubioStipec M\n",
      "11093 11095\n",
      "[] Wells JE\n",
      "11096 11098\n",
      "[] Wickramaratne PJ\n",
      "11099 11101\n",
      "[] Wittchen HU\n",
      "11102 11104\n",
      "[] Yeh EK\n",
      "11114 11117\n",
      "[] Arch Gen Psychiatry\n",
      "11118 11121\n",
      "[] 1997;54:305-309\n",
      "11122 11123\n",
      "[] 32\n",
      "11124 11126\n",
      "[] Kessler RC\n",
      "11134 11136\n",
      "[] Tsuang MT\n",
      "11140 11142\n",
      "[] Zahner GEP\n",
      "11145 11146\n",
      "[] Textbook\n",
      "11147 11148\n",
      "[] Psychiatric\n",
      "11150 11152\n",
      "[] New York\n",
      "11153 11154\n",
      "[] NY\n",
      "11155 11159\n",
      "[] John Wiley & Sons\n",
      "11160 11161\n",
      "[] 1995:179\n",
      "11162 11163\n",
      "[] 197\n",
      "11164 11165\n",
      "[] 33\n",
      "11166 11168\n",
      "[] Joyce PR\n",
      "11170 11171\n",
      "[] JA\n",
      "11172 11176\n",
      "[] Oakley-Browne MA\n",
      "11177 11179\n",
      "[] Wells JE\n",
      "11180 11182\n",
      "[] Hornblow AR\n",
      "11192 11194\n",
      "[] Compr Psychiatry\n",
      "11195 11196\n",
      "[] 1989;30:303\n",
      "11197 11198\n",
      "[] 312\n",
      "11199 11200\n",
      "[] 34\n",
      "11201 11203\n",
      "[] Jacobi F\n",
      "11204 11206\n",
      "[] Wittchen HU\n",
      "11207 11209\n",
      "[] Holting C\n",
      "11210 11212\n",
      "[] Hofler M\n",
      "11216 11218\n",
      "[] Muller N\n",
      "11219 11222\n",
      "[] Lieb R. Prevalence\n",
      "11238 11245\n",
      "[] the German Health Interview and Examination Survey\n",
      "11246 11247\n",
      "[] GHS\n",
      "11249 11251\n",
      "[] Psychol Med\n",
      "11252 11253\n",
      "[] 2004;34:597\n",
      "11254 11255\n",
      "[] 611\n",
      "11256 11257\n",
      "[] 35\n",
      "11261 11263\n",
      "[] Angermeyer MC\n",
      "11264 11266\n",
      "[] Bernert S\n",
      "11267 11269\n",
      "[] Bruffaerts R\n",
      "11270 11272\n",
      "[] Brugha TS\n",
      "11273 11275\n",
      "[] Bryson H\n",
      "11276 11279\n",
      "[] de Girolamo G\n",
      "11280 11282\n",
      "[] Graaf R\n",
      "11283 11285\n",
      "[] Demyttenaere K\n",
      "11286 11288\n",
      "[] Gasquet I\n",
      "11292 11294\n",
      "[] Katz SJ\n",
      "11295 11297\n",
      "[] Kessler RC\n",
      "11298 11300\n",
      "[] Kovess V\n",
      "11301 11303\n",
      "[] Lepine JP\n",
      "11304 11306\n",
      "[] Ormel J\n",
      "11307 11309\n",
      "[] Polidori G\n",
      "11310 11312\n",
      "[] Russo LJ\n",
      "11313 11315\n",
      "[] Vilagut G\n",
      "11316 11318\n",
      "[] Almansa J\n",
      "11319 11323\n",
      "[] Arbabzadeh-Bouchez S\n",
      "11324 11326\n",
      "[] Autonell J\n",
      "11327 11329\n",
      "[] Bernal M\n",
      "11330 11334\n",
      "[] Buist-Bouwman MA\n",
      "11335 11337\n",
      "[] Codony M\n",
      "11338 11345\n",
      "[] Domingo-Salvany A, Ferrer M\n",
      "11346 11348\n",
      "[] Joo SS\n",
      "11349 11350\n",
      "[] Martinez\n",
      "11354 11356\n",
      "[] Matschinger H\n",
      "11357 11359\n",
      "[] Mazzi F\n",
      "11360 11362\n",
      "[] Morgan Z\n",
      "11363 11365\n",
      "[] Morosini P\n",
      "11366 11368\n",
      "[] Palacin C\n",
      "11369 11371\n",
      "[] Romera B\n",
      "11372 11374\n",
      "[] Taub N\n",
      "11375 11377\n",
      "[] Vollebergh WA\n",
      "11378 11379\n",
      "[] ESEMeD\n",
      "11384 11392\n",
      "[] European Study of the Epidemiology of Mental Disorders\n",
      "11404 11405\n",
      "[] Europe\n",
      "11408 11418\n",
      "[] the European Study of the Epidemiology of Mental Disorders (\n",
      "11422 11426\n",
      "[] Acta Psychiatr Scand Suppl\n",
      "11427 11430\n",
      "[] 2004;420:28-37\n",
      "11431 11432\n",
      "[] 36\n",
      "11433 11435\n",
      "[] Barlow DH\n",
      "11436 11438\n",
      "[] Vermilyea J\n",
      "11439 11441\n",
      "[] Blanchard EB\n",
      "11442 11444\n",
      "[] Vermilyea BB\n",
      "11445 11448\n",
      "[] Di Nardo PA\n",
      "11449 11451\n",
      "[] Cerny JA\n",
      "11458 11460\n",
      "[] Abnorm Psychol\n",
      "11461 11464\n",
      "[] 1985;94:320-328\n",
      "11465 11466\n",
      "[] 37\n",
      "11467 11469\n",
      "[] Craske MG\n",
      "11470 11471\n",
      "[] Phobic\n",
      "11485 11487\n",
      "[] Clin Psychol\n",
      "11488 11489\n",
      "[] 1991;11:599\n",
      "11490 11491\n",
      "[] 620\n",
      "11492 11493\n",
      "[] 38\n",
      "11494 11496\n",
      "[] Craske MG\n",
      "11508 11510\n",
      "[] Dobson KS\n",
      "11511 11513\n",
      "[] Craig KD\n",
      "11518 11522\n",
      "[] Cognitive-Behavioral Therapy\n",
      "11523 11525\n",
      "[] Vol 2\n",
      "11526 11528\n",
      "[] Thousand Oaks\n",
      "11529 11530\n",
      "[] Calif\n",
      "11531 11533\n",
      "[] Sage Publications\n",
      "11534 11537\n",
      "[] 1996:145-173\n",
      "11538 11539\n",
      "[] 39\n",
      "11540 11542\n",
      "[] White KS\n",
      "11543 11545\n",
      "[] Barlow DH\n",
      "11553 11555\n",
      "[] Barlow DH\n",
      "11566 11571\n",
      "[] Treatment of Anxiety and Panic\n",
      "11575 11577\n",
      "[] New York\n",
      "11578 11579\n",
      "[] NY\n",
      "11580 11582\n",
      "[] Guilford Publications\n",
      "11583 11586\n",
      "[] 2002:328-379\n",
      "11587 11588\n",
      "[] 40\n",
      "11589 11591\n",
      "[] Crowe RR\n",
      "11592 11594\n",
      "[] Noyes R\n",
      "11595 11597\n",
      "[] Pauls DL\n",
      "11598 11600\n",
      "[] Slymen D.\n",
      "11607 11610\n",
      "[] Arch Gen Psychiatry\n",
      "11611 11614\n",
      "[] 1983;40:1065-1069\n",
      "11615 11616\n",
      "[] 41\n",
      "11617 11618\n",
      "[] Rapee\n",
      "11618 11619\n",
      "[] RM\n",
      "11620 11623\n",
      "[] Murrell E. Predictors\n",
      "11627 11630\n",
      "[] J Anxiety Disord\n",
      "11631 11634\n",
      "[] 1988;2:203-217\n",
      "11635 11636\n",
      "[] 42\n",
      "11637 11641\n",
      "[] Wittchen H-U\n",
      "11642 11644\n",
      "[] Essau CA\n",
      "11659 11661\n",
      "[] Walker JR\n",
      "11662 11664\n",
      "[] Norton GR\n",
      "11665 11667\n",
      "[] Ross CA\n",
      "11670 11672\n",
      "[] Panic Disorder\n",
      "11673 11674\n",
      "[] Agoraphobia\n",
      "11680 11681\n",
      "[] Practitioner\n",
      "11682 11683\n",
      "[] Belmont\n",
      "11684 11685\n",
      "[] Calif\n",
      "11686 11688\n",
      "[] Brooks/ Cole\n",
      "11689 11692\n",
      "[] 1991:103-149\n",
      "11693 11694\n",
      "[] 43\n",
      "11695 11697\n",
      "[] Norton GR\n",
      "11698 11700\n",
      "[] Harrison B\n",
      "11701 11703\n",
      "[] Hauch J\n",
      "11704 11707\n",
      "[] Rhodes L. Characteristics\n",
      "11715 11717\n",
      "[] Abnorm Psychol\n",
      "11718 11721\n",
      "[] 1985;94:216-221\n",
      "11722 11723\n",
      "[] 44\n",
      "11724 11726\n",
      "[] Norton GR\n",
      "11727 11729\n",
      "[] Dorward J\n",
      "11730 11732\n",
      "[] Cox BJ\n",
      "11733 11734\n",
      "[] Factors\n",
      "11745 11746\n",
      "[] 1986;17:239\n",
      "11747 11748\n",
      "[] 252\n",
      "11749 11750\n",
      "[] 45\n",
      "11751 11753\n",
      "[] Bouton ME\n",
      "11754 11756\n",
      "[] Mineka S\n",
      "11757 11759\n",
      "[] Barlow DH\n",
      "11774 11777\n",
      "[] 2001;108:4-32\n",
      "11778 11779\n",
      "[] 46\n",
      "11780 11782\n",
      "[] Clark DM\n",
      "11789 11792\n",
      "[] Behav Res Ther\n",
      "11793 11794\n",
      "[] 1986;24:461\n",
      "11797 11798\n",
      "[] 47\n",
      "11799 11801\n",
      "[] Craske MG\n",
      "11802 11804\n",
      "[] Barlow DH\n",
      "11815 11817\n",
      "[] Clin Psychol\n",
      "11818 11819\n",
      "[] 1988;8:667\n",
      "11822 11823\n",
      "[] 48\n",
      "11824 11826\n",
      "[] Telch MJ\n",
      "11827 11829\n",
      "[] Brouillard M\n",
      "11830 11832\n",
      "[] Telch CF\n",
      "11833 11835\n",
      "[] Agras WS\n",
      "11836 11838\n",
      "[] Taylor CB\n",
      "11849 11852\n",
      "[] Behav Res Ther\n",
      "11853 11856\n",
      "[] 1989;27:373-383\n",
      "11857 11858\n",
      "[] 49\n",
      "11859 11861\n",
      "[] Langs G\n",
      "11862 11864\n",
      "[] Quehenberger F\n",
      "11865 11867\n",
      "[] Fabisch K\n",
      "11868 11870\n",
      "[] Klug G\n",
      "11871 11873\n",
      "[] Fabisch H\n",
      "11874 11876\n",
      "[] Zapotoczky HG\n",
      "11890 11892\n",
      "[] Affect Disord\n",
      "11893 11896\n",
      "[] 2000;58:43-50\n",
      "11897 11898\n",
      "[] 50\n",
      "11899 11901\n",
      "[] Wang PS\n",
      "11902 11904\n",
      "[] Lane M\n",
      "11905 11907\n",
      "[] Olfson M\n",
      "11908 11910\n",
      "[] Pincus HA\n",
      "11911 11913\n",
      "[] Wells KB\n",
      "11914 11916\n",
      "[] Kessler RC\n",
      "11917 11920\n",
      "[] Twelve-month\n",
      "11926 11929\n",
      "[] the United States\n",
      "11932 11937\n",
      "[] the National Comorbidity Survey Replication\n",
      "11938 11941\n",
      "[] Arch Gen Psychiatry\n",
      "11942 11943\n",
      "[] 2005;62:629\n",
      "11944 11945\n",
      "[] 640\n",
      "11946 11947\n",
      "[] 51\n",
      "11948 11950\n",
      "[] Otto MW\n",
      "11951 11954\n",
      "[] Deveney C. Cognitive\n",
      "11969 11971\n",
      "[] Clin Psychiatry\n",
      "11972 11973\n",
      "[] 2005;66(suppl\n",
      "11973 11976\n",
      "[] 4):28-32\n",
      "11977 11978\n",
      "[] 52\n",
      "11979 11981\n",
      "[] Westen D\n",
      "11982 11984\n",
      "[] Morrison K.\n",
      "12013 12016\n",
      "[] Consult Clin Psychol\n",
      "12017 12018\n",
      "[] 2001\n",
      "12019 12020\n",
      "[] 69:875\n",
      "12023 12024\n",
      "[] 53\n",
      "12025 12027\n",
      "[] Milrod B\n",
      "12028 12030\n",
      "[] Busch F\n",
      "12031 12033\n",
      "[] Leon AC\n",
      "12034 12035\n",
      "[] Aronson\n",
      "12037 12039\n",
      "[] Roiphe J\n",
      "12043 12045\n",
      "[] Singer M\n",
      "12046 12048\n",
      "[] Shapiro T\n",
      "12049 12051\n",
      "[] Goldman H\n",
      "12055 12057\n",
      "[] Shear MK\n",
      "12075 12076\n",
      "[] 2001;10\n",
      "12077 12078\n",
      "[] 239\n",
      "12081 12082\n",
      "[] 54\n",
      "12083 12085\n",
      "[] Pollack MH\n",
      "12093 12095\n",
      "[] Clin Psychiatry\n",
      "12103 12104\n",
      "[] 55\n",
      "12105 12106\n",
      "[] Bakker\n",
      "12108 12111\n",
      "[] van Balkom AJ\n",
      "12112 12114\n",
      "[] Stein DJ\n",
      "12123 12126\n",
      "[] Int J Neuropsychopharmacol\n",
      "12127 12128\n",
      "[] 2005;8:473\n",
      "12132 12140\n",
      "[] REPRINTED) ARCH GEN PSYCHIATRY/VOL 63\n",
      "12141 12142\n",
      "[] APR\n",
      "12144 12145\n",
      "[] 424\n",
      "12146 12147\n",
      "[] 2006\n",
      "12147 12150\n",
      "[] American Medical Association\n",
      "ORIGINAL ARTICLE The Epidemiology of Panic Attacks, Panic Disorder, and Agoraphobia in the National Comorbidity Survey Replication Ronald C. Kessler, PhD; Wai Tat Chiu, AM; Robert Jin, MA; Ayelet Meron Ruscio, PhD; Katherine Shear, MD; Ellen E. Walters, MS Context: Only limited information exists about the epidemiology of DSM-IV panic attacks (PAs) and panic disorder (PD). Objective: To present nationally representative data about the epidemiology of PAs and PD with or without agoraphobia (AG) on the basis of the US National Comorbidity Survey Replication findings. Design and Setting: Nationally representative faceto-face household survey conducted using the fully structured World Health Organization Composite International Diagnostic Interview. Participants: English-speaking respondents (N=9282) 18 years or older. Main Outcome Measures: RespondentswhometDSMIV lifetime criteria for PAs and PD with and without AG. Results: Lifetime prevalence estimates are 22.7% for isolated panic without AG (PA only), 0.8% for PA with AG without PD (PA-AG), 3.7% for PD without AG (PD only), and 1.1% for PD with AG (PD-AG). Persistence, lifetime number of attacks, and number of years with attacks increase monotonically across these 4 subgroups. All 4 subgroups are significantly comorbid with other lifetime DSM-IV disorders, with the highest odds for PD-AG and the lowest for PA only. Scores on the Panic Disorder Severity Scale are also highest for PD-AG (86.3% moderate or severe) and lowest for PA only (6.7% moderate or severe). Agoraphobia is associated with substantial severity, impairment, and comorbidity. Lifetime treatment is high (from 96.1% for PD-AG to 61.1% for PA only), but 12-month treatment meeting published treatment guidelines is low (from 54.9% for PD-AG to 18.2% for PA only). Conclusion: Although the major societal burden of panic is caused by PD and PA-AG, isolated PAs also have high prevalence and meaningful role impairment. Arch Gen Psychiatry. 2006;63:415-424 EPIDEMIOLOGICAL SURVEY INvestigators have helped advance understanding of panic by studying the prevalence and distribution,1-3 onset and course,4 associations with comorbid disorders,5-7 and societal costs.8,9 Despite these advances, important questions remain unanswered about the epidemiology of panic,10 among the most important of them regarding the finding that many people have isolated panic attacks (PAs) that do not meet criteria for panic disorder (PD). These people have elevated prevalence of other mental disorders.6,11 They report greater impairment, use of psychotropic medication, and psychiatric help-seeking than people with many Axis I disorders.8 Such findings have led to the view that PAs are fairly nonspecific risk markers for psychopathology.12 Some people with isolated PAs meet criteria for agoraphobia (AG).13 It is not known, though, whether the persistent course and poor outcome associated with AG among people with PD14 also apply to PAs with AG. As a result, the boundary between PA and PD and the relative role of AG within each are not well understood. Investigation and comparison of these symptom presentations in community samplesmighthelpclarifytheseissues.The current report presents initial data of this sort from the recently completed US National Comorbidity Survey Replication (NCS-R). METHODS SAMPLE The NCS-R is a nationally representative survey of 9282 English-speaking household residents18yearsorolderinthecoterminousUnited States. Face-to-face interviews were performed between February 2001 and April 2003. The response rate was 70.9%. Consent was oral rather Author Affiliations: Department of Health Care Policy, Harvard Medical School, Boston, Mass (Drs Kessler and Ruscio, Messrs Chiu and Jin, and Ms Walters); and the Western Psychiatric Institute and Clinic, Pittsburgh, Pa (Dr Shear). (REPRINTED) ARCH GEN PSYCHIATRY/VOL 63, APR 2006 WWW.ARCHGENPSYCHIATRY.COM 415 ©2006 American Medical Association. All rights reserved. Downloaded From: http://archpsyc.jamanetwork.com/ on 04/10/2014 \f",
      "than written to parallel the baseline NCS procedures. The human subjects committees of Harvard Medical School (Boston, Mass) and the University of Michigan (Ann Arbor) approved the NCS-R recruitment and consent procedures. Respondents were interviewed in 2 parts. The part 1 interview, administered to all respondents, included the core diagnostic assessment. The part 2 interview, administered to all part 1 respondents who met criteria for any lifetime core disorder plus a probability subsample of others (for a total of 5692 part 2 respondents), was used to assess correlates and disorders of secondary interest. The part 1 sample is used here to examine prevalence and course, clinical severity and role impairment, and most aspects of comorbidity. The part 2 sample is used to examine comorbidity with disorders of secondary interest to the survey, sociodemographic correlates, and treatment. The part 1 sample was weighted to adjust for differential probability of selection and discrepancies between the sample and the US population concerning census sociodemographic and geographic variables. The part 2 sample was weighted additionally to adjust for differential probability of selection from the part 1 sample. More details on NCS-R sampling and weights are reported elsewhere.15 PANIC AND AG Panic and AG were assessed using the World Mental Health Survey Initiatiave version of the World Health Organization Composite International Diagnostic Interview (CIDI),16 a fully structured lay-administered diagnostic interview (available at www.hcp.med.harvard.edu/wmhcidi). The assessment of panic was comparable to that in previous versions of the CIDI, except that a distinction was made between uncued PAs (described as occurring \"out of the blue\" with no triggering event) and cued PAs. A series of parallel questions was asked about each of these 2 types of attacks. Panic disorder was defined as the occurrence of 4 or more uncued PAs not caused by substance use or a general medical condition accompanied by 1 month or more of persistent concern about recurrence, worry about the implications of the attacks, or significant change in behavior because of the attacks. Agoraphobia was defined as anxiety about 2 or more situations that had to include being in crowds, going to public places, traveling by yourself, or traveling away from home associated with a fear of having a PA and fear that it might be difficult or embarrassing to escape. This fear had to result in avoidance of the feared situations, distress when exposed to these situations, or the necessity of a companion during these situations. We used these classifications to define 4 subgroups for comparative analysis: PA without PD or AG (PA only), PA with PD and AG (PA-AG), PD without AG (PD only), and PD with AG (PD-AG). The PA-only category is not a codable DSM-IV12 disorder; PA-AG is a subset of the DSM-IV category AG without a history of PD, excluding respondents with AG who never had a PA. This latter subgroup is not considered in this report because we focus exclusively on people with a history of panic. As detailed elsewhere,17,18 blinded clinical reappraisal interviews using the lifetime nonpatient version of the Structured Clinical Interview for DSM-IV (SCID)19 were administered to a probability subsample of 325 NCS-R respondents to assess concordance with CIDI diagnoses. The CIDI-SCID concordance for PD diagnosis had an area under the receiver operating characteristic curve of 0.72, a moderate  value (standard error) of 0.45 (0.15), and a high odds ratio (OR) of 56.3 (95% confidence interval, 15.5-204.6). No bias was found in the CIDI prevalence estimate compared with that in the SCID by using a McNemar test (2 1 =0, P=.82). The CIDI-SCID concordance was not assessed for PA because PA was not evaluated separately in the SCID; concordance also was not assessed for AG because AG occurred too infrequently in the clinical reappraisal study for reliable analysis of concordance. The DSM-IV requires recurrent uncued PAs, which could be interpreted as 2 or more, for a PD diagnosis. However, CIDI respondents who reported 2 or 3 lifetime uncued PAs generally were found in the SCID to have had only 1 full PA with additional limited-symptom attacks. Validity of the CIDI in relation to the SCID consequently was improved when we required at least 4 lifetime uncued attacks in the CIDI. The McNemar test result documents that the CIDI PD prevalence estimate does not differ significantly from the SCID estimate despite the SCID requiring only 2 attacks. COURSE, SEVERITY, AND IMPAIRMENT Respondents who met DSM-IV lifetime criteria for PA were asked to estimate the age of onset (AOO) of their first attack and AOO of having 4 uncued attacks with a month of persistent worry. They also were asked to estimate their age at the most recent attack, lifetime number of uncued and cued attacks, and number of years with at least 1 attack. Clinical severity was assessed only for 12-month cases by using a fully structured version of the 7-question Panic Disorder Severity Scale (PDSS) that was developed specifically for the NCS-R. (Question wording is posted at www.hcp.med.harvard.edu/ncs.) The clinicianadministered version of the PDSS yields a reliable and valid assessment of overall PD clinical severity.20 A separate fully structured version of the PDSS, developed independently of the NCS-R version but with similar wording, has excellent concordance with the clinician-administered version.21 Published PDSS cut points (none, mild, moderate, or severe) were used to define severity. Although 2 of the 7 PDSS questions assess role impairment, a more generic measure of role impairment, the Sheehan Disability Scale (SDS),22 also was included in each section of the CIDI. The SDS asked respondents with 12-month panic to focus on the 1 month in the past year when their panic, their worry about having another PA, or their restriction of activity because of this worry interfered most with their life and activities and to rate this interference on a 0 to 10 visual analog scale with response options of none (0), mild (1-3), moderate (46), severe (7-9), or very severe (10). Interference ratings were obtained for 4 role domains: home management, work, social life, and personal relationships. Responses were combined by taking the highest score across the 4 ratings and collapsing the severe and very severe response categories. COMORBID DSM-IV DISORDERS The NCS-R was used to assess a number of other DSM-IV disorders: other anxiety disorders (generalized anxiety disorder, specific phobia, social phobia, posttraumatic stress disorder, obsessive-compulsive disorder, and adult manifestations of separation anxiety disorder), mood disorders (major depressive disorder, dysthymic disorder, and bipolar disorder I or II), substance use disorders (alcohol and illicit drug abuse and dependence, in which abuse and dependence on specific illicit drugs were combined with polysubstance abuse and dependence), and impulse-control disorders (intermittent explosive disorder and adult manifestations of 3 child-adolescent impulsecontrol disorders: attention-deficit/hyperactivity disorder, oppositional-defiant disorder, and conduct disorder). Organic exclusion rules and diagnostic hierarchy rules were used in making all diagnoses. As reported in more detail elsewhere,18 blinded clinical reappraisal interviews using the nonpatient version of the SCID19 showed generally good concordance between CIDI and SCID diagnoses of anxiety, mood, and substance use dis(REPRINTED) ARCH GEN PSYCHIATRY/VOL 63, APR 2006 WWW.ARCHGENPSYCHIATRY.COM 416 ©2006 American Medical Association. All rights reserved. Downloaded From: http://archpsyc.jamanetwork.com/ on 04/10/2014 \f",
      "orders,withareaunderthereceiveroperatingcharacteristiccurve in the range of 0.65 to 0.81,  in the range of 0.33 to 0.70, and ORs in the range of 6.3 to 877.0. Diagnoses of impulse-control disorders were not validated because the SCID does not assess these disorders. TREATMENT Two questions about lifetime and 12-month treatment of panic were asked at the end of the panic section. Part 2 respondents additionally were asked more general questions about whether they ever received treatment for any problems with your emotions or nerves or your use of alcohol or drugs and, if so, about types of professionals seen.23 Treatment was distinguished in 5 sectors: psychiatry, nonpsychiatry mental health specialty, general medical, human services, and complementaryalternative. Questions about treatment in the 12 months before interview asked about number and duration of visits; number and duration of psychotherapy sessions; and name, dose, and duration of each medication used. No information was obtained about the content of psychotherapy. A rough measure of 12-month guideline-concordant treatment of panic was developed using these reports on the basis of available evidencebased guidelines.24 Guideline-concordant treatment was defined as receiving either pharmacotherapy (at least 2 months of an appropriate medication, defined as antidepressants or anxiolytics,25 plus at least 4 visits to any type of medical physician) or psychotherapy (at least 8 visits with any health care or human services professional lasting an average of at least 30 minutes). The decision to require at least 4 physician visits for pharmacotherapy was based on the recommendation of at least 4 visits for medication evaluation, initiation, and monitoring during the early and continuation phases of PD medication treatment.24 The decision to require at least 8 psychotherapy sessions was based on the fact that clinical trials demonstrating effectiveness generally have included at least 8 psychotherapy visits.24 Because respondents who began a course of treatment only shortly before the interview could not fulfill the requirements, we counted respondents with at least 2 visits to an appropriate treatment sector if they were in treatment at the time of interview. ANALYSIS METHODS Cross-tabulations were used to estimate prevalence and patterns of treatment. The actuarial method26 was used to estimate AOO distributions. Mean comparisons were used to examine illness course and severity or impairment. Logistic regression analysis27 was used to estimate associations with sociodemographic variables and comorbid DSM-IV disorders. Because the NCS-R sample design featured weighting and clustering, all analyses used the Taylor series design-based method,28 implemented in the SUDAAN software system.29 Significance tests of sets of coefficients in the logistic regression equations were made using Wald 2 tests based on design-corrected coefficient variance-covariance matrices. Statistical significance was evaluated using 2-sided, design-based P.05-level tests. RESULTS PREVALENCE Twenty-eight percent (standard error) (28.3% [1.0]) of respondents met criteria for lifetime PA and 11.2% (0.5) for 12-month PA, whereas 4.7% (0.3) of respondents (roughly one sixth of those with lifetime PA) met criteria for lifetime PD and 2.8% (0.2) for 12-month PD. Eight tenths of 1% of all respondents (roughly 3% of those with a lifetime PA) met criteria for lifetime PA-AG and 0.4% (0.1) for 12-month PA-AG, whereas 1.1% (0.1) of respondents (approximately one fifth of those with lifetime PD and 60% of those with lifetime PA-AG) met criteria for lifetime PD-AG and 0.4% (0.1) for 12-month PD-AG. COURSE OF ILLNESS As described, respondents with lifetime panic were placed into 4 mutually exclusive subgroups (Figure 1): PA only, 22.7% of the sample; PA-AG, 0.8%; PD only, 3.7%; and PD-AG, 1.1%. A small proportion of respondents without PD (12.0% with PA only and 10.7% with PA-AG) reported a sufficient number of uncued attacks to qualify for PD (with means of 31.0 and 131.4 lifetime uncued attacks, respectively) but failed to meet other requirements for a PD diagnosis (Table 1). Most respondents in 3 of the 4 subgroups, the exception being PD only, reported at least 1 cued lifetime attack (from 67.9% in PD-AG to 87.6% in PA-AG). A significantly lower 46.8% of PD-only cases reported any cued lifetime attack. Mean number of cued attacks among those with any varies significantly across subgroups (F3,1568 =18.2, P.001). Panic disorder is associated with a significantly higher mean number of cued attacks than PA among those without (121.8 vs 38.3, z=6.6, P.001) and those with (134.4 vs 78.2, z=2.1, P=.03) AG. Agoraphobia is associated with a significantly higher mean number of cued attacks among those with PA (78.2 vs 38.3, z=2.4, P=.02) but not among those with PD (134.4 vs 121.8, z=0.53, P=.60). In the subsample of respondents who reported ever PA Only (22.7%) Any PAs (28.3%) PD Only (3.7%) PD-AG (1.1%) PA-AG (0.8%) Figure 1. Lifetime prevalence estimates of DSM-IV panic attacks (PAs) and panic disorder (PD) with and without agoraphobia (AG). PA only indicates lifetime history of PA but not PD or AG; PA-AG, lifetime history of PA with AG but not PD; PD only, lifetime history of PD without AG; PD-AG, lifetime history of PD with AG. The prevalence estimates of PD only (3.7%) and PD-AG (1.1%) sum to more than the observed 4.7% prevalence of all PD because of rounding. (REPRINTED) ARCH GEN PSYCHIATRY/VOL 63, APR 2006 WWW.ARCHGENPSYCHIATRY.COM 417 ©2006 American Medical Association. All rights reserved. Downloaded From: http://archpsyc.jamanetwork.com/ on 04/10/2014 \f",
      "having a cued attack, the mean number of such attacks substantially exceeds the mean number of uncued attacks in the PD-only subgroup (121.8 vs 31.3, z=7.4, P.001) and in the PD-AG subgroup (134.4 vs 46.0, z=4.0, P.001). No meaningful difference exists in mean AOO of PA among the 4 subgroups (21.5-22.7; F3,2188 =0.9, P=.44); the entire PA AOO distribution is similar across these subgroups (Figure 2). Mean AOO of PD is only about 1 year later than mean AOO of PA and does not differ significantly between the PD-only and PD-AG subgroups (23.6 vs 22.9, F3,1568 =0.5, P=.62). Persistence (12month prevalence of PA among lifetime cases), however, varies substantially, from 35.7% in PA only to 62.6% in PD-AG (2 3 =48.7, P.001). Persistence is significantly higher in the PD than PA subgroups in the absence of AG (57.4% vs 35.7%, z=5.4, P.001) and the presence of AG (62.6% vs 41.1%, z=3.0, P=.002) but does not vary as a function of AG either in the 2 PA subgroups (41.1% vs 35.7%, z=0.9, P=.34) or in the 2 PD subgroups (62.6% vs 57.4%, z=0.9, P=.36). Mean number of years with attacks also varies significantly across the subgroups (F3,2188 =46.7, P.001) with the same rank ordering as persistence. SOCIODEMOGRAPHIC CORRELATES We failed to find consistent variation in magnitude of significant sociodemographic correlates of lifetime prevalence across the 4 subgroups, although the ORs associated with being female are noticeably higher for the PD than the PA subgroups, whereas the ORs associated with other employment status are noticeably higher for the AG than non-AG subgroups (Table 2). Age of 60 years or older (vs younger ages) and non-Hispanic blacks (vs nonHispanic whites) have reduced odds of panic in all 4 subgroups, although not all are significant. Women and previously married people have consistently elevated odds of panic in all 4 subgroups. Respondents classified as having other employment status, made up largely of the unemployed and disabled, have elevated odds of all outcomes other than PA only, whereas retired people have elevated odds of PD-AG but not the other 3 outcomes. None of these associations is strong in substantive terms, though, as indicated by the Pearson contingency coefficients for the set of sociodemographic predictors all being quite small (in the range of 0.01 to 0.02). COMORBIDITY Respondents in all 4 panic subgroups have significantly increased odds of virtually all other lifetime DSM-IV disorders assessed in the survey (Table 3). One or more comorbid conditions are found in 71.9% of the PA-only Table 1. Prevalence, Persistence, and Course of Panic Among Respondents in 4 Mutually Exclusive Lifetime Panic Subgroups Parameter PA Only (n = 1672) PA-AG (n = 71) PD Only (n = 344) PD-AG (n = 105) 2 3 Lifetime prevalence and persistence* Prevalence 22.7 (1.0) 0.8 (0.1) 3.7 (0.2) 1.1 (0.1) NA 1 Lifetime cued attacks 76.2 (1.2) 87.6 (4.4) 46.8 (3.0) 67.9 (5.5) 90.7 4 Lifetime uncued attacks 12.0 (1.1) 10.7 (4.1) 100.0 (0) 100.0 (0) 0.1 F3,9278 Age of onset of PA 22.7 (0.5) 22.1 (1.7) 22.7 (0.8) 21.5 (1.0) 0.9 PD onset NA NA 23.6 (0.9) 22.9 (1.0) 0.5 AG onset NA 19.3 (1.8) NA 17.0 (1.4) 0.9 Course of illness* 2 3 12-mo persistence* 35.7 (1.5) 41.1 (5.5) 57.4 (3.7) 62.6 (4.4) 48.7 F3,9278 Years with attacks 4.7 (0.2) 6.6 (1.1) 8.3 (0.6) 10.7 (1.1) 20.4 1 Lifetime cued attacks 38.3 (4.5) 78.2 (16.0) 121.8 (11.9) 134.4 (20.7) 18.2 4 Lifetime uncued attacks 31.0 (4.5) 131.4 (29.4) 31.3 (2.7) 46.0 (7.8) 4.3 Median 1 lifetime cued attacks 6.0 (0.3) 9.2 (2.2) 17.2 (8.8) 34.1 (70.4) NA Median 4 lifetime uncued attacks 11.5 (0.9) 100.2 (48.3) 10.0 (0.7) 16.6 (3.5) NA Abbreviations: AG, agoraphobia; NA, not applicable; PA, panic attack; PD, panic disorder; PA only, lifetime history of PA but not of PD or AG; PA-AG, lifetime history of PA with AG but not of PD; PD only, lifetime history of PD without AG; PD-AG, lifetime history of PD with AG. *Data are given as percentage (standard error). Data are given as mean (standard error) unless otherwise indicated.  Significant at P=.05, 2-sided test. 100 80 70 60 50 30 10 90 40 20 0 0 20 10 30 50 70 90 40 60 PA Only PA-AG PD Only PD-AG 80 100 Age of Onset, y Cumulative Probability of Lifetime Prevalence Figure 2. Age of onset of first lifetime panic attack in 4 mutually exclusive lifetime panic subgroups (2 3 =6.9, P=.07). See legend to Figure 1 for an explanation of abbreviations. (REPRINTED) ARCH GEN PSYCHIATRY/VOL 63, APR 2006 WWW.ARCHGENPSYCHIATRY.COM 418 ©2006 American Medical Association. All rights reserved. Downloaded From: http://archpsyc.jamanetwork.com/ on 04/10/2014 \f",
      "subgroup, 83.1% of the PD-only subgroup, and 100% of the other 2 subgroups. The ORs for particular comorbid conditions differ significantly across the 4 subgroups, with the lowest ORs consistently in the PA-only subgroup. In the case of comorbidity with other anxiety disorders and major depression, AG is more important than PD, as shown by the PA-AG ORs (4.4-24.0) consistently being higher than the PD-only ORs (2.0-5.4) and often as high as the PD-AG ORs (2.5-25.8). In the case of the other mood disorders and alcohol use disorders, the PA-AG ORs (3.2-5.1) are comparable to the PD-only ORs (3.5-5.4), whereas the PD-AG ORs (5.6-13.6) are considerably larger. A distinct pattern for drug use disorders for the ORs is associated with all 3 AG or PD subgroups to be comparable in magnitude (3.4-5.8). TWELVE-MONTH CLINICAL SEVERITY AND ROLE IMPAIRMENT Summary PDSS ratings of clinical severity vary significantly across the four 12-month panic subgroups (2 3 =34.3-102.9, P.001), with the highest ratings in the PD-AG subgroup (86.3% with moderate or severe rating, and 42.4% with severe rating) and the lowest in the PA-only subgroup (6.7% with moderate or severe rating, and 0.3% with severe rating) (Table 4). ReTable 2. Sociodemographic Correlates of 4 Mutually Exclusive Lifetime Panic Subgroups* Characteristic Odds Ratio (95% Confidence Interval) PA Only (n = 5172) PA-AG (n = 3572) PD Only (n = 3844) PD-AG (n = 3604) Age, y 18-29 1.0 1.0 1.0 1.0 30-44 1.0 (0.7-1.3) 1.6 (0.6-4.4) 1.5 (1.1-2.1) 1.7 (1.0-2.8) 45-59 0.9 (0.7-1.2) 1.7 (0.5-6.0) 1.3 (0.9-1.8) 1.3 (0.7-2.4) 60 0.4 (0.2-0.6) 0.5 (0.1-3.7) 0.4 (0.2-0.7) 0.1 (0-0.2) 2 29.2 4.0 24.2 35.5 Sex Male 1.0 1.0 1.0 1.0 Female 1.4 (1.2-1.7) 1.3 (0.8-2.3) 2.3 (1.8-3.0) 2.0 (1.3-3.2) 2 16.5 1.2 38.6 9.1 Race Hispanic 0.6 (0.4-0.8) 1.0 (0.3-3.2) 0.8 (0.5-1.3) 0.8 (0.3-2.1) Black 0.7 (0.5-0.8) 0.6 (0.3-1.5) 0.4 (0.3-0.6) 0.5 (0.2-1.0) Other 1.0 (0.6-1.5) 2.1 (0.6-7.0) 1.1 (0.6-2.0) 0.6 (0.2-1.9) White 1.0 1.0 1.0 1.0 2 27.7 2.5 23.5 5.1 Education, y 0-11 1.0 1.0 1.0 1.0 12 1.0 (0.7-1.3) 0.7 (0.3-1.7) 0.9 (0.6-1.3) 0.9 (0.4-2.1) 13-15 0.9 (0.7-1.2) 0.9 (0.4-2.0) 1.2 (0.8-1.9) 0.8 (0.3-1.9) 16 0.9 (0.7-1.2) 0.5 (0.2-1.5) 0.8 (0.5-1.2) 0.7 (0.3-2.1) 2 0.7 1.9 10.3 0.7 Marital status Married/cohabitating 1.0 1.0 1.0 1.0 Separated/widowed/divorced 1.1 (0.8-1.4) 2.2 (1.1-4.2) 1.6 (1.2-2.1) 1.3 (0.7-2.3) Never married 1.0 (0.8-1.2) 1.2 (0.5-3.2) 1.2 (0.8-1.8) 0.9 (0.4-2.0) 2 0.5 6.3 10.3 1.2 Employment status Working 1.0 1.0 1.0 1.0 Student 0.8 (0.5-1.4) 0.8 (0.2-3.5) 0.4 (0.1-1.4) 1.5 (0.5-4.9) Homemaker 0.8 (0.5-1.3) 2.0 (0.8-5.1) 1.1 (0.7-1.7) 1.3 (0.5-3.7) Retired 1.0 (0.6-1.5) 1.2 (0.2-6.6) 1.0 (0.5-1.9) 4.3 (1.6-11.3) Other 1.1 (0.9-1.5) 3.6 (1.8-7.1) 1.5 (1.0-2.2) 3.8 (2.1-6.8) 2 1.7 18.4 15.1 30.9 Annual family income Low 1.2 (0.9-1.6) 1.0 (0.5-2.3) 1.3 (0.9-2.0) 1.4 (0.6-3.2) Low-average 1.0 (0.8-1.2) 0.9 (0.4-2.0) 1.4 (0.9-2.1) 0.8 (0.4-1.7) High-average 1.2 (1.0-1.4) 0.7 (0.3-1.7) 1.3 (0.8-2.1) 0.9 (0.5-1.6) High 1.0 1.0 1.0 1.0 2 8.4 0.9 2.5 2.2 Abbreviations: AG, agoraphobia; PA, panic attack; PD, panic disorder; PA only, lifetime history of PA but not PD or AG; PA-AG, lifetime history of PA with AG but not PD; PD only, lifetime history of PD without AG; PD-AG, lifetime history of PD with AG. *Based on multivariate logistic regression analyses that separately compare respondents in each of the 4 panic subgroups with respondents who have no lifetime history of panic; the sample sizes differ because respondents in each of the 4 mutually exclusive panic subgroups (1672 PA only, 72 PA-AG, 344 PD only, and 104 PD-AG) are compared separately with the 3500 respondents who have no history of panic. Significant at the P.05 level, 2-sided test. (REPRINTED) ARCH GEN PSYCHIATRY/VOL 63, APR 2006 WWW.ARCHGENPSYCHIATRY.COM 419 ©2006 American Medical Association. All rights reserved. Downloaded From: http://archpsyc.jamanetwork.com/ on 04/10/2014 \f",
      "spondents in the PA-AG subgroup have higher PDSS ratings (45.3% with moderate or severe rating, and 20.2% with severe rating) than those in the PD-only subgroup (46.1% with moderate or severe rating, and 6.0% with severe rating). Summary SDS ratings of role impairment are similar to PDSS ratings in being highest in the PD-AG subgroup (95.0% with moderate or severe rating, and 84.7% with severe rating) and lowest in the PA-only subgroup (21.3% with moderate or severe rating, and 11.1% with severe rating). Unlike PDSS ratings, however, the PA-AG subgroup has lower SDS ratings (58.8% with moderate or severe rating, and 39.0% with severe rating) than the PDonly subgroup (76.8% with moderate or severe rating, and 56.2% with severe rating), although the modal rating is severe in all 3 subgroups other than in the PA-only subgroup. In the latter, the modal rating is no disability (70.6%). TREATMENT Most patients with PD obtained lifetime treatment for psychiatric problems, although somewhat more so among those with AG (96.1%) than without (84.8%) (Table 5). Lifetime treatment proportions are lower in the PA-AG (74.7%) and PA-only (61.1%) subgroups. The proportions that obtained panic-specific treatment are only slightly lower than overall treatment in the PD-only (70.3% vs 84.8%) and PD-AG (85.0% vs 96.1%) subgroups, but substantially lower in the PA-only (16.2% vs 61.1%) and PA-AG (37.6% vs 74.7%) subgroups. The most common site of treatment was the general medical sector in 3 of the 4 subgroups (32.3%-70.4%). The exception is PA-AG, in which nonmedical mental health treatment (46.1%) is slightly more common than general medical treatment (42.7%). As with lifetime treatment, the proportion of 12month cases that received treatment in the year before interview is highest in the PD-AG subgroup (72.6%), lowest in the PA-only subgroup (45.7%), and intermediate in the PA-AG (60.8%) and PD-only (66.9%) subgroups. Also similar to the lifetime treatment data, 12-month panic-specific treatment made up a higher proportion of all treatment in the PD-only (43.9% vs 66.9%) and PD-AG (52.7% vs 72.6%) subgroups than in the PA-only (14.7% vs 45.7%) and PA-AG (29.7% vs 60.8%) subgroups. Twelve-month treatment was obtained in the general medical sector more often than in any other sector in each Table 3. Comorbidities of 4 Mutually Exclusive Lifetime Panic Subgroups With Other DSM-IV Disorders* Disorder PA Only PA-AG PD Only PD-AG 2 3 Percentage OR (95% CI) Percentage OR (95% CI) Percentage OR (95% CI) Percentage OR (95% CI) Other anxiety disorders Generalized anxiety disorder 10.0 2.4 (1.7-3.2) 31.9 8.5 (4.9-14.6) 21.3 4.4 (2.9-6.8) 15.0 2.6 (1.4-4.8) 33.6 Specific phobia 21.0 2.4 (2.0-3.0) 73.7 24.0 (13.8-41.4) 34.3 3.8 (2.7-5.3) 75.2 25.8 (14.3-46.6) 153.8 Social phobia 18.8 1.9 (1.6-2.4) 65.5 16.6 (7.7-35.8) 31.1 3.1 (2.3-4.2) 66.5 15.5 (9.3-25.8) 82.4 Posttraumatic stress disorder 12.0 3.0 (2.3-3.9) 24.2 5.8 (2.3-14.6) 21.6 5.0 (3.4-7.5) 39.6 11.6 (6.8-19.7) 40.7 Obsessive-compulsive disorder 2.1 1.5 (0.5-4.3) 0 NA 8.2 5.4 (1.8-16.1) 19.6 20.2 (5.5-73.9) 20.8 Separation anxiety disorder 7.7 3.1 (2.3-4.0) 13.8 6.3 (2.7-14.5) 11.0 4.4 (2.6-7.5) 23.5 11.6 (7.1-19.0) 40.6 Any other anxiety disorder 45.0 3.2 (2.7-3.8) 94.9 77.9 (24.9-244.1) 66.0 7.2 (5.5-9.3) 93.6 56.2 (22.4-141.0) 143.7 Mood disorders Major depressive disorder 28.2 2.1 (1.8-2.4) 48.7 4.4 (2.6-7.4) 34.7 2.0 (1.5-2.7) 38.5 2.5 (1.5-4.0) 8.2 Dysthymia 5.0 3.2 (2.4-4.3) 10.0 5.0 (2.1-12.0) 9.6 5.0 (2.9-8.8) 14.6 8.9 (4.2-18.8) 6.9 Bipolar disorder I or II 7.1 2.8 (2.3-3.5) 15.5 5.1 (2.7-9.6) 14.4 5.4 (3.6-7.9) 33.0 13.6 (8.0-23.2) 52.3 Any mood disorder 36.0 2.5 (2.2-2.8) 64.2 7.1 (4.1-12.3) 50.0 3.3 (2.4-4.5) 73.3 10.0 (5.0-19.9) 35.3 Impulse-control disorders Attention-deficit/hyperactivity disorder 11.7 2.3 (1.6-3.3) 28.8 NA 13.0 2.6 (1.5-4.5) 36.2 NA 20.0 Oppositional defiant disorder 13.6 2.5 (1.8-3.5) 12.2 NA 13.0 2.4 (1.5-3.7) 27.6 NA 7.3 Conduct disorder 12.3 1.9 (1.4-2.6) 12.4 NA 21.7 4.2 (2.8-6.4) 22.5 NA 18.8 Intermittent explosive disorder 7.8 1.7 (1.3-2.2) 21.8 5.3 (2.4-11.6) 11.8 2.5 (1.4-4.4) 9.0 1.7 (0.8-3.6) 9.5 Any impulse-control disorder 33.7 2.3 (1.8-2.8) 63.2 NA 47.2 4.3 (2.8-6.6) 59.5 NA 24.6 Substance use disorders Alcohol abuse or dependence 19.3 2.2 (1.8-2.7) 27.0 3.2 (1.5-6.7) 25.0 3.5 (2.5-4.9) 37.3 5.6 (2.7-11.5) 11.5 Alcohol dependence 8.5 2.4 (1.8-3.2) 14.2 4.0 (1.6-9.7) 12.8 4.1 (2.6-6.3) 23.4 7.3 (3.0-17.6) 12.1 Illicit drug abuse or dependence 13.0 2.4 (1.8-3.0) 17.7 3.4 (1.6-7.3) 17.5 3.6 (2.3-5.4) 20.6 3.9 (2.1-7.2) 7.3 Illicit drug dependence 5.6 3.0 (2.0-4.4) 10.6 5.8 (2.1-16.0) 9.1 5.2 (3.1-8.7) 9.3 4.6 (1.9-10.9) 6.0 Any substance use disorder 21.4 2.2 (1.8-2.6) 31.4 3.5 (1.8-6.9) 27.0 3.3 (2.4-4.5) 37.3 4.8 (2.4-9.5) 9.8 Any disorder 71.9 3.3 (2.8-4.1) 100.0 NA 83.1 6.5 (3.7-11.7) 100.0 NA 5.3 Abbreviations: AG, agoraphobia; CI, confidence interval; NA, not applicable; OR, odds ratio; PA, panic attack; PD, panic disorder; PA only, lifetime history of PA but not PD or AG; PA-AG, lifetime history of PA with AG but not PD; PD only, lifetime history of PD without AG; PD-AG, lifetime history of PD with AG. *Based on a separate multivariate logistic regression equation for each row of the table in which dummy variables defining the 4 panic subgroups are used to predict lifetime occurrence of the comorbid disorder controlling for age at interview (in 5-year age intervals), sex, and race-ethnicity. The ORs compare respondents in each of the 4 panic subgroups with respondents who have no lifetime history of panic. Significant at the P.05 level, 2-sided test. Insufficient precision for estimation because of the low prevalence of PA-AG and PD-AG. (REPRINTED) ARCH GEN PSYCHIATRY/VOL 63, APR 2006 WWW.ARCHGENPSYCHIATRY.COM 420 ©2006 American Medical Association. All rights reserved. Downloaded From: http://archpsyc.jamanetwork.com/ on 04/10/2014 \f",
      "of the 4 subgroups (25.5%-46.0%). The proportions that obtained treatment consistent with basic treatment guidelines did not differ markedly across the 3 subgroups with PD or AG (40.6%-54.9%). Although treatment meeting basic guidelines was received by a substantially lower proportion of patients in the PA-only subgroup (18.2%), published treatment guidelines apply to PD and AG, not to isolated PAs. COMMENT These results should be interpreted in light of several limitations. First, the response rate was only 70%. As described in more detail elsewhere,15 we assessed this problem in a nonrespondent survey in which a subsample of initial nonrespondents was offered a large financial incentive ($100) to complete a short (15-minute) telephone interview that included CIDI diagnostic stem questions. No significant difference was found in panic stem question endorsement compared with responses in the main survey sample, indirectly arguing against large nonresponse bias on the basis of panic. Second, although good concordance with SCID PD diagnoses was found, no validity data were obtained for PA or AG. Third, possibly biased information about AOO, persistence, and other important course and treatment variables were obtained retrospectively. As described in more detail elsewhere,16 a number of strategies were used in the NCS-R to reduce recall bias. Evidence exists that these strategies improved the accuracy of retrospective AOO reports,30 but we have no data about effects on other aspects of recall. With these limitations as a backdrop, the NCS-R lifetime prevalence estimates of DSM-IV PD and PD-AG (4.7% and 1.1%, respectively) are similar to the DSM-III-R1 estimates in the baseline NCS (3.5% and 1.5%, respectively). The NCS-R estimate of PD-only prevalence (3.7%) is substantially higher than in the NCS (2.0%).2 Although higher than in earlier epidemiological surveys,31 the concordance of the NCS-R PD prevalence estimate with an independent SCID estimate argues against upward bias. In the case of AG, the concern is more with downward than upward bias because the CIDI requirement of anxiety about multiple situations is stricter than the DSM-IV requirement. Estimates of persistence, sociodemographic correlates, and psychiatric comorbidity are broadly consistent with the baseline NCS1,2,32 and other previous epidemiological surveys,14,31,33-35 although direct comparison is not possible because previous surveys did not disaggregate panic into the 4 subgroups considered here. High prevalence among women, low prevalence among the elderly, and strong comorbidity with other anxiety and mood disorders are all noteworthy consistencies with previous survey findings. One notable difference is a much higher estimated lifetime prevalence of PAs in the NCS-R (28.3%) than in the NCS (7.3%), a discrepancy presumably caused by the more detailed stem questions in the DSM-IV version of the CIDI than in the DSM-III-R version that suggests PAs were underestimated in the baseline NCS. We are aware of no previous general population research in which investigators compared the prevalence and correlates of isolated PAs vs PD with and without AG. The most striking results of this comparison are that isolated PAs are common and significantly comorbid with other DSM-IV disorders. These results are consistent with results from clinical studies.36,37 Most people with isolated PAs fail to meet PD criteria because they never had recurrent uncued attacks, although they typically had numerous cued attacks. Another notable subgroup result is that cued attacks are more common than uncued attacks even among people with PD. This finding is especially striking given that probing often uncovers initially unrecognized panic cues,38,39 which means that the NCS-R probably leads to underestimating the proportion of attacks that are cued. We also found that persistence and lifetime number of attacks are more strongly related to PD than to AG; that comorbidity, especially with other anxiety disorders, is more strongly related to AG than to PD; and that isolated PAs are associated with substantial role impairment when they occur in conjunction with AG. The subgroup results suggest that AG and PD are to some extent distinct, as about 40% of all respondents with PA and AG never met criteria for PD. This finding is consistent with family aggregation studies, which show that Table 4. Clinical Severity and Role Impairment Among Respondents in 4 Mutually Exclusive 12-Month Panic Subgroups Parameter Percentage (Standard Error) 2 3 PA Only (n = 701)* PA-AG (n = 37)* PD Only (n = 120)* PD-AG (n = 41)* Clinical severity Severe 0.3 (0.2) 20.2 (7.1) 6.0 (2.5) 42.4 (8.0) 34.3 Moderate 6.4 (0.8) 25.1 (7.9) 40.1 (4.8) 43.9 (10.1) 102.9 Mild 14.9 (2.0) 25.1 (5.6) 37.8 (5.7) 13.7 (4.5) 61.9 None 78.4 (2.2) 29.6 (8.3) 16.1 (4.4) 0 NA Impairment§ Severe 11.1 (1.1) 39.0 (7.9) 56.2 (5.0) 84.7 (5.3) 108.4 Moderate 10.2 (1.5) 19.8 (8.0) 20.6 (4.4) 10.3 (5.0) 119.8 Mild 8.1 (1.2) 11.7 (5.9) 13.8 (3.1) 5.0 (3.0) 62.9 None 70.6 (2.0) 29.4 (8.8) 9.4 (3.3) 0 62.9 Abbreviations: AG, agoraphobia; NA, not applicable; PA, panic attack; PD, panic disorder; PA only, lifetime history of PA but not PD or AG; PA-AG, lifetime history of PA with AG but not PD; PD only, lifetime history of PD without AG; PD-AG, lifetime history of PD with AG. *The number of respondents in each subgroup who reported 12-month prevalence does not equal the sample size in Table 1 multiplied by the estimate of 12-month persistence in that table because persistence is estimated on weighted data and the sample sizes report the actual numbers of (unweighted) cases. The original Panic Disorder Severity Scale categories of severe and very severe were collapsed to define the severe category reported here. Significant at the P.05 level, 2-sided test. §Responses to the 4 Sheehan Disability Scale questions (impairments in work, home, social, and personal relationship functioning) were combined by assigning respondents their most severe score across the 4. The original Sheehan Disability Scale categories of severe and very severe were collapsed to define the severe category reported here. Because the number of respondents with at least mild impairment is the additive inverse of the number with no impairment, the 2 3 value in this row is identical to the value in the preceding row. (REPRINTED) ARCH GEN PSYCHIATRY/VOL 63, APR 2006 WWW.ARCHGENPSYCHIATRY.COM 421 ©2006 American Medical Association. All rights reserved. Downloaded From: http://archpsyc.jamanetwork.com/ on 04/10/2014 \f",
      "risk of AG is significantly elevated among relatives of people with PA-AG40 and relatives of people with PD-AG compared with those with PD only.39,41 Family genetic studies also suggest that AG and PD may have at least some distinct pathogenic mechanisms.42,43 At the same time, our finding of higher conditional prevalence of AG among people with PD than PA is consistent with the strong association between AG and PD long observed in clinical settings. The subgroup results document monotonic increases from PA only to PD-AG in number of attacks, comorbidity, clinical severity, role impairment, and treatment seeking, with intermediate values for PA-AG and PD only. Together with the finding that a high proportion of AG is associated with PA, these results could be interpreted as suggesting that panic exists along a continuum in which PA and PD differ in degree rather than in kind. This interpretation is consistent with prior findings that infrequent, spontaneous PAs are common in the general population,41,42 that these attacks typically include fewer and less severe symptoms than those in patients with PD,43 and that infrequent PA aggregates with PD in families.40,44 The distinction between cued and uncued attacks might be called into question as part of this same line of thinking based on the view that most PAs are to some extent cued.37,45,46 It would be premature to conclude from these results that the boundary between PA and PD is arbitrary. Nevertheless, given the high prevalence of PA only and the negative outcomes associated with PA only, future researchmightprofitablyattempttostudyPAonlyandevaluate whether diagnostic criteria or symptom thresholds for PD should be modified to improve differentiation between pathological and normal panic experiences. An innovation of the NCS-R was the use of a fully structured version of the PDSS to assess clinical severity. Although lower than in clinical samples, 86.3% of respondents with PD-AG and 45.3% to 46.1% of those with PA-AG and PD only were in the clinically important range on the PDSS. A related finding is that clinical severity assessed in the PDSS and role impairment assessed in the SDS appear to be influenced nearly as much by AG (PA-AG vs PA only) as by PD (PD only vs PA only). This finding is consistent with prior findings that AG is associated with panic severity, anticipatory anxiety, and cognitive correlates of severity41,47-49 and our finding that AG is more common among people with PD than PA. Also consistent with this pattern is the higher average lifetime number of PAs among respondents with vs those without AG in both the PA and PD samples. One possible interpretation of this pattern is that AG is a severity marker of panic, although this is at least superficially inconsistent with the notion in previous paragraphs that AG is distinct from PD disorder. Another possibility is that AG has a direct effect on impairment. The treatment results are consistent with previous NCS-R reports that most people with PD eventually obtain treatment,23 that most active cases receive treatment in a given year,50 and that most current treatment (45%-60% across the 3 PD and/or AG subgroups) fails to meet basic treatment guidelines.50 The latter result is all the more striking in that our definition of treatment quality is liberal. For example, no distinction was made among psychotherapies despite much more evidence for the effectiveness of some types of psychotherapy than others in treating panic,51-53 nor was a distinction made among antidepressants or anxiolytics despite much more evidence for the effectiveness of some than others.54,55 In interpreting the finding that many patients fail to receive guideline-concordant treatment, some patients were so classified because they dropped Table 5. Lifetime and 12-Month Treatment of Respondents in 4 Mutually Exclusive Panic Subgroups Treatment Percentage (Standard Error) 2 3 * PA Only PA-AG PD Only PD-AG Lifetime treatment (n = 1672) (n = 71) (n = 344) (n = 105) Psychiatrist 24.2 (1.2) 39.4 (6.6) 37.9 (2.5) 58.4 (4.9) 58.5 Other mental health 26.5 (1.3) 46.1 (7.1) 38.0 (2.8) 48.1 (4.2) 32.7 General medical 32.3 (1.2) 42.7 (6.4) 56.0 (2.9) 70.4 (4.9) 88.1 Human services 15.1 (1.3) 26.6 (6.1) 17.6 (2.3) 16.5 (4.1) 4.7 Complementary-alternative 15.9 (1.0) 35.5 (7.1) 19.1 (1.9) 28.3 (4.7) 31.0 Panic-specific treatment 16.2 (1.2) 37.6 (6.6) 70.3 (2.8) 85.0 (4.3) 101.1 Any treatment 61.1 (1.3) 74.7 (5.4) 84.8 (1.8) 96.1 (1.7) 107.5 12-mo treatment (n = 701) (n = 36) (n = 120) (n = 42) Psychiatrist 12.1 (1.8) 21.6 (7.4) 27.2 (4.7) 34.6 (7.1) 24.7 Other mental health 15.2 (1.4) 21.1 (8.1) 28.7 (4.7) 41.0 (6.4) 33.8 General medical 25.5 (1.7) 30.6 (7.9) 46.0 (5.0) 45.1 (7.4) 25.1 Human services 8.5 (1.2) 21.6 (7.3) 12.7 (3.0) 14.3 (6.1) 7.7 Complementary-alternative 6.2 (1.0) 11.7 (5.7) 9.7 (3.0) 15.9 (5.8) 7.5 Panic-specific treatment 14.7 (1.4) 29.7 (8.9) 43.9 (4.5) 52.7 (7.3) 123.7 Any treatment 45.7 (2.4) 60.8 (8.4) 66.9 (4.6) 72.6 (6.5) 24.3 Guideline-concordant treatment 18.2 (1.7) 40.6 (9.0) 45.1 (5.0) 54.9 (6.3) 54.5 Abbreviations: AG, agoraphobia; PA, panic attack; PD, panic disorder; PA only, lifetime history of PA but not PD or AG; PA-AG, lifetime history of PA with AG but not PD; PD only, lifetime history of PD without AG; PD-AG, lifetime history of PD with AG. *This set of statistics tests the significance of the differences among the 4 percentages in each row. Significant at the P.05 level, 2-sided test. (REPRINTED) ARCH GEN PSYCHIATRY/VOL 63, APR 2006 WWW.ARCHGENPSYCHIATRY.COM 422 ©2006 American Medical Association. All rights reserved. Downloaded From: http://archpsyc.jamanetwork.com/ on 04/10/2014 \f",
      "out of treatment prematurely rather than because treatment providers delivered inappropriate care. Both problems need to be addressed in future practice-oriented research. Submitted for Publication: April 5, 2005; final revision received July 13, 2005; accepted September 15, 2005. Correspondence: Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115 (kessler@hcp.med.harvard .edu). Funding/Support: The National Comorbidity Survey Replication (NCS-R) is supported by grant U01MH60220 from the National Institute of Mental Health (NIMH), with supplemental support from the National Institute of Drug Abuse (NIDA), the Substance Abuse and Mental Health Services Administration, grant 044708 from The Robert Wood Johnson Foundation, and the John W. Alden Trust. Disclaimer: The views and opinions expressed in this report are those of the authors and should not be construed to represent the views of any of the sponsoring organizations, agencies, or US government. Additional Information: Collaborating investigators include Ronald C. Kessler (principal investigator, Harvard Medical School), Kathleen Merikangas (coprincipal investigator, NIMH), James Anthony (Michigan State University, East Lansing), William Eaton (The Johns Hopkins University, Baltimore, Md), Meyer Glantz (NIDA), Doreen Koretz (Harvard University, Cambridge, Mass), Jane McLeod (Indiana University, Bloomington), Mark Olfson (New York State Psychiatric Institute, College of Physicians and Surgeons of Columbia University, New York), Harold Pincus (University of Pittsburgh, Pittsburgh, Pa), Greg Simon (Group Health Cooperative, Seattle, Wash), Michael Von Korff (Group Health Cooperative), Philip Wang (Harvard Medical School), Kenneth Wells (University of California, Los Angeles), Elaine Wethington (Cornell University, Ithaca, NY), and HansUlrich Wittchen (Max Planck Institute of Psychiatry, Munich, Germany, and Institute of Psychology, Technical University Dresden, Dresden, Germany). A complete list of NCS publications and the full text of all NCS-R instruments is available at http://www.hcp.med.harvard .edu/ncs. Send correspondence to ncs@hcp.med.harvard .edu. The NCS-R is performed in conjunction with the World Health Organization World Mental Health (WMH) Survey Initiative. These activities were supported by grant R01 MH070884 from NIMH; the John D. and Catherine T. MacArthur Foundation; the Pfizer Foundation; grants R13-MH066849, R01-MH069864, and R01-DA016558 from the US Public Health Service; grant FIRCA R01TW006481 from the Fogarty International Center; the Pan American Health Organization; Eli Lilly and Company; Ortho-McNeil Pharmaceutical, Inc; GlaxoSmithKline; and Bristol-Myers Squibb. A complete list of WMH publications is available at http://www .hcp.med.harvard.edu/wmh/. Acknowledgment: We thank the staff of the WMH Data Collection and Data Analysis Coordination Centres for assistance with instrumentation, fieldwork, and consultation on data analysis. REFERENCES 1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19. 2. Eaton WW, Kessler RC, Wittchen HU, Magee WJ. Panic and panic disorder in the United States. Am J Psychiatry. 1994;151:413-420. 3. Sheikh JI, Leskin GA, Klein DF. Gender differences in panic disorder: findings from the National Comorbidity Survey. Am J Psychiatry. 2002;159:55-58. 4. Burke KC, Burke JD Jr, Regier DA, Rae DS. Age of onset of selected mental disorders in five community populations. Arch Gen Psychiatry. 1990;47:511-518. 5. Kessler RC. The prevalence of psychiatric comorbidity. In: Wetzler S, Sanderson WC, eds. Treatment Strategies for Patients With Psychiatric Comorbidity. New York, NY: John Wiley & Sons; 1997. 6. Kessler RC, Stang PE, Wittchen HU, Ustun TB, Roy-Byrne PP, Walters EE. Lifetime panic-depression comorbidity in the National Comorbidity Survey. Arch Gen Psychiatry. 1998;55:801-808. 7. Roy-Byrne PP, Stang P, Wittchen HU, Ustun B, Walters EE, Kessler RC. Lifetime panic-depression comorbidity in the National Comorbidity Survey: association with symptoms, impairment, course and help-seeking. Br J Psychiatry. 2000; 176:229-235. 8. Klerman GL, Weissman MM, Ouellette R, Johnson J, Greenwald S. Panic attacks in the community: social morbidity and health care utilization. JAMA. 1991; 265:742-746. 9. Markowitz JS, Weissman MM, Ouellette R, Lish JD, Klerman GL. Quality of life in panic disorder. Arch Gen Psychiatry. 1989;46:984-992. 10. Wittchen HU, Essau CA. Epidemiology of panic disorder: progress and unresolved issues. J Psychiatr Res. 1993;27(suppl 1):47-68. 11. Goodwin RD, Gotlib IH. Panic attacks and psychopathology among youth. Acta Psychiatr Scand. 2004;109:216-221. 12. Reed V, Wittchen HU. DSM-IV panic attacks and panic disorder in a community sample of adolescents and young adults: how specific are panic attacks? J Psychiatr Res. 1998;32:335-345. 13. Katschnig H, Amering M. The long-term course of panic disorder and its predictors. J Clin Psychopharmacol. 1998;18(6)(suppl 2):6S-11S. 14. Eaton WW, Anthony JC, Romanoski A, Tien A, Gallo J, Cai G, Neufeld K, Schlaepfer T, Laugharne J, Chen LS. Onset and recovery from panic disorder in the Baltimore Epidemiologic Catchment Area follow-up. Br J Psychiatry. 1998;173:501-507. 15. Kessler RC, Berglund P, Chiu WT, Demler O, Heeringa S, Hiripi E, Jin R, Pennell BE, Walters EE, Zaslavsky A, Zheng H. The US National Comorbidity Survey Replication (NCS-R): design and field procedures. Int J Methods Psychiatr Res. 2004; 13:69-92. 16. Kessler RC, Ustun TB. The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res. 2004;13:93-121. 17. Kessler RC, Abelson J, Demler O, Escobar JI, Gibbon M, Guyer ME, Howes MJ, Jin R, Vega WA, Walters EE, Wang P, Zaslavsky A, Zheng H. Clinical calibration of DSM-IV diagnoses in the World Mental Health (WMH) version of the World Health Organization (WHO) Composite International Diagnostic Interview (WMHCIDI). Int J Methods Psychiatr Res. 2004;13:122-139. 18. Kessler RC, Berglund P, Demler O, Jin R, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593-602. 19. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP). New York: Biometrics Research, New York State Psychiatric Institute; 2002. 20. Shear MK, Rucci P, Williams J, Frank E, Grochocinski V, Vander Bilt J, Houck P, Wang T. Reliability and validity of the Panic Disorder Severity Scale: replication and extension. J Psychiatr Res. 2001;35:293-296. 21. Houck PR, Spiegel DA, Shear MK, Rucci P. Reliability of the self-report version of the Panic Disorder Severity Scale. Depress Anxiety. 2002;15:183-185. 22. Leon AC, Olfson M, Portera L, Farber L, Sheehan DV. Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. Int J Psychiatry Med. 1997;27:93-105. 23. Wang PS, Berglund P, Olfson M, Pincus HA, Wells KB, Kessler RC. Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:603-613. 24. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Panic Disorder. Washington, DC: American Psychiatric Association Press; 1998. 25. Schatzberg AF, Nemeroff CB, eds. Textbook of Psychopharmacology. Washington, DC: American Psychiatric Publishing; 2004. (REPRINTED) ARCH GEN PSYCHIATRY/VOL 63, APR 2006 WWW.ARCHGENPSYCHIATRY.COM 423 ©2006 American Medical Association. All rights reserved. Downloaded From: http://archpsyc.jamanetwork.com/ on 04/10/2014 \f",
      "26. Halli SS, Rao KV, Halli SS. Advanced Techniques of Population Analysis. New York, NY: Plenum Publishing Corp; 1992. 27. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York, NY: John Wiley & Sons; 2000. 28. Wolter KM. Introduction to Variance Estimation. New York, NY: Springer-Verlag NY Inc; 1985. 29. SUDAAN. Professional Software for Survey Data Analysis. Version 8.0.1. Research Triangle Park, NC: Research Triangle Institute; 2002. 30. Kna ¨uper B, Cannell CF, Schwarz N, Bruce ML, Kessler RC. Improving the accuracy of major depression age of onset reports in the US National Comorbidity Survey. Int J Methods Psychiatr Res. 1999;8:39-48. 31. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lepine JP, Newman SC, Oakley-Browne MA, RubioStipec M, Wells JE, Wickramaratne PJ, Wittchen HU, Yeh EK. The cross-national epidemiology of panic disorder. Arch Gen Psychiatry. 1997;54:305-309. 32. Kessler RC. Epidemiology of psychiatric comorbidity. In: Tsuang MT, Tohen M, Zahner GEP, eds. Textbook in Psychiatric Epidemiology. New York, NY: John Wiley & Sons; 1995:179-197. 33. Joyce PR, Bushnell JA, Oakley-Browne MA, Wells JE, Hornblow AR. The epidemiology of panic symptomatology and agoraphobic avoidance. Compr Psychiatry. 1989;30:303-312. 34. Jacobi F, Wittchen HU, Holting C, Hofler M, Pfister H, Muller N, Lieb R. Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med. 2004;34:597-611. 35. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, de Girolamo G, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lepine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh-Bouchez S, Autonell J, Bernal M, Buist-Bouwman MA, Codony M, Domingo-Salvany A, Ferrer M, Joo SS, Martinez-Alonso M, Matschinger H, Mazzi F, Morgan Z, Morosini P, Palacin C, Romera B, Taub N, Vollebergh WA; ESEMeD/MHEDEA 2000 Investigators, European Study of the Epidemiology of Mental Disorders (ESEMeD) Project. 12-Month comorbidity patterns and associated factors in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl. 2004;420:28-37. 36. Barlow DH, Vermilyea J, Blanchard EB, Vermilyea BB, Di Nardo PA, Cerny JA. The phenomenon of panic. J Abnorm Psychol. 1985;94:320-328. 37. Craske MG. Phobic fear and panic attacks: the same emotional states triggered by different cues? Clin Psychol Rev. 1991;11:599-620. 38. Craske MG. Cognitive-behavioral approaches to panic and agoraphobia. In: Dobson KS, Craig KD, eds. Advances in Cognitive-Behavioral Therapy. Vol 2. Thousand Oaks, Calif: Sage Publications; 1996:145-173. 39. White KS, Barlow DH. Panic disorder and agoraphobia. In: Barlow DH, ed. Anxiety and Its Disorders: The Nature and Treatment of Anxiety and Panic. 2nd ed. New York, NY: Guilford Publications; 2002:328-379. 40. Crowe RR, Noyes R, Pauls DL, Slymen D. A family study of panic disorder. Arch Gen Psychiatry. 1983;40:1065-1069. 41. Rapee RM, Murrell E. Predictors of agoraphobic avoidance. J Anxiety Disord. 1988;2:203-217. 42. Wittchen H-U, Essau CA. The epidemiology of panic attacks, panic disorder, and agoraphobia. In: Walker JR, Norton GR, Ross CA, eds. Panic Disorder and Agoraphobia: A Comprehensive Guide for the Practitioner. Belmont, Calif: Brooks/ Cole; 1991:103-149. 43. Norton GR, Harrison B, Hauch J, Rhodes L. Characteristics of people with infrequent panic attacks. J Abnorm Psychol. 1985;94:216-221. 44. Norton GR, Dorward J, Cox BJ. Factors associated with panic attacks in nonclinical subjects. Behav Ther. 1986;17:239-252. 45. Bouton ME, Mineka S, Barlow DH. A modern learning theory perspective on the etiology of panic disorder. Psychol Rev. 2001;108:4-32. 46. Clark DM. A cognitive approach to panic. Behav Res Ther. 1986;24:461-470. 47. Craske MG, Barlow DH. A review of the relationship between panic and avoidance. Clin Psychol Rev. 1988;8:667-685. 48. Telch MJ, Brouillard M, Telch CF, Agras WS, Taylor CB. Role of cognitive appraisal in panic-related avoidance. Behav Res Ther. 1989;27:373-383. 49. Langs G, Quehenberger F, Fabisch K, Klug G, Fabisch H, Zapotoczky HG. The development of agoraphobia in panic disorder: a predictable process? J Affect Disord. 2000;58:43-50. 50. Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:629-640. 51. Otto MW, Deveney C. Cognitive-behavioral therapy and the treatment of panic disorder: efficacy and strategies. J Clin Psychiatry. 2005;66(suppl 4):28-32. 52. Westen D, Morrison K. A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapies. J Consult Clin Psychol. 2001; 69:875-899. 53. Milrod B, Busch F, Leon AC, Aronson A, Roiphe J, Rudden M, Singer M, Shapiro T, Goldman H, Richter D, Shear MK. A pilot open trial of brief psychodynamic psychotherapy for panic disorder. J Psychother Pract Res. 2001;10: 239-245. 54. Pollack MH. The pharmacotherapy of panic disorder. J Clin Psychiatry. 2005;66 (suppl 4):23-27. 55. Bakker A, van Balkom AJ, Stein DJ. Evidence-based pharmacotherapy of panic disorder. Int J Neuropsychopharmacol. 2005;8:473-482. (REPRINTED) ARCH GEN PSYCHIATRY/VOL 63, APR 2006 WWW.ARCHGENPSYCHIATRY.COM 424 ©2006 American Medical Association. All rights reserved. Downloaded From: http://archpsyc.jamanetwork.com/ on 04/10/2014 \f",
      "\n"
     ]
    }
   ],
   "source": [
    "for idx, row in df.iterrows():\n",
    "    print(len(row.NC), len(row.NER))\n",
    "    allText = row.rawContent.split(sep=\" \")\n",
    "    for i in row.NER:\n",
    "        print(allText[i[2]-1:i[3]-1], i[0])\n",
    "#         allText[i[2]-1:i[3]-1] = [\"<NER>\"]\n",
    "#         print(row['doc'][i[2]:i[3]])\n",
    "#         break\n",
    "    print(\" \".join(allText))\n",
    "#     print(row['doc'][i[2]:i[3]])\n",
    "    break"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "NLP",
   "language": "python",
   "name": "nlp"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
